The characterisation of Plc1 : a phospholipase C enzyme identified in the fission yeast Schizosaccharomyces pombe by Brind, Robert Ian
University of Warwick institutional repository: http://go.warwick.ac.uk/wrap
A Thesis Submitted for the Degree of PhD at the University of Warwick
http://go.warwick.ac.uk/wrap/4018
This thesis is made available online and is protected by original copyright.
Please scroll down to view the document itself.
Please refer to the repository record for this item for information to help you to
cite it. Our policy information is available from the repository home page.
The characterisation of Plcl: 
phospholipase C enzyme identiried in the fission yeast 
Schizosaccharomycespombe 
A thesis submitted to 
The University of Warwick 
For the degree of 
Doctor of Philosophy 
Robert Ian Brind 
Dept. Biological Sciences 
The University of Warwick 
February 2000 
Table of contents 
Chapter I General Introduction 
....................................................................... 15 
1.1 Cellular communication ............................................................................... 16 
1.2 phosphoinositide metabolism and its cellular roles ..................................... 17 
1.2.1 Enzymes involved in the synthesis of phosphoinositicles .................... 
19 
1.2.1.1 Phosphaticlylinositol 3-kinase 
.......................................................... 
19 
1.2.1.2 Phosphatidylinositol-4-phosphate 5-kinase 
.................................... 
20 
1.2.1.3 Inositol polyphosphate 5-phosphatase ............................................ 
21 
1.2.1.4 Inositol 1,4,5-P3 3-kinase 
................................................................ 
22 
1.2.1.5 Inositol polyphosphate I -phosphatase ............................................ 
22 
1.2.1.6 Inositol monophosphatase ............................................................... 
23 
1.2.1.7 Inositol polyphosphate 3-phosphatase ............................................ 
23 
1.2.1.8 Phosphatidylinositol transfer protein .............................................. 
23 
1.2.2 The roles of phosphatidylinositols in cells ............................................... 
25 
1.2.2.1 Phosphatidylinositol 3-phosphate 
................................................... 
25 
1.2.2.2 Phosphatidylinositol 3,5-bisphosphate 
............................................ 
25 
1.2.2.3 Phosphatidylinositol 3,4,5-trisphosphate ........................................ 
27 
1.2.2.4 Phosphatidylinositol 4,5-bisphosphate ............................................ 
27 
1.2.3 The roles of inositol-polyphosphates in cells ...................................... 
30 
1.2.3.1 Inositol 1,4,5-trisphosphate 
............................................................. 
30 
1.2.3.2 Inositol 1.3,4,5-tetrakisPhosphate ................................................... 
32 
1.2.3.3 Inositol hexakisphosphate ............................................................... 
33 
1.3 Phospholipase C ............................................................................................. 
34 
1.3.1 The structure of PLCs ............................................................................ 34 
1.33.1.1 The X and Y Catalytic Domain ....................................................... 36 
1.3.1.2 The pleckstrin homology domain .................................................... 36 
1.3.1.3 The C2 domain ................................................................................ 
38 
1.3.1.4 The EF domain ................................................................................ 39 
1.3.2 The regulation of the PLC isozymes ...................................................... 40 
1.3.2.1 Regulation of mammalian PLC-p ................................................... 40 
1.3.2.2 Regulation of PLC-7 isozymes ......................................................... 43 
1.3.2.3 Regulation of PLC-6 isozymes ........................................................ 46 
1.4 Phospholipase C in yeast .............................................................................. 49 
1.4.1 The identification of PLC I in S. cerevisiae ......................................... 49 
1.4.2 The identification of Plc I in Sz. pombe ............................................... 54 
Chapter 2 Materials and Methods .................................................................... 57 
2.1 Materials ....................................................................................................... 
58 
2.1 .1 
General laboratory reagents ................................................................. 58 
2.1 .2 
Molecular biology reagents .................................................................. 58 
2.1 .3 
ElectrophoresiS reagents ....................................................................... 
58 
2.1 .4 
Determining Protein concentrations ..................................................... 58 
2.1 .5 
Photographic Supplies .......................................................................... 
59 
2.1 .6 
Radioisotopes ....................................................................................... 
59 
2 
2.1.7 Determining cell volumes .................................................................... 
59 
2.1.8 Scintillation counting ........................................................................... 
59 
2.1.9 Growth media ....................................................................................... 
60 
2.1.9.1 Selective Medium (a. a. ) ................................................................. 60 
2.1.9.2 DMM .............................................................................................. 
61 
2.1 AI Yeast strains ....................................................................................... 63 2.2 Methods 
........................................................................................................ 64 
11.1 General molecular biology techniques ................................................. 64 2.2.1 
.1 Cloning techniques .......................................................................... 64 ". 11 .2 Transformation of Escherichia coli ................................................ 64 2.2.1 .3 Polymerase 
Chain Reaction ............................................................ 64 2.2.1 .4 Transformation of Yeast cells ......................................................... 65 2.2.1 .5 Double-stranded DNA sequencing ................................................. 66 2.2.1 .6 Preparation of genomic DNA .......................................................... 67 2.2.1 .7 Southern Blot analysis ..................................................................... 67 2.2.2 Assaying Plc I activity in vitro ............................................................ 67 2.2.2 
.1 
Production of crude yeast extract used for Plc I assay .................... 
67 
.... .2 PLC assay ......................................................................................... 
68 
2.2.3 Growing cells on microscope slides ..................................................... 69 
2.2.4 Expression of Plcl in ApIcI strains ...................................................... 69 
2.2.5 Statistical treatment of data .................................................................. 
70 
Chapter Xonstructs .......................................................................................... 71 
3.1 Constructs containing modified versions of the p1c] gene ........................... 72 
3.1.1 General information applying to all modifications of the p1c] gene 
introduced by PCR ........................................................................................... 
72 
3.1.2 Expression vectors ................................................................................. 
72 
3.1.3 Constructs ............................................................................................... 
72 
3.1.3.1 Fusing the HIS6 tag to p1c] ............................................................... 72 
3.1.3.2 Cloning a truncated form of p1c] to improve PCR efficiency ......... 73 
3.1.3.3 The mutagenesis of lysine 582 ......................................................... 73 
3.1.3.4 The mutagenesis of arginine 693 ..................................................... 73 
3.1.3.5 The use of overlapping PCR to mutagenise arginine 873 and glycine 
481 .......................................................................................................... 
73 
3.1.3.6 Cloning of Rat PLC-6 ...................................................................... 
74 
3.1.3.7 Producing a truncated form of p1c] .................................................. 74 
3.1.3.8 Fusing the N-terminus of p1c] to Rat PLC-6 ................................... 
74 
3.1.3.9 Expressing the N-terminal domain of Plc I ...................................... 75 
Results ................................................................................................................. 
92 
Chapter 4 Disruption of plcl ............................................................................. 
93 
4.1 Introduction ................................................................................................... 
94 
4.1.1 Creation of the plcl. -. -ura4+ disruption construct ................................. 95 
4.1.2 Southern blot analysis ofplcl. -. -ura4+ disruptants ............................... 95 
4.2 Characterisation of ApIcI cells ..................................................................... 98 
3 
4.2.1 The disruption of p1c] affects the growth rate of cells in rich and 
minimal media .................................................................................................. 
98 
4.2.2 Expression of Plcl in vivo .................................................................. 102 
4.2.3 Determining the cellular phenotype of ApIcI cells ............................ 
104 
4.3 Summary .................................................................................................... 
106 
Chapter 5 The characterisation of Plel ......................................................... 
107 
5.1 Introduction ................................................................................................ 
108 
5.1.1 An assay to determine the activity of Plc I ......................................... 
108 
5.1.2 The pREP expression vectors ............................................................. 
109 
5.1.3 Expressing Plc I in Sz. pombe ............................................................. 
109 
5.1.4 Expression of Plc I containing the Hexahistidine-tag ........................ 
112 
5.2 Possible substrate mixtures for Plcl .......................................................... 
115 
5.2.1 Phosphatidy1choline and Phosphatidylethanolamine ......................... 
115 
5.2.2 Dodecylmaltoside and sodium cholate ............................................... 
117 
5.3 Optimising the conditions for Plc I activity ............................................... 
119 
5.3.1 A precise ratio of sodium cholate to PIP2 is necessary for Plc I activity. 
............................................................................................................ 
119 
5.3.2 Plc I activity is dependent upon temperature ..................................... 
121 
5.3.3 Plc I activity is affected by pH ........................................................... 
124 
5.4 Summary of the characterisation of Plc I ................................................... 
127 
Chapter 6 Investigating the role for Plcl signalling in Sz. pombe ............... 
128 
6.1 Introduction ................................................................................................ 
129 
6.1.1 The role of Plc I might be discovered through controlled expression 129 
6.1.2 Using S. cerevisiae PLC I as a model ................................................. 
130 
6.2 Expression of the temperature sensitive mutants in vitro .......................... 
132 
6.2.1 Plc I mutants are more sensitive to temperature when assayed in vitro ... 
........................................................................................ 
132 
6.2.2 Preparation of the extract is vital in producing functional Plc I mutants. 
............................................................................................................ 
136 
6.3 Expression of the Plc I mutants in vivo ...................................................... 
139 
6.3.1 Cell growth is not dependent upon the expression levels tested ........ 139 
6.3.2 In vivo growth assays ......................................................................... 
140 
6.4 Cells lacking Plcl display a very distinct phenotype ................................. 
144 
6.5 Summary .................................................................................................... 
146 
Chapter 7 IdentifYing the possible substrates for Pld ................................. 
147 
7.1 Introduction ................................................................................................ 
148 
7.1.1 Mammalian PLCs are able to hydrolyse PIP2, PIP and PI ................. 
149 
7.1.2 The substrate of Plc I .......................................................................... 
149 
7.2 The active site of phospholipase C ............................................................. 
152 
7.2.1 Precise amino acid configuration within the active site is essential for 
PLC activity ................................................................................................... 
152 
4 
7.2.2 Amino acid chan2e and shane is imoortant for Plc I activitv ............. 155 7.3 Determining the hydrolysis activity of the active site mutants in vitro ..... 157 
7.4 Expression of the active site mutants in vivo ............................................. 160 
7.5 Summary 
.................................................................................................... 163 
Chapter 8 Investigating the N-terminal domain of Plcl ............................... 164 
8.1 Introduction 
................................................................................................ 165 
8.1.1 The regulation of mammalian PLCs .................................................. 165 
8.1.1.1 The regulation of PLC- P .............................................................. 165 
8.1.1.2 The regulation of PLC-y ............................................................... 165 
8.1.1.3 The regulation of PLC-6 .............................................................. 166 8.1.2 The N-terminus of yeast PLCs ........................................................... 166 8.1.3 The N-terminus of Sz. pombe Plc I ..................................................... 167 8.2 Plcl truncations .......................................................................................... 169 
8.2.1 Removal of the N-terminus results in a PLC structurally more similar to 
PLC-6 
................................................................................................................ 169 
8.2.2 Expressing the N-terminus ofk. pombe Plcl .................................... 169 
8.2.3 Expressing Rat PLC-6 in Sz., pombe cells .......................................... 170 
8.2.4 Fusion of the Plc I N-terminus to PLC-6 results in a mammalian PLC 
structurally similar to Sz. pombe .................................................................... 170 
8.3 Activity of the N-terminal domain mutants in vitro ................................... 172 
8.4 Expression of the N-terminal mutants in vivo ............................................ 175 
8.5 Summary .................................................................................................... 
178 
Chapter 9 Discussion ....................................................................................... 
179 
9.1 Overview .................................................................................................... 
180 
9.2 Regulation of Ple I ...................................................................................... 
180 
9.2.1 The N-terminus may be a site for Plc I regulation ............................. 180 
9.2.2 14-3 -3 proteins interact with the N-terminus of Plc I ......................... 
181 
9.2.3 [Ca 2+] might play a role in regulating Plc I activity ........................... 182 
9.2.4 Growth conditions that might regulate Plc I activity .......................... 182 
9.3 Pathways which may require Plc I activity ................................................ 184 
9.3.1 Plc I activity may be required for IP6 production ............................... 184 
9.3.2 Plc I is part of a complex that is involved in UV resistance ............... 185 
9.3.3 DAG may stimulate PKC in Sz. pombe ............................................. 186 
9.4 Summary .................................................................................................... 
187 
References .......................................................................................................... 
191 
Appendix ............................................................................................................ 
215 
5 
Illustrations 
Figures: 
1. The metabolism of phosphatidylinositols and inositol 
polyphosphates 18 
2. The metabolism of phosphatidylinositols in cell 26 
3. The role of Ptdlns 4,5-P2 in exocytosis 29 
4. The metabolism of polyphosphate inositols in cells 31 
5. The reaction catalysed by phospholipase C 35 
6. The structure of PLCs 37 
7. Activation of PLC-P 42 
8. Regulation of PLC-7 45 
9. Regulation of PLC-6 48 
10. A model suggesting the possible regulatory function of PLCI 53 
11. Comparing the structure of PLC-6 to PLC I and Plc 1 55 
12. Introducing a HIS6 tag on to the N-terminus of Plc 1 75 
13. Introducing a HiS6 tag on to the C-terminus of Plc 1 77 
14. Removing the central Ncol portion of p1c] for inverse PCR 78 
15. Replacing the lysine at position 582 with arginine 79 
16. Replacing the lysine at position 582 with alanine 80 
17. Replacing the arginine at position 582 with lysine 81 
18. Replacing the arginine at position 693 with leucine 82 
19. Replacing the arginine 873 with cysteine 83 
20. Replacing the glycine 481 with serine 85 
21. The cloning of Rat PLC-6 into the pREP3x vector 87 
22. Construction of p1c] without the N-terminal fragment 88 
23. Exchanging the domains between Sz. pombe p1c] and 
Rat PLC-6 89 
24. Amplification of the N-terminal domain of p1c] 91 
25. Southern blot analysis of ApIcI strains 97 
26. Growth rate of ApIcl in rich medium (YEALU) 100 
27. Growth rate of ApIcI in minimal medium (DMM) 101 
28. Expression of Plcl in vivo 103 
6 
29. Phenotype of ApIc] cells 105 
3 0. Activity levels of pREPp1c] in M and P cells 
3 1. Determining the activity of HiS6PIC I and Plc I HIS6 114 
32. The chemical structures of PC and PE 116 
33. Possible substrate mixtures for Plc 1 118 
34. Identifying the optimum sodium cholate concentration when 
assaying Plc I activity in vitro 120 
35. The temperature profile of Plcl 122 
36. pH profile of Plc 1 125 
37. Comparisons of the amino acid sequence in eukaryotic PLCs 131 
38. The temperature profile of Plc I [R873C] 134 
39. The temperature profile of Plc I [G481 S] 135 
40. Expression of the Plc I and the pREP vectors in ApIcI cells 141 
4 1. Expression of the Plc I mutants in vivo 142 
42. Growth assays 143 
43. Phenotype of the temperature sensitive mutants 145 
44. Comparison of the amino acid sequences within the X and Y 
regions of eukaryotic PLCs 151 
45. The active site of PLC-6 154 
45. The amino acid replacements carried out in the active site 
of PIC 1 156 
47. Activity of the active site mutants in vitro 159 
48. Expression of the active site mutants in vivo 162 
49. The structure of eukaryotic PLCs 168 
50. Constructs which may help identify the role of the Plcl 
N-terminus 171 
5 1. Determining the activity of the PLCs and their mutants 
in vitro 174 
52. Expression of the N-terminus mutants in vivo 177 
53. A summary of the possible PlcI responses in Sz. pombe 189 
7 
List of Tables 
Tables: 
1. Determining the nature of temperature inhibition 123 
2. Control assays to determine Plc I activity using different buffers 126 
3. Determining the nature of pH inhibition 126 
4. Demonstrating cellular growth temperature is vital in 
producing functional Plc I mutants 138 
8 
Acknowledgments 
I would like to say thank you to: 
John Davey for his supervision, 
Kevin Davis for all his advice on how to cook lovely food but I still went home 
to cook marmite on toast or bean feast, 
Graham Ladds for all his help and advice even though he supports Manchester 
United, 
Pete Watson for introducing me to the harsh realities of life (ohh why don't you 
like me Peter?? ), 
Mark (Didbot- every body calls you that) Didmon for being a great friend over 
the past 5 years, ahh just one year out!!, 
Cassandra Pateman for all her special cuddles, 
Panom Winyayong for teaching me how to say cheeky egg in Thai, 
Dale Powner for turning me into a beer monster, 
Mark Saxon for being a Chandler like figure when I had my Joey Tribbiani 
moments and for being a complete sadist in the gym when it came to doing abs 
sets,, 
Mark Rapson for introducing me to Jim and Spence, the world goes on standby 
when they get together!!, 
and Tracey Knott for her molecular biology help in the first 12 months. 
A special thanks to Clive and Carole Brind for all their help and support over 
the past 4 years and always believing in my ability. 
A special thanks to Vicky Lamberton without her I'm not sure that I would have 
survived the last 18 months. 
Thank you to S. G. Rhee who provided the clone of Rat PLC-61 
Thank you, to the BBSRC for their funding without it none of this would have 
been possible. 
9 
Declaration 
I hereby declare that the work described in this thesis was conducted by myself 
under the supervision of Dr John Davey with the exception of those instances 
where the contributions of others has been specifically acknowledged. 
None of the information contained herein has been used in any previous 
application for a degree. 
All sources of information have been specifically acknowledged by means of a 
reference. 
Robert Ian Brind 
10 
Abstract 
The p1c] gene product (Pic I) of the fission yeast Schizosaccharomycespombe 
(S.:. pombe) encodes a phosphoinositide-specific phospholipase C (PLC) and 
most closely resembles the 6 class of the PLC isozymes. PLC hydrolyses 
phosphatidylinositol 4,5-bisphosphate (PIPA producing two second messengers, 
inositol 1,4,5-trisphosphate (InsP3) and diacylglycerol (DAG). The work in this 
thesis is concerned with aspects of PLC signalling in Sz. pombe cells. 
S--- pombe cells lacking p1c] (ApIcl) display a distinct phenotype. Aplcl cells are 
viable they grow slowly at 29'C (and below) on rich medium, but are unable to 
grow under stressful conditions such as on minimal medium or at 37T. Loss of 
Plc I function has been shown to cause missegregation of chromosomes and 
enlarged cells with aberrant morphology (Fankhauser et al. 1995). Expression of 
Plc I in Aplcl cells complemented for the loss of Plc I and resulted in a wild-type 
Sz. pombe phenotype. 
Described in this thesis are the characterisation experiments carried out on Pic I. 
Extracts prepared from wild-type Sz. pombe cells have undetectable Pic I activity, 
so an assay was designed, to measure Pic I activity in vitro. The in vitro assay 
and expression of Pic I in ApIcl cells formed the basis of a set of experiments 
that helped identify a possible regulatory domain and roles for Pic I in Sz. pombe 
cells. Mutant forms of Pic I were assayed in vitro to determine their level of 
activity and were then expressed in ApIcI cells to see if they were able to 
complement for the loss of Pic I activity. 
Temperature sensitive mutants of Ple I were constructed. This illustrated what 
happened to a Sz. pombe cell with an active Plc I at 23'C but when incubated at 
37'C Plcl activity is switched off. This demonstrated that cells lacking Plcl 
activity could no longer divide and defects in cell wall structure began to appear. 
Active site mutants of Plc I were produced to identify whether InSP3 or DAG are 
important second messengers in Sz. pombe cells. The Plc I mutants were unable 
to hydrolyse PIP2 but could hydrolyse phosphatidylinositol (PI). These mutants 
hydrolyse PI producing DAG and InsP and were able to rescue the ApIcI 
phenotype. This suggests that DAG production may play an important role in 
regulating stress response pathways whereas InsP is recycled to produce 
phosphatidylinositols. 
Yeast PLCs have an extended N-terminal domain, which is not seen in any other 
eukaryotic PLCs. To investigate the role of this N-terminal domain, mutants of 
Plc I and PLC-6 were constructed. They demonstrated that without the N- 
terminus these mutants were active in vitro but were unable to complement for 
the loss of Plcl activity in ApIcI cells. This indicates that the N-terminal domain 
may play an important regulatory role. 
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1.1 Cellular communication 
Signal transduction is the process by which cells communicate, regulating their 
growth, development, and co-ordinating their functions. Extracellular molecules 
are released by particular cell types and are recognised by membrane-bound 
receptors. This subsequently results in the activation of an intracellular signal. 
The large number of stimuli that higher eukaryotic cells are exposed to makes the 
study of cellular communication in vivo difficult. So one alternative is to study 
signalling in organisms with less elaborate communication pathways. Signalling 
in the genetically tractable fission yeast Schizosaccharomycespombe (Sz. pombe) 
has been well characterised and provides a simpler model to study cell 
communication. Phosphatidylinositol-specific phospholipase C (PLC) is an 
important part of cell signalling as it generates two second messengers which 
have many functions. Sz. pombe contains a PLC and therefore makes this an 
ideal organism to elucidate the role of PLC in yeast and it may give insights into 
alternative roles of PLCs in higher eukaryotes. 
This general introduction will consider phosphatidylinositols, how they are 
synthesised, and their role within eukaryotic cells. It will discuss the structure of 
mammalian PLC isoforms, how they are regulated and will introduce what is 
known about the structure and function of yeast PLCs. 
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1.2 phosphoinositide metabolism and its cellular roles 
Phosphoinositides and their role within cell membranes was first observed by 
Hokin and Hokin (1955). This led to the discovery that phosphoinositides are 
actively metabolised and undergo accelerated turnover when cells are stimulated 
by various agonists. The metabolism of phosphoinositides and their role in 
signal transduction has therefore been extensively studied. The current 
understanding of phosphoinositide-mediated metabolic pathways is summarised 
in Figure 1. This section will be concerned with discussing the roles of these 
different phosphoinositides, the different enzymes involved in their synthesis, 
and finally the regulators of these enzymes. 
The major phosphoinositides that are present within resting cells are 
phosphatidyl inositol (Ptdlns), phosphatidylinositol 3-phosphate (Ptdlns 3-P), 
phosphatidylinositol 4-phosphate (PtdIns 4-P) and phosphatidylinositol 4,5- 
bisphosphate (Ptdlns 4,5-P2). These phosphoinositides are maintained in 
equilibrium by a number of kinases and phosphatases. 
Perhaps the best characterised signal transduction pathway involving 
phosphoinositide turnover is the activation of phosphatidylinositol-specific 
phospholipase C (PLC) (PLC is discussed in detail in section 1.3). Extracellular 
agonists binding to receptors at the cell surface eventually result in the activation 
of PLC. Once activated PLC is able to hydrolyse PtdIns, PtdIns 4-P and PtdIns 
4,5-P2 generating two second messengers diacylglycerol (DAG) and soluble 
inositol phosphates. These include mositol I -phosphate (Ins I -P), inositol 1,4- 
bisphosphate (Ins 1,4-P2) and inositol 1,4,5-tris phosphate (Ins 1,4,5-P3) 
respectively. Once these second messengers have performed their function, they 
are recycled by a series of kinases, phosphatases and phosphatidylinositol 
synthase to synthesise PtdIns, PtdIns 4-P and PtdIns 4,5-P2- 
17 
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Figure 1 The metabolism of phosphatidylinositols and inositol polyphosphates 
A diagram demonstrating that phosphatidylinositol metabolism takes place in the lipid 
bilayer and inositol polyphosphate metabolism takes place within the cytosol. The link 
between these two different pathways is phospholipase C whose catalytic action (green 
arrows) results in the breakdown of phosphatidylinositols into inositol polyphosphates 
and diacylglycerol (DAG). The blue writing indicates kinase action whereas red 
writing indicates phosphatase action. 
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1.2.1 Enzymes involved in the synthesis of phosphoinositides 
1.2.1.1 Phosphatidylinositol 3-kinase 
The substrates for phosphoinositide 3-kinase (PI 3-K) are PtdIns, PtdIns 4-P and 
PtdIns 4,5-P2. PI 3-K phosphorylates the 3-position on the inositol ring resulting 
in PtdIns 3-P, PtdIns 3, +P2 and PtdIns 3,4,5-P3 respectively. PI 3-K has been 
purified from a number of sources (Otsu, et al., 199 1; Gout, et al., 1992). It 
consists of two types of subunits with molecular weights of 85kDa and II OkDa. 
The 85kDa subunit interacts with phosphotyrosine residues in activated growth 
factor receptors and with tyro s ine-pho sphoryl ated substrates of receptor tyrosine 
kinases. The I 10 kDa subunit is thought to be the catalytic subunit (Gout et al., 
1992). It would seem therefore, that the 85 kDa subunit brings the I 10 kDa 
subunit into close apposition to activated tyrosine kinases. VPS34 is a gene in 
yeast that was found to encode a PI 3-K (Schu et al., 1993). Experiments carried 
out on mammalian cells using the PI 3-K inhibitor wortmannin have 
demonstrated that fluid uptake is affected and recycling of transmembrane 
receptors is reduced suggesting that this enzyme is required for these functions 
(Clague et al., 1995; Shepherd et al., 1995; Li et al., 1995). Yeast VPS mutants 
encode proteins that are involved in sorting and delivery of soluble hydrolases 
from the Golgi to the vacuole (Stack (i) et al., 1995). VPS34 is found in a 
complex with a serine threonine kinase VPS 15 that associates with the Golgi 
complex and endosomal membranes (Stack (ii) et al., 1995). The function of 
VPS 15 is to activate and recruit VPS34 to the appropriate membrane site (Stack 
(ii) et al., 1995). One possible function of PtdIns 3-P production at locallsed 
membrane areas is that it may promote vesicle coat proteins which might 
catalyse transport reactions (Stack (i) et al., 1995). This suggests that PI 3-K and 
its metabolites have the same function as important regulators of vesicular traffic 
in both mammalian and yeast cells. 
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1.2.1.2 Phosphatidylinositol-4-phosphate 5-kinase 
The enzymes that produce PtdIns 4,5-bisphosphate in vitro fall into two related 
subfamilies, type I and type 11 phosphatidylinositol-4 phosphate 5-kinase (PIP- 
5K), based upon their sequence similarity and enzymatic properties (Loijens et 
al.,, 1996). It was Previously thought that Ptd1ns 4,5-P2 was created by first 
producing PtdIns 4-P from Ptd1ns using phosphatidylinositol 4-kinase (PI-4K) 
and then phosphorylating the 5 position of the inositol ring by PIP-5K. As 
predicted, type I PIP5-K does phosphorylate the 5 position of the inositol ring but 
surprisingly the type I PIP5-K also phosphorylates the PtdIns at the 4 position of 
the inositol ring (Rameh et al., 1997). Furthermore reports have indicated that 
type I and Type 11 PIP 5-K can phosphorylate PtdIns 3-P at position 4, producing 
PtdIns 3,4-P2 (Zhang et al., 1997). PtdIns 3,4-P2 is not a substrate for type 11 PIP 
5 -K but Zhang and Maj erus (199 8) indicated that PtdIns 3,4,5 -P3 may form 
directly from PtdIns 3-P without the intermediate (PtdIns 3,4-P2) dissociating 
from the enzyme. The type I PIP 5-K can phosphorylate PtdIns 3,4-P2 to give 
PtdIns 3,4,5-P3, but it can also synthesise PtdIns 3,4,5-P3 directly from PtdIns 3- 
P in a concerted effort (Zhang and Majerus, 1998). Other reports have 
demonstrated that type I PIP 5-K converts Ptd1ns 3-P into PtdIns 3,5-P (Dove et 
al., 1997). Large quantities of the type 11 PIP5-K is found in certain tissues 
including brain, blood cells and platelets (Ling et al., 1989; Borenenkov and 
Anderson, 1995; Hinchcliffe et al., 1996), suggesting that PtdIns 4,5-P2 produced 
by this alternative way may be important in several different cell types. Type 11 
PIP 5-K isolated from platelets, associates with the cytoskeleton and PIP 5-K 
alters the protein conformation in response to thrombin, indicating that type 11 
PIP 5-K activity may be regulated by various signal transduction pathways 
(Hinchcliffe et al., 1996) 
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1.2.1.3 Inositol polyphosphate 5-phosphatase 
Inositol polyphosphate 5-phosphatase (5-Pase) hydrolyses the 5-position of the 
inositol ring. Seven mammalian 5-Pases have been identified and they can be 
categorised into four groups. 
Group I only hydrolyse the soluble Ins 1,4,5-P3 and Ins 1,3,4,5-P4 and the most 
likely function of this enzyme is to terminate signals transmitted by these second 
messengers (Laxminarayan et al., 1993). 
Group 11 5-Pase hydrolyse the four substrates Ins 1,4,5-P3, Ins 1,3,4,5-P4, Ptd1ns 
4.5-P2 and PtdIns 3,4,5-P3. A particular group II 5-Pases is deficient in patients 
suffering from a human disorder known as oculocerebrorenal syndrome of Lowe 
(OCRL). This affects the eye lens, brain and kidneys (Atree et al., 1992). The 
OCRL group Il 5-Pase prefers the lipid substrate PtdIns 4,5-P2 (Zhzng and 
Majerus., 1998). Another group 11 5-Pase is synaptojanin that functions in 
synaptic vesicle trafficking (McPherson et al., 1996). Synaptojanin may function 
with dynamin and amphiphysin. Dynamin is a GTPase that participates in 
recycling of synaptic vesicles membranes and amphiphysin co-localises with 
dynamin in nerve terminals (McPherson et al., 1994; McPherson et al 1996). In 
synaptic vesicle endocytosis is regulated by the amounts of specific PtdIns 
metabolites (Camilli et al., 1996). 
Group III enzymes include two tyrosine-phosphorylated 5-Pases, SIP- I 10 and 
SHIP-140. This group only hydrolyses Ins 1,3,4,5-P4 and PtdIns 3,4,5-P3 
(Damen et al., 1996). SIP- I 10 and SHIP- 140 are encoded by the same gene but 
are expressed as alternatively spliced gene products (Zhang and Majerus, 1998). 
They contain phosphotyrosine-binding sites and an SH2 domain enabling them to 
form complexes with signalling molecules after stimulation of cells by cytokines 
and growth factors. 
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A group IV 5-Pase has been identified by three groups (Jackson et al., 1995; Lu 
ct al., 1996-, Guiherme et al., 1996) although it has not been isolated or cloned. 
This 5-Pase hydrolyses one substrate, Ptdlns 3,4,5-P3, and this activity has been 
shown to be associated with PI 3-K but the function for this is unclear (Jackson 
et al., 1995. 
A 5-Pase has been identified in the budding yeast, Saccharomyces cerevisiae (S. 
cerevisiae) and has been designated INP51 (Stoltz et al., 1998). The primary 
structure closely resembles the type 11 5-Pase synaptojanin and exhibits 5-Pase 
activity towards the substrate Ptdlns 4,5-P2- When INP51 is deleted it results in a 
phenotype that grows significantly faster than the parental strain at temperatures 
below 15T (Stoltz et al., 1998). Cells lacking INP51 have almost 4 times more 
PtdIns 4,5-P2 and Ins 1,4,5-P3 (Stoltz et al., 1998) suggesting that 5-Pase activity 
is required for proper maintenance of Ptd1ns 4,5-P2 levels. 
1.2.1.4 Inositol 1,4,5-P3 3-kinase 
Inositol 1,4,5-P3 3-kinase (Insl, 4,5-P3 3-K) is a widely distributed souble enzyme 
that converts Ins I 4,5-P3 to Ins 1,3,4,5-P4 in the presence of Mg2+ and ATP 
(Irvine et al., 1986). In hepatocytes, the enzyme is stimulated by the action of 
Ca 2+ and protein kinase A (PKA) but is inhibited by protein kinase C (PKC) (Sim 
et al., 1990). Insl, 4,5-P3 3-K is widespread in the brain but is particularly 
concentrated in the cerebellar Purkinje cells suggesting that its activity is 
important within these tissues (Mailleux et al., 1992). 
1.2.1.5 Inositol polyphosphate 1-phosphatase 
Inositol polyphosphate I -phosphatase (I -Pase) hydrolyses Ins 1,3,4-P3 and Ins 
I 
ý4-P2 tO 
Ins 3,4-P2 and Ins 4-P, respectively (Inhorn et al., 1987). 1 -Pase 
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requires Mg 2+ for activity but is inhibited by Ca 2+ at physiological concentrations 
(Inhorn and Majerus, 1988). Lithium ions inhibit both Ins 1,3,4-P3 and Ins 1,4-P2 
hydrolysis uncompetitive ly - 
1.2.1.6 Inositol monophosphatase 
Inositol monophosphatase (mono-Pase) hydrolyses phosphate groups of all 
inositol monophosphates with the exception of Inositol 2-phosphate (Ackermann 
et al., 1987. Inhorn et al., 1987). Mono-Pase isolated from bovine and rat brain 
is a homodimer (Gee et al., 1988). Treatment of bovine mono-Pase with the 
arginine-specific reagent phenylglyoxal resulted in enzyme inactivation, 
suggesting that an arginine is involved in catalysis (Jackson et al., 1989). 
1.2.1.7 Inositol polyphosphate 3-phosphatase 
Inositol polyphosphate 3-phosphatase (3-Pase) has been purified and 
characterised but not cloned. 3-Pase catalyses the hydrolysis of PtdIns 3-P and 
soluble Ins 1,3 -P2 to PtdIns and Ins I -P, respectively (Caldwell et al., 199 1). 
Two isoforms of 3-Pase have been identified in rat brain, types I and 11, and both 
are able to hydrolyse both the lipid and soluble substrate but type 11 has a twenty 
times less efficiency to Ins 1,3-P2 (Majerus, 1992). 
1.2.1.8 Phosphatidylinositol transfer protein 
Phosphatidylinositol transfer protein (PITP) is a cytosolic protein that has the 
ability to transfer Ptdlns and pho sphatidylcho line (PC) between membrane 
bilayers in vitro (Wirtz, 1991). Two isoforms of PITP have been identified in 
mammalian cells, a and P. They were classified depending upon there lipid 
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binding properties. For example, PITPu. can reversibly bind PtdIns and PC, but 
has a sixteen times greater affinity for Ptdlns than for PC (van Paridon et al., 
1987). PITPP can transfer sphingomyelin (a lipid formed from ceramide 
containing a phosphocholine head group) in addition to Ptdlns and PC. PITP is 
involved in many functions including the delivery of PtdIns to signalling 
complexes including PIP4-K and PIP5-K resulting in Ptdlns 4,5-P2 production 
(Cunningham et al., 1995; 1996). PITP may also have a role in exocytosis by 
promoting PtdIns 4,5-P2 production and recruiting specific proteins required for 
exocytosis (Fensome et al., 1996). PITP's involvement in vesicular traffic in 
yeast has also been identified. The gene SEC] 4 in the budding yeast S 
cerevisiae has been shown to encode a PITP (Novick et al., 1980; Bankaitis et 
al., 1990). The activity of SEC 14 appears to act as a sensor of the Golgi 
membrane phospholipid content. SEC 14 has been shown to regulate the cytidine 
diphosphate-choline pathways, thus regulating PC blosynthesis and maintaining 
the appropriate lipid concentration (McGee et al., 1994). SEC 14 can also 
functionally substitute for the mammalian PITP in cell free studies suggesting 
that there may be a general role for this protein in vesicular transport (Ohashi et 
al.,, 1995). 
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1.2.2 The roles of phosphatidylinositols in cells 
This section will be concerned with the roles that the phosphatidylinositols play 
within the cell. Phosphatidylinositols constitute about 10% of the total 
membrane phospholipid and they have many roles, including signalling, 
facilitating vesicle traffic, and even helping to organise cytoskeletal development 
(see Figure 2). 
1.2.2.1 Phosphatidylinositol 3-phosphate 
Phosphatidylinositols containing a phosphate on the 3' position of the inositol 
ring may act as second messengers within mammalian cells, but they are not 
substrates for phospholipase C. They also do not appear to produce soluble 
inositol polyphosphates (Hughes and Michell, 1993). The production of Ptdlns 
3P may regulate Golgi to lysosome traffic and might affect endocytosis in yeast. 
Production of Ptdlns 3P by PI 3-K (VPS34) may either recruit or activate 
effector molecules, such as vesicle coat proteins that catalyse this transport 
reaction (DeCamilli et al., 1996). Inactivation of VPS34 results in reduced 
concentrations of Ptdlns 3P which appears to affect the latter stages of the 
endocytosis (Munn and Riezman, 1994). 
1.2.2.2 Phosphatidylinositol 3,5-bisphosphate 
Yeast cells are able to synthesise PtdIns 3,5-P2 using PI 3-K in response to 
hyperosmotic stress. Mammalian cells are also able to synthesise Ptdlns 3,5-P2 
but in response to hypo-osmotic shock (Dove et al., 1997). Yeast cells lacking 
PI 3K have reduced Golgi to vacuole trafficking. Results indicate that Ptdlns 
3ý5-P2 is synthesised from Ptdlns 3-P in response to hyperosmotic stress. PtdIns 
3,5-P2 may therefore be involved in adaptation response that involves accelerated 
golgi-to-vacuole vesicle trafficking events (Dove et al., 1997). 
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Figure 2 The metabolism of phosphatidylinositols in cells 
A schematic diagram of a cell, it demonstrates how phosphatidylinositol metabolism 
takes place in the lipid membrane bilayer. It suggests how they are synthesised and 
how there are recycled within the membrane. The roles of these phospatidylinositols 
and how their production is regulated is explained in sections 1.2.1.1-1.2.1.8 It 
demonstrates the role of phospholipase C whose catalytic action (green arrows) results 
in the break down of phosphatidylinositols into inositol polyphosphate(s) and 
diacylglycerol (DAG). The blue writing indicates kinase action whereas red writing 
indicate phosphatase action. 
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1.2.2.3 Phosphatidylinositol 3,4,5-trisphosphate 
PtdIns 3,4,5-P3 may interact with Rab5 (Li, G. et al., 1995). Rab proteins are 
members of the Ras GTPase superfamily and are involved in specific stages of 
the exocytic or endocytic pathways (Simons and Zerial, 1993). Rab proteins are 
soluble until nucleotide exchange results in them binding to the membrane. It is 
thought that PtdIns 3,4,5-P3 may facilitate nucleotide exchange on Rab5 either 
directly or indirectly resulting in the activation of exocytic or endocytic pathways 
(DeCamilli et al., 1996). 
1.2.2.4 Phosphatidylinositol 4,5-bisphosphate 
One of the cellular roles of PtdIns 4,5-P2 includes regulating vesicle exocytosis. 
PtdIns 4,5-P2 has been shown to interact with many proteins involved in the 
formation and trafficking of vesicles (Terui et al., 1994). Ptdlns 4,5-P2 has been 
shown to stimulate guanine nucleotide exchange and activate ARF I (ADP 
ribosylation factor) (Terui et al., 1994). ARF I participates in vesicle coat 
recruitment and is required for the formation of carrier vesicles (Donaldson and 
Klausner, 1994). GTP-bound ARF I associates with membranes and activates the 
attachment of coat proteins, such as COP I and clathrin (Rothman, 1994). 
Activated ARF I also works in co-operation with PtdIns 4,5 -P2, activating an 
isoform of phospholipase D (PLD) (Figure 3). PLD hydrolyses the phospholipid, 
pho sphatidylcho line (PC) into phosphatidic acid (PA) and choline. PA is then 
able to activate. PIP 5-K generating more Ptdlns 4,5-P2 (Cockcroft et al., 
1994). 
This may be an amplification loop that results in a localised increase 
in PtdIns 
4,5-P2 and PA in a vesicular carrier (DeCamilli et al., 1996). Ptdlns 
4,5-P2 and 
PA have also been shown to interact with ARF GTPase activating proteins 
(GAPs) (Liscovitch and Cantley, 1995). GTP hydrolysis results in ARF 
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returning to its soluble form and this is required for uncoating prior to fusion 
with the target compartment (Rothman, 1994). 
PtdIns 4,5-P2 may be involved in the regulation of the cytoskeleton by affecting 
the interaction of a number of cytoskeletal components with actin. These 
cytoskeletal components which interact with PtdIns 4,5-P2 include, profilin and 
gelsolin. Once interacted with PtdIns 4,5-P2 profilin promotes and stabilises the 
formation of actin filaments,, whereas, gelsolin severs the actin filaments 
(Homma and Emori, 1995). Profilin is found in close apposition with the inner 
leaflet of the plasma membrane where it can bind up to 5 molecules of PtdIns 
4.5-P2 (Goldschmidt-Clermont et al., 1990; Yonezawa et al., 1991). Binding of 
profilin to PtdIns 4,5-P2 inhibits the interaction of profilin with actin. It also 
inhibits PtdIns 4,5-P2 hydrolysis by PLC (except for PLC-yl when 
phosphorylated and activated by growth factors it is able to hydrolyse protein 
bound PtdIns 4,5-P2 (Goldschmidt-Clermont et al., 1991)). Homma and Emori 
(1995) demonstrated that gelsolin co-purified with PLC-6, suggesting that PLC-6 
may also be involved in the hydrolysis of protein-bound PtdIns 4,5-P2 affecting 
actin assembly. 
All other phosphatidylinositols shown in Figure 2 have short half-lives, 
suggesting that they are only produced as intermediates before producing 
biologically active molecules. These biologically active molecules include 
PtdIns 3-P, PtdIns 3,5-P2, Ptdlns 3,4,5-P3 and PtdIns 4,5-P2- 
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Figure 3 The role of PtdIns 4,5-P2 in exocytosis 
Panel A demonstrates how Ptdlns 4,5-P2 (PIP2) may stimulate guanine nucleotide 
exchange on ARF I. Once ARF I has bound to the membrane it works in co-operation 
with PtdIns 4,5-P2 to stimulate PLD. PLD hydrolyses phosphatidylcho line into 
phosphatidic acid (PA) and choline. Panel B demonstrates that PA activates PIP5-K 
generating more PtdIns 4,5-P2. This generation of PtdIns 4,5-P2 creates an amplification 
loop as it activates PLD, resulting in a localised increase in PtdIns 4,5-P2- Panel C 
shows how this localised increase in PtdIns 4,5-P2 may result in vesicle production. 
Panel D demonstrates how this cycle could be switched off, PtdIns 4,5-P2 and PA are 
known to interact with GAPs. GAP hydrolyses GTP on ARF I resulting in its 
inactivation. 
C 
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1.2.3 The roles of inositol- poly phosphates in cells 
A number of external signals, such as ligands binding to receptors and osmotic 
stress, generate inositol polyphospahtes (InsPPs). lnsPPs are soluble molecules 
that pass through the cytosol to their target binding proteins (Figure 4). The 
binding proteins include receptors located on the surface of the endoplasmic 
reticulum and nuclear membranes and many kinases and phosphatases that are 
involved in lnsPPs metabolism (see Sections 1.2.1.3-1.2.1.8). 
1.2.3.1 Inositol 1,4,5-tris phosphate 
PtdIns 4,5-P2 hydrolysis by PLC results in the release of second messengers Ins 
1,4,, 5-P3 and DAG (Figure 5). Ins 1,4,5-P3 is soluble so it passes through the 
cytosol to the endoplasmic reticulurn (ER) where it binds to its receptor (Furuichi 
et al., 1989). The Ins 1,4,5-P3 receptor appears to be a tetramer and each 
monomer appears to have seven membrane- spanning domains. The majority of 
the protein is thought to reside in the cytoplasm with the carboxyl terminus 
residing in the lumen of the ER (Furuichi et al., 1989). The tetramer appears to 
form the functional Ins 1 4,5 -P3-sensitive Ca 
2+ channel. The Ins 1,4,5-P3 
receptor shows close structural and functional similarity to the ryanodine 
receptor (RYR) (Takeshima et al., 1989). The RYR however, is almost twice as 
large as the Ins 1,4,5-P3 receptor and has an equal number of membrane- 
spanning domains with both the amino and carboxyl terminus on the cytoplasmic 
side of the ER membrane (Takeshima et al., 1989). Upon binding of Ins 1,4,5- 
P3,, the Ins 1,4,5-P3 receptor undergoes a large conformational change which is 
perhaps related to the coupling process leading to channel opening (Sudhof, 
1990). Both the Ins 1,4,5-P3 and ryanodine receptors are known to release Ca 
2+ 
the Ins 1,4,5-P3 receptor releases Ca 
2+ from the intracellular stores of the ER in 
response to Ins 1,4,5-P3 binding to it. 
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Figure 4 The metabolism of phosphatidylinositols in cells 
A diagram demonstrating how inositol polyphosphate metabolism takes place in the 
cytosol. It suggests how they are synthesised and how there are recycled resulting in 
the production of phosphatidylinositols. The role of inositol polyphosphates and how 
their production is regulated is explained in detail in sections 1.2.3.1-1.2.3.3. It 
demonstrates the role of phospholipase C whose catalytic action (green arrows) results 
in the breakdown of phosphatidylinositols into inositol polyphosphate(s) and 
diacylglycerol (DAG). The blue writing indicates kinase action whereas the red 
writing indicates phosphatase action. 
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Another protein that binds Ins 1,4,5-P3, is Ins 1,4,5-P3 kinase (InsP 3-K). This 
synthesises Ins 1,3,4,5-P4 from Ins 1,4,5-P3. Ins 1,4,5-P3 kinase is discussed in 
more detail in section 1.2.1.4. As there is no recognisable Ins 1,4,5-P3 receptor 
or Ca2+ channel in the S cerevisiae genome, it is unlikely that Ins 1,4,5-P3 
regulates intracellular Ca 2+ in yeast cells (Ongusaha et al., 1998). Instead, Ins 
1,4,5-P3 production is more likely to be a precursor for mositol phosphate 
metabolism. 
1.2.3.2 Inositol 1,3,4,5-tetrakisphos ph ate 
There is evidence for a protein that binds inositol 1,3,4,5-tetrakisphosphate (Ins 
1,3,4,5-P4) that has been purified form porcine membranes (Donie et al., 1990). 
The Ins 1,3,4,5-P4 receptor shows approximately 100 times greater affinity for 
Ins 1,3,4,5-P4 than for Ins 1,4,5-P3 (Majerus, 1992). Ins 1,3,4,5-P4 receptors 
have been located in the plasma membrane of endothelial cells which have 
greater affinity for Ins 1,3,4,5-P4 than for Insl, 4,5-P3 (Ludhov and Clapham, 
1992). In olfactory cells there are Ca 2+ channels that are equally sensitive to the 
binding of both Ins 1,4,5-P3 and Ins 1,3,4,5-P4 (Kalinov et al., 1992). 
An alternative target protein for Ins 1,3,4,5-P4 is 5-phosphatase (Figure 4). Once 
bound it dephosphorylates the 5' position resulting in Ins 1,3,4-P3, which is the 
precursor for inositol hexkisphosphate (InS-P6) production in mammalian cells. 
In yeast cells, only small amounts of Ins 1,3,4,5-P4 are produced, but this is 
quickly phosphorylated to Ins 1,3,4,5,6-P5 and then to Ins-P6 (Ongusaha et al., 
1998). 
1.2.3.3 Inositol hexakisphosphate 
Inositol hexakisphosphate (Ins-P6) can be made by receptor-independent 
pathways or from receptor- generated Ins 1,4,5-P3 via Ins 1,3,4,5-P4, Ins 1,3,4-P3, 
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Ins I 3,4,6-P4 etc. (Figure X). Infusion of Ins-P6 into the brain stem of rats was 
found to reduce blood pressure and heart rate (Vallejo et al 1987). Subsequent 
studies have revealed that it may also simulate Ca 2+ entry into neurones, pituitary 
cells and adrenal cells (reviewed in Hughes and Michell, 1993). Beek and Keen 
(1991) have demonstrated that in vitro Ins-P6 inhibits assembly proteins (AP) 
such as AP-2 and AP- 180 which facilitate membrane traffic (Chang et al., 1993; 
Anderson et al 1995). AP-2 is associated with clathrin-coated vesicles at the 
plasma membrane and is involved in regulating receptor-mediated endocytosis 
and exocytosis (Chang et al., 1993). AP- 180 is a nerve terminal -specific clathrin 
adaptor (Anderson et al 1995). A possible role for Ins-P6 may be regulating 
endocytosis and exocytosis of clathrin-coated vesicles (Li, C. et al 1995). 
Ins-P6 in pancreatic-P cells inhibits the serine-threonine protein phosphatases, 
types 1,2A and 3 (PPases) (Larsson et al., 1997). Protein dephosphorylation by 
the PPases modulates the activity of the voltage-gated L-type Ca 2+ channels 
(Catterall, 1995). Incubation of pancreatic-P cells with glucose resulted in an 
increase in Ins-P6 production, this stimulated the activity of L-type Ca 2+ channels 
by suppression of the PPases (Larsson et al., 1997). 
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1.3 Phospholipase C 
As discussed in Section 1.2, many cellular signals are derived from the 
metabolism of phosphoinositides. One enzyme that facilitates the metabolism of 
phosphoinositides is phospholipase C. Metabolism of phosphatidylinositol 4,5- 
bisphosphate (PtdIns 4,5-P2) by phospholipase C generates the second 
messengers inositol 1,4,5-trisphosphate (Ins 1,4,5-P3) and diacylglycerol (DAG) 
(Figure 5). Ins 1,4,5-P3 and DAG are known to modulate intracellular responses 
through the release of Ca 2+ and activation of PKC, respectively. Once 
mammalian PLCs had been isolated, conserved domains could be identified. 
This led to the subdivision of mammalian PLCs into three isozymes, designated 
P, y and 6 (Rhee et al., 1989). Each isozyme has numerous members. For 
example, there are at least nine distinct subtypes of PLC isozymes (P 1, P2, P3, P 
4,71, y2,61,62,63 and 64) based upon comparisons of their primary amino acid 
sequences (Rhee and Choi, 1992). Homologues have also been identified in 
plants, lower eukaryotes and prokaryotes (reviewed in Noh et al., 1995; Heinz et 
al., 1995). This section will review the PLC isozymes, concentrating on their 
structure and regulation. 
1.3.1 The structure of PLCs 
All PLCs contain four conserved domains. These include the X and Y catalytic 
domain, the pleckstrin homology domain, the EF hand domain, and the C2 
domain. The structure and function of these domains are discussed in the 
following sections. 
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Figure 5 The reaction catalysed by phospholipase C 
Phospholipase C hydrolyses PtdIns 4,5-P2 producing the second messengers 
soluble Ins I 4,5-P3 which passes into the cytosol and DAG which is 
hydrophobic and remains in the membrane. This bifurcating signalling 
pathway controls many intracellular responses. 
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1.3.1.1 The X and Y Catalytic Domain 
The X and Y domains are highly conserved and form the catalytic core of the 
molecule. This was confirmed by the crystal structure of rat PLC-61 (Essen et 
al., 1996). Although the X and Y domains are separated in the primary structure 
(Figure 6), once it undergoes tertiary structure formation they from the two 
halves of the catalytic domain. The X and Y domain create a structure that 
resembles a triosephosphate isomerase motif (TIM barrel motif). This structure 
consists of eight interacting P-sheets linked with a-helices (Farber, 1993). PLCs 
hydrolyse three possible substrates; PtdIns, PtdIns 4-P, and PtdIns 4,5-P2, with 
the highest affinity for PtdIns 4,5-P2 and the lowest affinity for PtdIns (Essen et 
al., 1996). This is based upon specific interactions created between the substrate 
and the amino acids that make up the active site. Mutations of specific amino 
acids within the active site of PLCs results in reduced catalytic activity or altered 
affinity for the substrate (Cheng et al., 1995; Ellis et al., 1995; Simoes et al., 
1995; Wang et al., 1996). See Chapter 7 for more information on active site 
mutations. 
1.3.1.2 The pleckstrin homology domain 
PLC isozymes contain a pleckstrin homology (PH) domain located at the N- 
terminus of the protein (Figure 6). PLCs are not the only proteins that contain a 
PH domain, they have been identified in more than 100 proteins through 
sequence and structural similarities (Paterson et al., 1995). Although PH 
domains display little sequence homology, they show structural similarity. The 
PH domain consists of seven anti-parallel P pleated sheets with an (x helix at the 
carboxyl -terminal end. The PH domain of PLC-61 
binds PtdIns 4,5-P2 100 times 
stronger than the PH domains on pleckstrin, spectrin and dynamin (Macias et al., 
1994; Yoon et al., 1994; Ferguson et al., 1995; Hyvonen et al., 1995). Interaction 
of the PLC-61 PH domain with PtdIns 4,5-P2 is different from the 
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Figure 6 The structure of mammalian PLCs 
C-terminus 
Mammalian PLCs contain four conserved domains. These include the 
pleckstrin homology domain (PH), the EF hand domain, the X and Y catalytic 
domain and the C2 domain. PLC-p has an extended C-terminal domain and 
PLC-y has an extra four domains. These extra domains in PLC-p and PLC-7 
are involved in their regulation. 
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catalytic domain, as the PH domain is able to bind PtdIns 3,4,5-P3 (Garcia et al., 
1995) (as stated in section 1.2.2.3, PLCs are unable to hydrolyse Ptdlns 3A5-P3)- 
The PH domain is not required for PLC activity but deletion of this domain can 
affect the function of the enzyme. When any of the basic amino acids were 
replaced in the N-terminal 60 residues of PLC-61 there was a reduction in ligand 
binding, PtdIns 4,5-P2 hydrolysis, and loss of membrane attachment (Yagisawa 
et al., 1998). 
1.3.1.3 The C2 domain 
The C2 domain is identified at the C-terminus of all PLCs (Figure 6). The C2 
domains were originally identified as homologous regions in Ca 2+ -dependent 
protein kinase C (Kalbuchi et al., 1989). The structure of the C2 domain in PLC- 
61 comprises of eight P sheets with four of the sheets creating the core domain, 
two loops from the ends of the core create a Ca 2+-binding site (Essen et al., 
1996). The function of the C2 domain in PLCs is not fully understood but 
evidence from other proteins containing C2 domains, such as synaptotagmin and 
annexin V, suggests that it may be involved in membrane binding. The C2A 
domain of synaptotagmin binds to acidic phospholipids in a Ca 2+ -dependent 
manner (Davletov and Sudhof, 1993; Chapman and Jahn, 1994). In the 
membrane-binding protein annexin V, the recognition site for the head group of 
phosphatidylserine consists of two adjacent Ca 
2+ 
-binding sites (Essen et al., 
1996). A similar mode of phospholipid binding by the C2 domain in PLC-6 may 
be possible. 
Essen et al., (1996) proposed a two step 'tether and fix' membrane binding 
mechanism for PLC's. The PH domain tethers the enzyme to the membrane by 
specific binding to PIP2 and the C2 domain fixes the catalytic domain in a 
productive orientation relative to the membrane. 
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1.3.1.4 The EF domain 
EF hands were first identified in parvalbumin which, contains two similar Ca 2+_ 
binding sites (Herzberg et al., 1986). These Ca 2+ -binding sites are formed by 
two (x-helices that are separated by a loop. The EF hand is formed by the two a- 
helices forming a structure that resembles the forefinger and thumb of a right 
hand; the Ca 2+ -binding site is the loop between the two helices. Subsequent X- 
ray crystallographic studies have demonstrated that many proteins that bind Ca 2+ 
contain EF hands (Essen et al., 1996). These include PLCs. The EF hands in 
PLCs consist of four loops (Figure 6) but only loops one and two are able to bind 
Ca2+ (Essen et al., 1996).. The EF hand of PLC-81 is crucial as deletion of about 
half abolishes PIP2 hydrolysis activity (Ellis et al., 1993). Mutants where 
conserved acidic amino acids in the EF motif were replaced by alanine showed 
nearly the same PLC activity and Ca 2+ dependency as the wild-type (Nakashima 
et al., 1995). This suggests that, although the EF hand is required for enzyme 
activity, it is not the site that regulates the Ca 2+ -dependence of the reaction 
(Nakashima et al., 1995; Drayer et al., 1995). 
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1.3.2 The regulation of the PLC isozymes 
From Figure 6 it can be seen that mammalian PLC-P and PLC-y contain an 
extended C-terminus and an extra four domains,, respectively. This next section 
will discuss these extra domains identified in PLC-P and PLC-7 and their roles in 
regulation. PLC-6 consists of the four domains that are common to all PLCs. 
The regulation of this isozyme is unknown but this next section will identify 
some of the possible regulators that have been suggested. 
1.3-2.1 Regulation of mammalian PLC-P 
The PLC-P family are regulated by G-protems which are coupled to seven- 
transmembrane (7-TM) spanning receptors (Figure 7) (Blank et al., 199 1; Wu et 
al., 1992). The 7-TM receptors that activate PLC-P via G-proteins include 
thromboxane, bradykinin, angiotensin, histamine, vasopressin and muscarinic 
acetylcholine (Gutowski et al., 1991; Shenker et al., 1991; Wange et al., 1991; 
Bernstein et al., 1992). The domains within the muscarinic acetylcholine 
receptor that are responsible for interacting with the G-protein are thought to be 
the second and third intracellular loops of the receptor (Wong et al., 1990). 
Activation of the receptor results in the G(x subunit releasing the bound GDP and 
binding GTP in its place. This causes dissociation of the Goc subunit from the Py 
subunits of the heterotrimeric G-protein and these subunits can then activate 
PLC-P (for a review of G-proteins see Sprang, 1997). 
Stimulatory relationships between the currently known isoforms of PLC-P 1-4 
and cc subunits of the Gq subfamily ((xq, CC IIýU 14-16) have been firmly established 
in vitro. PLC-P I and PLC-P3 isozymes were shown to be more responsive to 
G(xq, G(xj 1 and Ga16 (Hepler et al., 1993; Kozasa, et al., 1993; Smrcka et al., 
1993) whereas activation of PLC-P2 is through G(x16 (Wu et al., 1992). PLC-P4, 
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originally identified in mammalian retina (Lee, C-W. et al., 1993), is stimulated 
by the Gq subfamily (Lee, C-W. ci al., 1994). 
The V subunits of G-proteins have also proven to be effective regulators of 
PLC-P activity. This was first reported in liver cells (Blank et al., 1992). 
Effective regulation of the V subunits requires prenylation of the 7 subunit 
(Dietrich et al., 1994). Comparisons of the purified isoforms of PLC-P suggest 
that there are different levels of regulation exerted by the Py subunits. PLC-P3 
apparently is the most sensitive to V activation with PLC-P I being the least 
sensitive and PLC-P2 somewhere in-between (Smrcka and Sternweis, 1993; Park 
et al., 1993). The isoform PLC-P4 is insensitive to activation by the P7 subunits 
(Lee et al., 1994). 
From Figure 7 it can be seen that PLC-P isozymes have an extended C-terminal 
domain. This is thought to be critical for Ga activation. Expression of PLC-P I 
lacking amino acids 903 to 1142 (Wu et al., 1993), or PLC-P2 lacking the C- 
terminal 350 amino acids (Lee, S. B. et al., 1993), resulted in loss of activation by 
G(x. Mutations of basic amino acid residues in the C-terminus displayed reduced 
responses to Gcc (Kim et al., 1996). Expression of PLC-P2 and PLC-P3 missing 
the C-terminus retained full stimulation by Py subunits (Lee, S. B. et al., 1993; 
Blank et al., 1993). 
The Py subunit may interact with a site on the first half of the Y catalytic domain. 
Expression of peptides containing the X/Y connector region and first half of the 
Y catalytic domain could block stimulation of PLC-P2 by the P7 subunits (Kuang 
et al., 1996). A fusion protein containing the first half of the Y catalytic domain 
was also shown to bind the P7 subunits (Kuang et al., 1996). 
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Figure 7 Activation of PLC-P 
Activation of PLC- P is illustrated by the MI muscarinic acetylcholine receptor 
(MAChR) -dependent activation through the heterotrimeric G-protein, Gq. The 
ligand acetylcholine (Ach) binds to the MAChR which results in a conformational 
change in the receptor causing dissociation of the heterotrimeric GDP-bound Gq 
to yield GTP-bound G(Xq . 
PLC- P then binds the GTP-bound G(Xqvia the 
carboxyl -terminal region, activating PLC hydrolysis of PtdIns 4,5-P2. 
42 
1.3.2.2 Regulation of PLC-7 isozymes 
Polypeptide growth factors, such as platelet derived growth factor (PDGF), 
epidermal growth factor (EGF) and nerve growth factor (NGF), mediate their 
responses by binding to their respective receptors on the surface of the cell 
(Figure 8A). Each of these growth factor receptors have a similar cytoplasmic 
region that contains a tyrosine kinase domain. The growth factors bind to their 
receptor, which facilitates the rapid translocation of PLC-7 to particulate 
fractions. PLC-7 has four additional domains that are positioned between the X 
and Y catalytic domains (Figure 8A). These four domains comprise of one PH 
domain made up of two halves (see section 1.3.1.2 for review), two SH2 domains 
and an SH3 domain. The SH2 domains target PLC-7 to the growth factor 
receptors whereas targeting to other proteins containing proline rich sequences 
could be modulated via the SH3 domain (Pawson, 1995). It has been suggested 
that the SH3 domain might target PLC-7 to the cytoskeleton, and the binding of 
dynamin (Bar-Sagi et al., 1993; Scalfe et al., 1994). Binding to the receptors via 
the SH2 domain may have a role in regulating the basal activity of PLC-y. For 
example, disruption of the SH2/SH3 domain by proteolysis resulted in a PLC-7 
with increased activity (Fernald et al., 1994). Co-expression of the N-terminus, 
incorporating the X catalytic domain of PLC-7, with the C-terminus including the 
Y domain, yielded an enzyme with higher activity than the complete enzyme 
(Hortsman et al., 1996). Finally, when the SH2/SH3 domains were expressed 
and added to PLC-7 in vitro, the activity of PLC-7 was inhibited (Homma and 
Takenawa, 1992). 
The sites where PLC-y are phosphorylated by the growth factor receptors include 
Tyr 771, Tyr 783 and Tyr 1254 (Kim et al., 1990; Wahl et al., 1990; Kim et al., 
1991). PLC-y substituted with Phe at Tyr 783 still associated with the PDGF- 
receptor and was phosphorylated at a serine residue in response to PDGF, similar 
to wild-type enzyme, but there was no IP3 produced (Kim et al., 1991). 
This 
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suggests that phosphorylation at Tyr 783 is essential for PLC-7 translocation or 
binding to the receptor but not activation. Unphosphorylated PLC-7 was 
selectively inhibited in the presence of the actin-binding protein profilin which, 
like PLC-y, has a high affinity for PtdIns 4,5-P2. Only the phosphorylated 
enzyme catalyses the hydrolysis of profilin-bound PtdIns 4,5-P2 releasing profilin 
and affecting actin polymerisation (Goldschmidt-Clermont et al., 1991. This was 
suggested to be the link between transmembrane signalling and cellular 
responses such as, cell shape and motility (Goldschmidt-Clermont et al., 1991). 
It also led to speculation that phosphorylation prevents the interaction of PLC-7 
with inhibitory proteins (Noh et al., 1995). 
Activation of PLC-7 can also be achieved through the action of non-receptor 
protein tyrosine kinases (NR-PTK) (Figure 813), in response to the binding of 
ligands to cell surface receptors in leukocytes (Todderud et al., 1990). The T- 
cell antigen receptor complex (TCR) transduces many signals across the plasma 
membrane, but none of the proteins in the complex are protein kinases. TCR 
stimulation was shown to result in rapid phosphorylation of PLC-7 on both serine 
and tyrosine residues (Park et al., 1991; Liao et al., 1992). It is thought that TCR 
stimulation results in the translocation of a cytosolic kinase, which interacts with 
the SH2 domains of PLC-7 (Rhee and Choi, 1992) 
44 
Figure 8 Regulation of PLC-, y 
Activation of PLC- 7 is illustrated by the epidermal growth factor receptor (EGFR) 
(A), and the T-cell antigen receptor (TCR) dependent tyrosine phosphorylation of 
PLC- 7, (B). A demonstrates that EGF binds to its receptor which results in auto- 
phosphorylation of the receptor and then tyrosine phosphorylation of PLC- 7. This 
then allows the SH3 domain of PLC- 7 to interact with a cytoskeletal protein ('711). 
B demonstrates non-receptor tyrosine kinase activation of PLC- 7. A ligand binds to 
the TCR activating a cytosolic tyrosine kinase which phosphorylates PLC- 7. Once 
PLC- 7 in both cases has been phosphorylated it binds to cytoskeletal proteins and 
hydrolyses PtdIns 4,5-P2. 
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1.3.2.3 Regulation of PLC-6 isozymes 
Although PLC-6 has been widely characterised, the regulation of PLC-6 is not 
fully understood. This section will describe three possible mechanisms by which 
PLC-6 may be regulated (Figure 9). 
The first regulatory pathway may be through the GTP-binding protein Gh which 
was shown to stimulate the activity of PLC-6 (Feng et al., 1996). Gh was 
originally identified as a trans glutaminase enzyme (Nakaoka et al., 1994) that 
was regulated by guanine nucleotides and was purified in association with the 
aI -adrenergic receptor (Baek et al., 1993; Das et al., 1993). Reconstitution 
studies with PLC-6, the aI -adrenergic receptor, and Gh resulted in PtdIns 4,5 -P2 
hydrolysis (Das et al., 1993). Research carried out on the oxytocin receptor has 
demonstrated that Gh may be a signal mediator in this pathway, as Ptdlns 4,5-P2 
hydrolysis was increased by oxytocin binding to the receptor (Park et al., 1998). 
Co-immunopreciptation of PLC-6 in the oxytocin and cc I -adrenergic systems 
demonstrated that it only associates with the GTP-bound form of Gh (Das et al., 
1993; Park et al., 1998). 
Another potential pathway which may regulate PLC-6 involves a novel 
polypeptide with homology to proteins with RhoGAP activity (Homma and 
Emori, 1995). The deduced amino acid sequence shows similarity to GTPase 
activating protein (GAP) and possesses GAP activty for RhoA. Rho proteins 
have been shown to regulate various cell functions such as morphology, motility 
and cytokiesis. This novel protein, called RhoGAP (p 122), was shown to bind 
and regulate the activity of PLC-6 but not PLC-P or PLC-y (Homma and Emori, 
1995). This RhoGAP protein may provide a link between actin related 
cytoskeletal changes and the hydrolysis of PtdIns 4,5-P2 which binds actin 
binding proteins including gelsolin and profilin (see section 1.2.2.4 for more 
information). 
46 
Finally, PLC-6 could simply be regulated by Ca 2+ concentration within the cell. 
It has been demonstrated that an increase in Ca 2+ concentration within a 
physiological range of 0.1 -10.0 ýtM is sufficient to stimulate PLC-5 activity 
(Allen et al., 1997). An increase in Ca 2+ concentration on its own was 
insufficient to stimulate PLC-y and PLC-P activity (Allen et al., 1997). The 
activity of PLC-6 can be further enhanced by the presence of 
phosphatidylinositol transfer protein (PITP) (see section 1.2.1.8 for more 
information on PITP). It has been suggested that the function of PITP is to 
supply and present the substrate (PtdIns 4,5-P2) that would otherwise become 
limiting (Allen et al., 1997). 
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Figure 9 Regulation of PLC-6 
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The activation of PLC- 6 is not fully understood but several possible 
regulators of its activity have been identified. PLC- 6 could be activated 
through the G-protein Gh. Epinephrine binds to the 7TM receptor and GTP is 
substituted for GDP on Ghwhich is then able to bind PLC- 6, resulting in its 
activation. PLC- 6 may be regulated through a novel protein described as 
RhoGAP. The binding of RhoGAP to PLC- 6 may be sufficient for its 
activation. Finally, fluctuations in Ca 2+ concentration within cellular 
compartments may be sufficient to stimulate PLC- 6. 
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1.4 Phospholipase C in yeast 
Investigations using genetical and biochemical techniques have helped increase 
our understanding of complex signalling pathways within the yeasts 
Saccharomyces cere0siae (S. cerevisiae) and Schizosaccharomycespombe (Sz. 
pombe). The evolutionary conservation of protein sequences and preservation of 
signalling principles allows us to use these systems as models, helping to develop 
ideas that can be investigated in higher eukaryotes. In signalling pathways where 
similarities can be drawn from yeast to higher eukaryotes, yeast have aided the 
identification of the regulators involved in the cell cycle progression, secretion 
and responses to extracellular agonists (Reed, 1992; Bennet and Scheller, 1993; 
Bardwell, et al., 1994). Using yeast may therefore help increase our 
understanding of the intricacies of phospholipase C signalling. This section will 
be concerned with reviewing the identification of the yeast PLCs and what is 
known about the signalling role they play in S. cerevisae and Sz. pombe. 
1.4.1 The identification of PLCI in S. cerevisiae 
Three groups have independently cloned an S. cerevisiae gene encoding a 
phospholipase C, termed PLC], with the predicted protein referred to as PLC I 
(Flick and Thorner, 1993; Payne and Fitzgerald-Hayes, 1993; Yoko-o et al., 
1993). Flick and Thorner (1993) and Yoko-o et al. (1993) used a similar PCR 
approach that utilised the high percentage of sequence similarity found within the 
X catalytic domain of PLCs. In contrast, Payne and Fitzgerald-Hayes (1993) 
isolated PLC] from a genetic screen designed to identify mutants that exhibit 
defects in chromosomal segregation. Molecular analysis by all three groups 
demonstrated that PLC] encoded a protein of 10 1 kDa with approximately 50 
and 26% identity to the highly conserved X and Y domains of PLC-6 I (Flick and 
Thorner, 1993; Payne and Fitzgerald-Hayes, 1993). The overall amino acid 
identity between PLC I and bovine PLC-52 is 25.1% which is the highest identity 
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between PLC I and other PLC isozymes (Yoko-o et al., 1993). PLC I does not 
contain the extended C-terminal domain present in the PLC-P family and it does 
not contain either of the SH2 or SH3 domains, both of which are present within 
the PLC-7 family. Partially purified PLC I using nickel chelate affinity 
chromatography has shown that PLC I hydrolyses phosphoinositides in a manner 
that is similar to higher eukaryotic cells (Flick and Thorner, 1993). On the basis 
of structural criteria, Yoko-o et al., (1993) and Payne and Fitzgerald-Hayes, 
(1993) suggested that PLC I be classified as a member of the PLC-6 family of 
enzymes. 
Disruption of the PLC] gene (APLCI) in S. cerevisiae is not lethal, 
demonstrating that PLC I activity is not required for essential cell functions under 
optimal growth conditions (Flick and Thorner, 1993; Payne and Fitzgerald- 
Hayes, 1993; Yoko-o et al., 1993). Instead, APLC1 cells are temperature 
sensitive for growth. They grow slower than wild-type cells at 230C and this 
growth defect was intensified at increasing temperatures until a complete 
termination of growth at 370C (Flick and Thorner, 1993). The APLCI mutants 
are not just sensitive to temperature but are also sensitive to osmotic stress, these 
cells do not grow on non-fermentable carbon sources and grow very badly on 
fermentable carbon sources other than glucose (Flick and Thorner, 1993; Payne 
and Fitzgerald-Hayes, 1993). It has been known for some time that the growth 
medium , in particular nitrogen concentration, stimulates signalling pathways 
within S. cerevisiae cells (Schomerus and Kuntzel, 1992). Nitrogen 
concentrations are known to regulate processes such as meiotic division and 
consequently sporulation (Flick and Thorner, 1993). The addition of nitrogen, 
but not glucose, to nutritional I y-depl eted wild-type cells has been shown to 
stimulate PIP2 hydrolysis (Hawkins et al., 1993; Schomerus and Kuntzel, 1992). 
This suggests that there may be a pathway in S. cerevisiae that requires the 
activation of PLC I in response to external changes in nitrogen levels. 
It has been reported that A-PLC] cells at restrictive temperatures (370C) are 
unable to perform cytokinesis, resulting in large multi-budded cells with each 
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bud possessing its own inherited DNA (Flick and Thorner, 1993). Payne and 
Fitzgerald-Hayes, (1993) reported that a mutant strain defective in PLC I activity 
had an increased rate of aberrant chromosomal segregation. It has been argued, 
however, that these are secondary effects brought about by alterations in PLC I 
activity and that the primary role of PLC I is not fully understood. 
Although the APLCI cells display a temperature sensitive phenotype, they show 
aberrant morphology and grow slowly on rich medium at 230C but not at all at 
temperatures which exceed 3 O'C. Mutant isoforms of PLC I were therefore 
isolated which contained amino acid substitutions in the conserved X and Y 
catalytic domains. These mutations were found to be temperature sensitive 
(Yoko-o et al., 1995). These mutants had a functional PLC I at temperatures 
below 290C but PLC I activity ceased at 3 VC. These temperature sensitive 
mutants may be useful when trying to identify other components in the S 
cerevisiae PLC I signalling pathway. 
Flick and Thorner (1998) identified two genes SPLI (PH081) and SPL2, that, 
when overexpressed, bypassed the temperature sensitive growth defect of A-PLC] 
cells. The PH081 gene encodes a protein which inhibits the PHO80 (cyclin) 
/PHO85 (protein kinase) Cdk complex. The second gene identified, SPL2, 
encodes a 17 kDa protein and displays some similarity to the PHO81 and other 
Cdk inhibitors. In addition to overproduction of PH08 I, two other conditions 
inactivate the PH080/PHO85 complex, a APHO80 mutation and growth on low 
phosphate medium (Flick and Thorner, 1998). The substrate of the 
PH080/PH085 (Cdk complex) is PH04 a transcriptional regulator. When 
PH04 is phosphorylated by the PHO80/PH085 complex it is excluded from the 
nucleus, but phosphate starvation stimulates PHO81 to inhibit PH080/PHO85 
Cdk activity (O'Neil et al., 1996). This allows unphosphorylated PH04 to 
accumulate in the nucleus and activate transcription of genes (Schneider et al., 
1994). 
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Flick and Thorner (1998) proposed a model to explain the interactions between 
PLC 1, SPL2 and the regulators of the PH080/PHO85 (Figure 10). In the 
absence of PLC] a pathway that controls growth at elevated temperatures or 
controls nutrient uptake or utilisation can not function because activity of the 
PH080/PHO85 is too high. The activity of PLC I can either stimulate the 
function of a downstream target "X" via an alternative pathway or stop the 
inhibitory action of the PH080/PHO85 on "Y'. Reduction of the 
PH080/PHO85 activity by overproduction of PHO81 or SPL2, growth on low 
phosphate medium, or a APHO81 mutant, will allow APLCI cells to grow at the 
non-permissive temperature. This study suggests that the gene products of 
PLC], PHO81, SPL2 and PHO801PHO85 are involved in overlapping regulatory 
pathways necessary for adaptation to changing nutrients and temperatures. 
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Figure 10 Model suggesting the possible regulatory function of PLO 
Diagram based on the model suggested by Flick and Thorner, (1998). It 
demonstrates the regulatory interactions between PLC 1, SPL2, PHO81 and the 
PH080/PHO85 complex. Inhibitory interactions are indicated by a blue bar and 
stimulatory interactions are indicated by a red arrow. Black arrows represent the 
outcome if "X" is stimulated. See text for further explanation. 
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1.4.2 The identification of Plcl in Sz. pombe 
Three groups simultaneously cloned anSz. pombe gene encoding a 
phospholipase C. This was designated p1c] with the predicted protein being 
referred to as Plc I (Andoh et al., 1995; Fankhauser et al., 1995; Slaaby and 
Davey, 1995). Two of the groups isolated the p1c] gene using a PCR-based 
approach exploiting the high level of sequence similarity found in the X catalytic 
domain (Andoh et al. ' 
1995; Slaaby and Davey, 1995). Conversely, Frankhauser 
et al., (1995), isolated the p1c] gene when screening for mutants defective in 
sensing phosphate concentrations. The predicted product PlcI has a calculated 
molecular mass of 102 kDa and exhibits approximately 55 and 29% identity to 
the conserved X and Y catalytic domains of the PLC-6 isoform (Andoh et al., 
1995, Fankhauser et al., 1995). The p1c] gene has been physically mapped on 
the left arm of chromosome 11 between the genes radl I and mei3 (Fankhauser et 
al., 1995). Although Plc I shows closest similarity to PLC-6, it exhibits an 
extended N-terminus which is not seen in the mammalian isoform of PLC-6 but 
it is seen to a lesser extent in the yeast S. cerevisiae (see Figure 11). Using HPLC 
analysis it has been demonstrated that Sz. pombe Plc I hydrolyses PIP2 into 
Ins I 4,5-P3 confirming that p1c] encodes a phospholipase C enzyme (Slaaby, 
1996). 
To investigate the role of this p1c] gene a disruption was carried out resulting in 
a Aplcl cell. Some aspects of the phenotype of the plcl disruptants of Sz. pombe 
resemble those of the PLC] disruptants of S. cerevisiae. Growth of cells was 
temperature sensitive in rich medium such as yeast extract and cells were unable 
to grow in minimal medium (Andoh et al., 1995; Fankhauser et al., 1995; Slaaby 
and Davey, 1995). The Aplcl cells of Sz. pombe are swollen and are unable to 
perform cytokinesis (Andoh et al., 1995; Slaaby, 1996). Slaaby (1996) also 
reported that the Aplcl mutant in Sz. pombe could not always perform 
chromosomal segregation similar to the APLCI mutant 
identified by Payne and 
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Figure 11 Comparing the structure of PLC-6 to PLCI and Plcl 
PLC-6 contains four conserved domains. These include the Pleckstrin 
Homology domain (PH), the EF hand domain, the X and Y catalytic domain 
and the C2 domain. PLC I from S cerevisiae and Plc I from Sz. pombe contain 
an extended N-terminus. The function of this N-terminus is not known and 
there appears to be no sequence similarity between the two yeast PLC N- 
terminal extensions. 
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Fitzgerald-Hayes, (1993) in S. cerevisiae. The growth defect at 370C of the 
Aplcl cells are weakly suppressed by a number of supplements which could be 
added to, or reduced when preparing the growth medium. These include the 
addition of 0.5M-KCI or 1.2M-sorbitol (Andoh et al., 1995), alternatively the 
phosphate concentration in the medium could be lowered (Fankhauser et al., 
1995). In comparison, a similar level of suppression was seen by an increase in 
phosphate concentration in S. cerevisiae APLC1 cells cultured at 370C (Flick and 
Thorner, 1998) but the addition of KCL or sorbitol had no suppressive effect 
(Andoh et al., 1995). Expression of the PLC] gene of S. cerevisiae suppressed 
the growth defect of Aplcl cells growing at 37T further evidence thatp/cl 
encodes a phospholipase C enzyme (Andoh et al., 1995). 
It is clear from these studies that the precise role of Plc I in Sz. pombe is still not 
fully understood. More research is required to identify the regulator(s) of Plc I 
and perhaps the signal transduction pathways that it interacts with. 
1.5 Aims of the thesis 
The aims of this project were to characterise Plc Ia phospholipase C enzyme 
identified in the fission yeast Shizosaccharomyces pombe. 
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Chapter 2 
Materials and Methods 
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2.1 Materials 
2.1.1 General laboratory reagents 
General laboratory reagents were supplied by either BDH Laboratory supplies 
(Poole, Dorset) or the Sigma Chemical Co. (Poole, Dorset), unless otherwise 
stated, and were of analytical grade. 
2.1.2 Molecular biology reagents 
Pharmacia Biotech (St. Albans, Herts. ) supplied T7 DNA polymerase, SP6 RNA 
polymerase 11. and all nucleotides. T4 DNA ligase and bacterial alkaline 
phosphatase were supplied by Gibco BRL (Paisley, Scotland). Boehringer 
Mannheim (Lewes, East Sussex) supplied PWO polymerase (Pyrococcus 
woesei). Alta Bioscience (University of Birmingham) made all oligonucleotides 
unless otherwise stated. Sigma Chemical Co. supplied all other molecular 
biology reagents unless stated otherwise. 
2.1.3 Electrophoresis reagents 
Agarose (low melting point and Ultrapure type-1) supplied from Gibco BRL. 
Acrylamide was supplied from Northumbria Biologicals Limited (Cramlington, 
Northurnbria) as a 30% (w/v) solution of 37: 5: 1 ratio acrylamide: bisacrylamide 
for SDS PAGE. For DNA sequencing gels, a 40% (w/v) solution 19: 1 ratio 
acrylarnide: bisacrylamide solution was used. 
2.1.4 Determining Protein concentrations 
Protein concentrations were determined colorimetrically using a protein-assay 
reagent supplied by Bio-Rad (Hemel Hempstead, Herts. ) using bovine serum 
albumin, (BSA) (Sigma A2153) as a standard. 
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2.1.5 Photographic Supplies 
Polaroid 667 land film was obtained from Polaroid UK Ltd. (St. Albans, Herts. ). 
Kodak Biomax MR autoradiographic film was obtained from Sigma Chemical 
Co. Fuji RX autoradiographic film was obtained from Fuji Photo Film Co., Ltd., 
Tokyo. Pictures of plates were were taken on a UVP GDS 8000 gel 
documentation system using Grab-it software. 
2.1.6 Radioisotopes 
[dATpY35S (1000 Ci/MMOI)], [14C] -labelled high protein molecular weight 
markers (Rainbow markers M765), and [dCTPy 
35S (6000 Ci/mmol) were 
supplied from Amersharn Life Sciences (Little Chalfont, Bucks. ). 
Phosphatidylinositol 4,5 bisphosphate [inositol-2_3 H (N)] and 
phosphatidylinositol [inositol-2_3 H (N)] were purchased from DuPont NEN 
(Boston, MA., USA). 
2.1.7 Determining cell volumes 
Cell volumes were determined as described in Davey 1991, on non-fixed cells 
using a C256 Coulter Channelyser supplied by Coulter electronics Ltd. (Luton, 
Beds. ). Isoton 11 azide-free electrolyte was also supplied by Coulter electronics 
Ltd. 
2.1.8 Scintillation counting 
All scintillation counting work was carried out using a Wallac 
1450 Microbeta 
Trilux, Liquid Scintillation and luminescence counter. The effective 
3H count 
for this machine is 50% as informed by the manufacturers instructions. 
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2.1.9 Growth media 
Luria broth, yeast extract and select agar were obtained from Gibco BRL. All 
components of selective media were obtained from Sigma Chemical Co. Media 
and plates used for the selective growth of yeast were made and used as 
described by Moreno et al. (199 1). Rich medium (YE) is yeast extract, 2% 
glucose and added amino acids as required (250ýtg/ml). Plates for the selective 
growth of yeast were made using DMM or amino acid (a. a. ) selective medium 
plus 1.5% agar. The composition of DMM is described within Davey et al. 
(1995). 
2.1.9.1 Selective Medium (a. a. ) 
Per litre: 
Yeast nitrogen base w/o a. a. 's 6.7g 
Glucose 20g 
Amino acid mix 1.5g 
Select aa mix 0.5g 
Amino acid mix: 
L-alanine 2g 
L-asparagine 2g 
L-cysteine 2g 
L-glutamine 2g 
L-glutamic acid 2g 
L-glyclne 2g 
L-isoleucine 2g 
L-lysine 2g 
L-phenylalanine 2g 
L-proline 2g 
L-serine 2g 
L-threonine 2g 
L-tryptophan 2g 
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L-tyrosine 2g 
L-valine 2g 
myo-inositol 2g 
para-amino benzoic acid 0.4g 
Select aa mix (four of the following are selected) 
L-histidine 2g 
L-methionine 2g 
adenine 2g 
uracil 2g 
L-leucine 4g 
2.1.9.2 DMM 
Per litre: 
NH4CI 5g 
Na2PO4 2.2g 
Pthalic acid 3g 
Glucose 20g 
Salts (50x stock) I Oml 
Vitamins (I 000x stock) Iml 
Minerals (10000x stock) I 00ýtl 
Stock solution of salts (50x) 
Per litre: 
MgC12.6H20 52.5g 
CaC12. H20 735mg 
KCI 50g 
Na2SO4 2g 
Stock solution of vitamins (I 000x) 
Per I 00ml: 
Nicotinic acid Ig 
Inositol Ig 
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Pantothenic acid I 00mg 
Biotin I mg 
Stock solution of minerals (10000x) 
Per I 00ml: 
Citric acid Ig 
Boric acid 500mg 
MnS04. H20 500mg 
ZnS04.7H20 400mg 
Molybdic acid 305mg 
FeC13.6H20 200mg 
KI I 00mg 
CUS04.5H20 40mg 
2.1.10 Bacterial strains 
Escherichia coli (E. coli) strain used for general molecular biology: 
Strain Genotype 
DH5(x supE44 hsdR 17 endA96 thi- I relA I 
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2.1-11 Yeast strains 
Strain Phenotype Genotype 
JY291 M mat] -M, ýmat2,3, -. -LEU2 
JY292 P mat] -P Amat2,3. -. -LEU2 
JY3 30 P leu- mat] -PJma12,3. -. -LEU2-, leul-32- 
JY383 
JY402 
P leu-, ura- 
M leu-, ura- 
mat] -P Jmat2,3. -. -LEU2-, ura4-D]8 
mat] -AIIJmat2,3. -. -LEU2-, ura4-D]8 
JY681 P leu-, ApIcl matl-P Amat2,3. -. -LEU2-, JpIcl 
JY 291 is a mating type stable M-cell, conversely JY 292 is a mating type stable 
P-cell. 
JY 330 is a mating type stable P-cell but contains the leul-32 mutation 
preventing the cell from producing leucine. This strain as transformed with the 
expression pREP vectors as these contain the LEU2 gene as a selectable marker 
(Maundrell, 1990). 
JY 383 is a mating type stable P-cell and JY 402 is a mating type stable M-cell. 
These cells also contain the leul-32 mutation but they also contain the ura4-D]8 
deletion preventing the cell from producing uracil. This will allow genetic 
disruption to be performed in these strains by re-introducing the ura4 gene a 
selectable marker allowing these cells to grow on uracil minus media 
JY 681 is a mating type stable P-cell, a JY 383 strain which has had the p1c] 
gene replaced by ura4. 
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2.2 Methods 
2.2.1 General molecular biology techniques 
2.2.1.1 Cloning techniques 
Standard recombinant DNA technology was achieved as described in Sambrook 
et al (1989), unless otherwise specified. Restriction endonuclease digestions 
were completed in accordance with the manufacturer's instructions. The 
digestion products were separated on a low melting point agarose gels. DNA 
was recovered from the agarose gels using the Gene Clean 11 Kit supplied by 
(Anachem, Luton, Beds. ) in compliance with the manufacturers instructions. 
After digestion and purification of the vector DNA, it was treated with bacterial 
alkaline phosphatase (Amersham Life Science). Before ligation, the vector was 
subjected to pheno I/chloro form extraction. 
2.2.1.2 Transformation of Escherichia coli 
Competent E. coli (DH5) were prepared in compliance with Sambrook et al. 
(1989). The transformation of competent E. coli was carried out as described by 
Hanahan (19 8 5). 
2.2.1.3 Polymerase Chain Reaction 
a) Purified DNA 
PCR on purified DNA used a reaction volume of I 00ýtl. 
To make up this volume 
primers added to a final amount of I ýtg and approximately 
Ing of DNA was 
added. Generally for products of I 000bp or 
less, aI min extension at 720C and a 
30 second 'melt' at 940C was used. Increased extension 
times were used on 
products that were longer; usually 
I min per I 000bp was used. Generally the 
annealing temperature for primers was 
550C for I min, but this could vary 
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depending on the template. 35 cycles were generally used for each reaction. The 
reaction concluded with incubation at 72'C for 7 min to allow full extension of 
the product. 
b) Screening plasmid DNA from bacterial cells 
The PCR screening of bacterial cells was performed on cells taken from a 
selective LB plate and placed in I 00ýtl of 5xTE (50mM Tris pH7.5,5mM EDTA. 
Sambrook et al., 1989). 1 ýtl of this solution was used in aI 00ýtl PCR reaction. 
Tween20 was added to the PCR mixture to a final concentration of 0.05% before 
the PCR reaction was carried out. 
c) Yeast Cells 
PCR on yeast DNA was performed on cell lysates produced by vortexing the 
cells with acid-washed glass beads (425-600 micron, Sigma Chemical Co. ). 
After vortexing for I min, a 50ýtl volume of 5xTE was added and the 
homogenate and glass beads were transferred to a 500ýtl microfuge tube. The 
500ýtl microfuge tube was pierced and placed in a 1.5ml microfuge tube and 
centrifuged at 13,000g for 10 s, allowing the homogenate to pass through the 
pierced holes but not the glass beads. I ýtl of this homogenate was used in a PCR 
reaction. 
2.2.1.4 Transformation of Yeast cells 
All yeast transformations were carried out using the lithium acetate method 
(Okazaki et al., 1990). A 50ml culture of yeast was cultured in YE to IX107 
cells/ml. These cells were harvested at 20OOg for 5 min in a centrifuge 
prewarmed to 290C. The cells were then washed in Solution I before resusprision 
in solution I at Ix 10 9 cells/ml. This cell suspension was incubated at 
290C for 
60-120 min. AI Oýtl volume containing I OOng of DNA was added to 
290[tl of 
solution 11 and was prewarmed to 290C. I 00ýd of cells were mixed with 
the 
DNA and incubated at 290C for a further 50 min. 
These cells were heat shocked 
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at 42'C for 15 min. The cells were collected by centrifugation (I OOOg for 3 min), 
resuspended in water and spread onto plates of selective medium. 
Solution 1: 0.1 M lithium acetate, pH 4.9 (with acetic acid) 
Solution 11: 50% w/v PEG 4000 in solution I 
2.2.1.5 Double-stranded DNA sequencing 
18ýd of DNA (1-2ýtg of 5kb DNA template) was mixed with 2ýd of I OM NaOH 
and incubated at room temperature for 5 min. 8ýd of 5M ammonium acetate was 
added to the mixture succeeded by I 00ýtl of 100% ethanol, the DNA was 
subsequently precipitated at -700C for 20 min. DNA was collected by 
centrifugation at 14,000g for 10 min at 4'C, this was followed by washing the 
DNA in 80% ethanol. The DNA was resuspended in 7ýd of water. To the DNA 
I ýd of primer (concentration 6.6ng/ýtl) and 2ýd of sequencing buffer was added. 
This mixture was incubated at 370C for 20 min. 5.5ýd of labelling mix was 
added to the mixture and incubated at room temperature for 5 min. 
Subsequently, 3ýd of the labelled mixture was added to each of the four tubes 
containing 2ýtl of either ddA, ddC, ddG and ddT termination mixtures and the 
samples were incubated at 370C for 5 min. The reactions were stopped by the 
addition of stop solution. Samples were heated to 80'C for 2 min before loading 
onto a sequencing gel. The full nucleotide and amino acid sequence of Plcl can 
be found in the appendix. 
Sequencing buffer: 200mM Tris pH 7.5,100MM M9CI2,25OmM NaCl 
Labelling mix: 18mM DTT, 0.55ýM dCTP, 0.55ýM dGTP and 
0.55ýM dTTP, 0.5U T7 polymerase/ýd, 
IýtCOATp735 SdATP(I 000 CI mmol)]/ýd. 
Termination mixes: dATP, dGTP, dTTP, and dCTP each at 80ýLM, 
50mM NaCl, 8ýM of respective dideoxy 
nucleotide. 
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Stop solution: 95% formamide, 0.05% bromophenol blue, 0.05% 
xylene cyanol, 20mM EDTA. 
2.2-1.6 Preparation of genomic DNA 
Yeast genomic DNA was prepared as described in Guthrie and Fink, (199 1). 
2.2.1.7 Southern Blot analysis 
Southern blot analysis was performed as described in Sambrook et al. ý 1989. 
Radioactively labelled probes were created using a Random Primed DNA 
Labelling Kit supplied from Boehringer Manheirn (Lewes, East Sussex) and was 
used in accordance with the manufacturers instructions. 
2.2.2 Assaying Plcl activity in vitro 
2.2.2.1 Production of crude yeast extract used for Plcl assay 
I 400ml of cells were cultured in DMM to 6.5x 10 6 cells ml-1 and transferred to 
50ml screw-cap tube. The 50ml screw-cap tube were centrifuged at 40OOg for 5 
min at 4'C; all of the medium was then removed. Each of the yeast cell pellets 
were washed in 2ml of Solution I and transferred to a 20ml universal. The cells 
were again centrifuged at 40OOg for 5 min at 4'C subsequently the solution I was 
removed and 5ml of acid washed glass beads (425-60OVtn. Sigma Chemical Co. ) 
were added, the screw-cap tube were then placed at 4'C. The cells and glass 
beads were vortexed for I min,, then placed at 4'C for I min, this was repeated 
five times. The 20ml universal bottom was pierced and was placed in a 50ml 
universal. The beads and homogenate were then washed with I ml of solution I 
and centrifuged at 20OOg for I min. The homogenate passes into the 50ml 
universal while the glass beads remain in the 20ml universal. The protein 
concentration was determined using Bio-Rad 'Protein Concentration Kit' 
(Hemel Hempstead, Herts. )using BSA as a standard. The protein concentration 
was approximately I Omg/ml. The extracts were stored in 20% glycerol at -200C. 
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Solution 1: 50mM Tris/HCI pH 7.5 
I mM EGTA 
20ýLl/rnl Yeast protease inhibitor cocktail (Sigma 
Chemical Co. P8215) 
2.2.2.2 PLC assay 
The substrate was prepared in a siliconised glass vial. To the glass vial 2ýtl of 
1.3mg/ml Of PIP2,2ýd of 3 H-PIP2 (0.02VtCi) (DuPont NEN, PIP2 [inositol-2- 
3 H(N)]) and 20OVil of chloroform /methanol (2: 1). This substrate mixture was 
dried under a stream of nitrogen. The mixture of radioactively labelled and non- 
radioactively labelled PIP2 was resuspended in 25Vtl of resuspension solution per 
reaction. This substrate mixture was then sonicated for 30 seconds at setting 5 
using the Soniprep 150 (Sanyo); this was repeated three times. For assays where 
PI hydrolysis was being measured the 3 H-PIP2 was replaced by 3 H-PI (0.02ýtCi) 
(DuPont NEN, PI [inositol-2 _3 H(N)]) but all other parameters were kept the 
same. 
Resuspension solution 
Per 25ýd reaction: 
16ýtl 10% w/v sodium cholate (Sigma C6445) 
9ýtl 50mM Tris/HCI pH 7.5 
Sodium cholate was added to the mixture as this is an anionic detergent and at 
the precise concentration (critical micelle concentration) it creates a micellar 
structure when sonicated. At lower or higher concentrations of sodium cholate 
the substrate PIP2 is not incorporated into a micellar structure which Plc I can 
bind to and hydrolyse. 25ýtl of crude yeast extract was mixed with 25ýd Of PIP2 
suspension at 300C. The reaction was stopped after the required length of time 
by the addition of 250ýtl of 0.6M HCI, then Iml of ice cold chloroform/methanol 
(2: 1) was added. The samples were vortexed for 30s followed by a 40OOg 
centrifugation for 2 min. The aqueous solution containing the 
3H-IP3 was drawn 
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off and mixed with 400[d of scintillation fluid. The radioactivity was determined 
using a Wallac 1450 Microbeta Trilux, Liquid Scintillation and Luminescence 
Counter. The effective 3H count for this machine is 50%. 
2.2.3 Growing cells on microscope slides 
The cells were cultured in the required medium at 23'C over night and then 
diluted to approximately Ix 10 3 cells/ml. The cells were placed on a microscope 
slide containing a small amount of medium containing I% (w/v) LMP agarose. 
A cover slip was placed over the top and a small amount of parafin wax, which 
has been melted, is used to seal the cover slip to the slide. The slide is sealed so 
that the medium does not dry out affecting cell growth. The cells are incubated 
at the required temperature for 24 hours and are then viewed using the Nomarski 
digital camera. 
2.2.4 Expression of Plel in A k] strains P 
The Aplcl Sz. pombe strain was cultured up overnight in YE medium (see 
Section 2.1.9) at 230C. Cells were transformed using the lithium acetate method 
(Okazaki et al., 1990) (see Section 2.2.1.4) except that, the cell suspension in 
Solution I was incubated at 230C for 60-120 min and the cells were heat shocked 
at 29'C. The transformants were incubated at 23'C on selective medium (aa). 
Colonies were autotrophically selected for. Colonies were selected and 
inoculated into I Oml of aa medium and were incubated for 48hrs. The cultures 
were then inoculated at 5x 1 05 cells/ml and incubated at 23'C for 24hrs. The cell 
volumes were calculated using a C256 Coulter Channelyser (see Section 2.1.7). 
After the 24hr period the cell volumes were calculated (see Section 2.1.7) and 
were collected by centrifugation (I OOOg for 3 min). The cells were resuspended 
in DMM (see Section 2.1.9.1) at a concentration of Ix 10 
6 cells/ml and then 5000 
cells were spread onto DMM. The plates were incubated at either 
23'C or at 
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37'C and colony formation was recorded by photographing the plates on the gel 
documentation system. 
2.2.5 Statistical treatment of data 
All PLC assays were completed in triplicate. The mean value for the assays were 
calculated and bars on the data indicate the standard range of the mean. This 
demonstrates the full range of the data from the lowest to the highest value. 
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Chapter 3 
Constructs 
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3.1 Constructs containing modified versions of the p1c] gene 
3.1.1 General information applying to all modifications of the p1c] gene 
introduced by PCR 
Due to the size of the pREP vectors, the PCR products of the modified p1c] 
genes in figures were first sub-cloned into the plasmid pBluescript KS 
(Stratagene, Cambridge, UK). Once cloned into the pKS vector, the sequences 
were confirmed by performing double-stranded DNA sequencing (see Methods 
for details). On the constructs where inverse PCR was carried out, double 
stranded DNA sequencing was performed once the construct had been ligated 
and was circularised. Once the constructs had been sequenced they were 
subsequently cloned into the yeast expression vectors pREP3x and pREP8 I x. 
3.1.2 Expression vectors 
Expression of the p1c] gene in Sz. pombe was achieved by using a set of 
expression vectors designed by Maundrell, (1990). The pREP vectors are based 
upon the thiamine -repre s sib le nmt] promoter. Two pREP vectors were used in 
this study; pREP3x and pREP81x. The vectors only differ by six nucleotides 
within the nmt] promoter region. This difference of six nucleotides results in 
different levels of expression (Maundrell, 1990). The vector pREP3x has the 
higher level of expression whereas pREP8 Ix has the lower level of expression 
(Maundrell, 1990; 1993). 
3.1.3 Constructs 
3.1.3.1 Fusing the HiS6 tag to plcl 
Construction of the N-terminal and C-terminal regions of Plc I 
fused to a series 
of six histidine residues is described in Figures 
12 and 13, respectively. These 
clones have six histidine residues introduced at either the 
N- or C- terminus of 
the Plcl protein 
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3.1.3.2 Cloning a truncated form of p1c] to improve PCR efficiency 
Due to problems associated with being unable to PCR the full-length p1c] gene, a 
truncated form of the p1c] gene was created. The complete p1c] gene was 
digested with Ncol and cloned into the Ncol site of the vector pGEM-5Zf' to 
produce the clone JD709 (Figure 14). The clone JD709 was used as a template 
for the next four constructs (Figures 15 -18). 
3.1.3.3 The mutagenesis of lysine 582 
A modified version of the p1c] gene was produced which replaced the lysine 
residue at position 582 with an arginine residue. This construct was produced as 
described in Figure 15. Another modification was made at position 582 but this 
time lysine at position 582 was replaced with alanine and this construct was 
produced as described in Figure 16. These versions of the p1c] gene were then 
cloned into both pREP3x and pREP8 I x. 
3.1.3.4 The mutagenesis of arginine 693 
A modified version of the p1c] gene was produced which replaced the arginine 
residue at position 693 with a lysine residue. This construct was produced as 
described in Figure 17. Another modification was made at position 693. This 
time, the arginine was replaced with a leucine and this construct was produced as 
described in Figure 18. These versions of the p1c] gene were then cloned into 
both pREP 3x and pREP 81x. 
3.1.3.5 The use of overlapping PCR to mutagenise arginine 873 and glycine 
481 
Figure 19 shows a construction of a mutated version of the p1c] gene where the 
arginine residue at position 873 has been replaced 
by a cysteine residue. This 
procedure involved a process of overlapping 
PCR where two fragments of the 
p1c] gene were produced which had complementary overhangs. 
The two 
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fragments were annealed together and PCR was performed to amplify the 
annealed fragment. After being cloned into pKS it was then cloned into the yeast 
expression vectors pREP3x and pREP81x. Figure 20 demonstrates that this 
procedure was repeated to create another mutated form of the pIc I gene but this 
time a serine residue replaced the glycine residue at position 481. 
3.1.3.6 Cloning of Rat PLC-6 
Figure 21 demonstrates how Rat PLC-6 was cloned from a pMT-2 plasmid 
containing the gene sent from S. G. Rhee (National Institute of Health, Bathseda, 
Maryland, USA). The sequence was confirmed in pKS and it was subsequently 
cloned into the yeast expression vectors pREP3x and pREP81x. ThepREP 
vectors do not contain an EcoRV site directly down stream of the promoter, so an 
end-filled BamH1 site was therefore used. The EcoRV sites introduced by the 
primers when cloning the Rat PLC-6 were also end-filled so the PCR product 
was cloned with blunt ends into the pREP vectors. 
3.1.3.7 Producing a truncated form of plcl 
Figure 22 describes the production of a truncated form of the pIc1gene. A PCR 
primer was designed which introduced an initiator codon at the leucine residue 
position 144. This fuses the A of the Atg (Metl) to the TG of cTG (Leul44), it 
therefore removes residues 2 to 144 inclusive. The truncated form of p1c] was 
then cloned into the pREP 3x and pREP 81x after the sequence was confirmed in 
pKS. 
3.1.3.8 Fusing the N-terminus of p1c] to Rat PLC-6 
Figure 23 a demonstrates how the p1c] gene and the Rat PLC-6 gene were cloned 
into the same pKS vector. The clone JD900 is the gene p1c] that 
has had the 
internal EcoRV sites removed by PCR. Although the EcoRV restriction sites 
have been removed the actual protein sequence remains the same. 
Digestion of 
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JD900 and partial digestion of JD673 (Rat PLC-8 in pKS) with EcoRV allowed 
ligation of the two genes together. Figure 23b demonstrates how two primers 
were used in an inverse PCR reaction creating a hybrid PLC. The N-terminus of 
the jVc] gene was ligated to the full length Rat PLC-6 gene thus circularising the 
plasmid. The sequence was confirmed and the subsequent hybrid PLC was 
cloned into pREP3 xr and pREP 81 xr (pREP vectors that now contain an EcoRV 
site downstream of the promoter) constructed by K. Davis (University of 
Warwick,, UK). 
3.1.3.9 Expressing the N-terminal domain of Plcl 
Figure 24 demonstrates the amplification of the N-terminus. The primers 
M 13 universal and J0622 were used to amplify the first 147 amino acids of Sz 
. pombe 
Plcl using the template JD645 (pKSpIcI). The primer J0622 was 
designed to introduce a stop codon directly after valine 147 and also introduce a 
BamHI restriction site. Once the sequence of the PCR product had been 
confirmed in pKS it was digested with BamHI and ligated into the BamHI 
digested pREP3x and pREP8 Ix vectors. 
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JD645 p1cl In pBluescript KS 
, 1051 
. 10387 
"CTTCTGTAAATCTTGCGACACAGGTAACCtagggg" 
5'ggggatccc a ccATGcatcatcatc at cat cat GGCGGCAATTGTGAAATGGTAACGTCG ý' 
P/cl ORF was amplified froill the clone JD645 
using the primers 10514 and . 10387 
His 6 Tag 
Digest with Banif-11 
His 6 Tag 
7mHl 
H'S6 Ta, 
RumHl 
Figure 12 Introducing a H'S6 tag into the N-terminus of Plcl 
The oligonucleotides J0387 and J0514 were used to PCR amplify plcl from the clone 
JD645. Both primers contain BamHI sites to assist the cloning of the PCR product. Primer 
J0514 contains a sequence CCACC immediately upstream of the initiator codon (shown in 
bold type) to increase the efficiency of translation (Kozac, 1994; 1986; Yuri et al., 1996). The 
sequence underlined represents the region that will encode the hexahistidine tag. The stop 
anticodon is shown on primer J0387 in bold type. Lower case letters represent sequence that 
is used in the primer but is not found in the p1c] gene. 
Digest vector 
with BamHI 
BuinHI 
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JD645pIcl in pBlUescript KS 
Jo 0515 
CTTCTGTAACCGCCGGtagtagtagt a 9t a gt a gATCTTGCGACACAGGTAAcctaggggc' did 
5'ggggatcccaccATGAATTGTGAAATGGTAACG-', ' 
10 
pIcI ORF was arnplified Crom the clone JD645 
LISHIg the primers 105 15 and . 10421 
a' 
I 'C 
His 6 Tag 
amHl 
Ligate 
Digest vector 
with BaniHI 
Batiffli 
BamHl 
Figure 13 Introducing a H'S6 tag into Plcl 
The oligonucleotides J0421 and J0515 were used to PCR amplify plcl from the clone 
JD645. Both primers contain BamHl sites to assist the cloning of the PCR product. Primer 
J0421 contains a sequence CCACC immediately upstream of the initiator codon to increase 
the efficiency of translation (Kozac, 1994; 1986; Yuri et al., 1996). The stop anticodon is 
shown on primer J051 5 in bold type and the sequence underlined represents the region that 
will encode the hexahistidine tag. Lower case letters represent sequence that 
is used in the 
primer but is not found in the p1c] gene. 
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The clone ID645 was digested with 
the restriction enzyme Ncol 
'ý5 -S 
A'Col 
Digest the vector 
Ligate 
r 
v% ith %, 'c, o I 
Ncol 
pGEM-5Zfplcl 
Ncol truncation 
Ncol 
Figure 14 Removing the central Ncol portion of p1c] for inverse PCR 
The clone JD645 was digested with Ncol, this central portion was then ligated into 
Ncol-digestedpGEM-5Zf This truncated form ofp1c] allowed inverse PCRto be 
performed, thus creating the active site mutants (see Figures 15-18 for details). 
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J D64 5 p1c I Qý 
In pBluescript KS 
P/cl truncation M 
pGEM-5ZF 
77"777ýý r-7717 
CN 
00 
lrý 00 
AAAGTCAAATGTTCAGCAACACCA 
... 
"GACTTGTTTTAAAACGAC-" 
KCSATP... 
10754 
CgtGTCAAATGTTCAGCAACACC" 
PCR I ys582Arg change 
J0755 
Ncol (299) 
tr unc 
'CM-5Zf 
pGEM 
tru ci 
P/Cjj Arg582 PICINcol 
Ligate truncatio 
Ncol(2779) 
p 
CRE 
(P 
3 xp 
JD7 (j , 
rlc]His Ar'-ýý 'S6 
INcol (299) (JD728) 
pGEM-5Zf 
plc]Ncol 
truncation 
Di2est 
Arg582 
Ncol(2779) 
Diýcyest vector 
with Ncol 
Ncol 
Ncol 
BumHl 
-of 
Ligate 
, VC01 
BamHl 
HI 
Ncol 
pREP3x Arg582 t 
p/c]HiS6[K582R] Ncol 
BaniHI 
Figure 15 Replacing the lysine at position 582 with arginine 
Inverse PCR was used to amplify the Ncol portion of p1c] and the pGEM-5Zf vector using 
the primers J0754 and J0755. Primer J0755 contains three bases (lowercase, bold) that 
are different to the wild-type sequence. This replaces the lysine codon from AAA (Bold) 
to arginine CGT. The PCR fragment was ligated to circularise the pGEM-5Zf vector. 
This was subsequently digested with Ncol and was ligated into the Ncol sites of JD728 
(which contains the flanking regions of p1c] and the C-terminal HiS6 tag). 
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(211 N 
N 
Plcl truncation in 
pGEM-5ZF 
Cý 
0ý rq rý 
-- 
t 
AAAGTCAAATGTTCAGCAACACCA... 
3'GACTTGTTTTAAAACGAC5' 
51 
ATP... 
gctGTCAAATGTTCAGCAACACC3' 
PCR Lys582A]a change 1- 
INcol (299) 
Ligate 
Ar"-ý 
pGEM-5Zf 
plc]Ncol 
truncation 
la582 
Ncol 
Ncol (299) 
pGEM-5Zf 
plc]Ncol Ala582 
truncation 
I 
Ncol(2779) 
Digest 
Ncol(2779) 
Ncol 
BamHl 
ol 
Ligate 
Ncol 
BamHl 
Ncol 
pREP3x Ala582 
plclHiS6[K582A] Ncol 
BamHl 
Figure 16 Replacing the lysine at position 582 with alanine 
Inverse PCR was used to amplify the Ncol portion of p1c] and the pGEM-5Zf vector using 
the primers J0754 and J0756. Primer J0756 contains three bases (lowercase, bold) that 
are different to the wild-type sequence. This replaces the lysine codon from AAA (Bold) to 
alanine GCT. The PCR fragment was ligated to circularise the pGEM-5Zf vector. This 
was subsequently digested with Ncol and was ligated into the Ncol sites of JD728 (which 
contains the flanking regions ofp1c] and the C-terminal HiS6 tag). 
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Figure 17 Replacing the arginine at position 693 with lysine 
BamHl 
Inverse PCR was used to amplify the Ncol portion of p1c] and the pGEM-5Zf vector using 
the primers J0750 and J075 1. Primer J0751 contains three bases (lowercase, bold) that 
are different to the wild-type sequence. This replaces the Arginine codon from CGT 
(Bold) with Lysine AAA. The PCR fragment was ligated to circularise the pGEM-5Zf 
vector. This was subsequently digested with Ncol and was ligated into the Ncol sites of 
JD728 (which contains the flanking regions ofp1c] and the C-terminal HiS6 tag). 
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Figure 18 Replacing the arginine at position 693 with alanine 
BamHl 
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Inverse PCR was used to amplify the Ncol portion of p1c] and the pGEM-5Zf vector using 
the primers J0750 and J0752. Primer J0752 contains three bases (lowercase, bold) that 
are different to the wild-type sequence. This replaces the Arginine codon from CGT 
(Bold) with Alanine TTA. The PCR fragment was ligated to circularise the pGEM-5Zf 
vector. This was subsequently digested with Ncol and was ligated into the Ncol sites of 
JD728 (which contains the flanking regions ofp1c] and the C-terminal HiS6 tag). 
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Figure 19 Replacing arginine 873 with cysteine 
Panel A demonstrates how the oligonucleotides J0512 and J0387 were used to PCR 
amplify a 115 bp region of p1c] from the clone JD645. Primer J0512 contains two codons 
(bold, lowercase) which are different to the wild-type sequence this replaces the arginine 
AGA for cysteme TGT. The stop anticodon is shown on primer J0387 in bold type. The 
lowercase letters indicate sequence that is used in the primer but is not found within the 
p1c] gene. Panel B demonstrates a second PCR amplification using the primers J0421 
and J0513 giving a 2640 bp product from the clone JD645. Primer J0513 contains the 
anticodon sequence which replaces arginine 873 with cysteine (lowercase, bold). Primer 
J0421 contains a sequence CCACC immediately upstream of the the initiator codon to 
increase the efficiency of translation (Kozac, 1984; 1986; Yuri et al., 1996). Panel C 
demonstrates a third PCR amplification using the products from the first two PCRs as a 
template and primers J0421 and J0387 creating a 2740 bp product. The primers J0421 
and J0387 contain BamHl sites to assist the cloning of this final PCR product. Panel D 
demonstrates that this PCR product was digested with BamHl and ligated into the 
appropriate vector. 
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Figure 20 Replacing glycine 481 with serine 
Panel A demonstrates how the oligonucleotides J0508 and J0387 were used to PCR 
amplify a 1290 bp region of p1c] from the clone JD645. Primer J0508 contains three 
codons (bold, lowercase) which are different to the wild-type sequence this replaces the 
glycine GGC to serine TCT. The stop anticodon is shown on primer J0387 in bold type. 
The lowercase letters indicate sequence that is used in the primer but is not found within 
the plcl gene. Panel B demonstrates a second PCR amplification using the primers 
J0421 and J0509 giving a 1470 bp product from the clone JD645. Primer J0509 contains 
the anticodon sequence which replaces glycine 481 with serine (lowercase, bold). Primer 
J0421 contains a sequence CCACC immediately upstream of the the initiator codon to 
increase the efficiency of translation (Kozac, 1984; 1986; Yuri et al., 1996). Panel C 
demonstrates a third PCR amplification using the products from the first two PCRs as a 
template and primers J0421 and J0387 creating a 2740 bp product. The primers J0421 
and J0387 contain BamHI sites to assist the cloning of this final PCR product. Panel D 
demonstrates that this PCR product was digested with BamHI and ligated into the 
appropriate vector. 
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Figure 21 The cloning of Rat PLC-6 into the pREP3x vector 
The oligonucleotides J0548 and J0549 were used to amplify the Rat PLC- 6 gene, by PCR, 
from the clone JD??? (supplied by S. G. Rhee, National Institute of Health, Maryland). 
Both primers contained EcoRV sites to assist the cloning of the PCR product. Primer 
J0548 contains the initiator codon (bold type) and J0549 contains the stop codon (bold 
type). Lower case letters indicate sequence used in the primer but not found within the Rat 
PLC- 6 gene. Due to the pREP vectors not containing an EcoRV site directly down stream 
of the nmt] promotor an end filled BamHI site was used instead. 
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Figure 22 Construction of p1c] without the N-terminal fragment 
Using the primers M13-20 and J0594 the N-terminal fragment ofp1c] was amplified. The 
template used was the construct JD900 (p1c] which has had the two Internal EcoRV sites 
removed and EcoRV sites introduced onto the N and C-terminus in order to facilitate 
cloning). J0594 introduces an initiator codon Met ATG (bold) at position 144. This uses 
the A of Atg (Metl) and the TG of cTG (Leu 144) removing residues 2 to 144 inclusive. 
Once amplified and digested with EcoRV this construct, plc]AN-terminus was cloned into 
pREP3xr (pREP vectors which contain an EcoRV site directly downstream of the nmt] 
promoter, constructed by K. Davis, University of Warwick 1999). 
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Figure 23a Exchanging domains between Sz. pombeplcl and Rat PLC- 6 
JD900 was digested with EcoRV, the p1c] gene was then ligated to JD673 which 
was partially digested with EcoRV. This meant that both Sz. Pombe p1c] and Rat 
PLC- 6 were cloned into the same pKS vector. 
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Figure 23b Exchanging domains between Sz. pombeplcl and Rat PLC-6 
The primers J01068 and J01069 were used to amplify the N-terminal section of 
Sz. pombe pIc 1, the Rat PLC- 5 gene and the pKS vector through inverse PCR. 
This created a 5674 bp PCR product which was ligated to circularise the pKS 
vector. The fusion product could then be digested with EcoRV and ligated into 
pP, EP3xr vector. 
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Figure 24 Amplification of the N-terminal domain of p1c] 
Using the primers Ml3uni and J0622 the N-terminal fragment ofp1c] was amplified. The 
template used was the construct JD645 (p1c] in the vector pBluscriptKS+). J0622 
introduces a stop codon ATC (bold) at amino acid position 148. Once amplified and 
digested with BamHI this construct, pIcIN-term was cloned into the yeast expression 
vectors pREP3 x and pREP8 I x. 
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Chapter 4 
Disruption of plcl 
93 
Introduction 
The p1c] gene was identified in Sz. pombe by several groups simultaneously 
(Ando ct al., 1995; Fankhauser et al., 1995; Slaaby and Davey, 1995). Slaaby 
and Davey, 1995, demonstrated thatSz. pombe deficient in Plcl (Ap1c]) grow 
slowly at low temperatures on rich media and exhibit swollen morphology. 
When cultured under unfavourable conditions, such as high temperature or on 
minimal media, the cells are unable to grow. This restrictive growth of ApIcl 
cells will help to determine the functional role of Plcl in vivo. The selective 
expression of mutants or varied expression levels within Ap1c] cells may induce 
changes in phenotype helping to identify the role of Ple I within the cell. This 
unhealthy phenotype displayed by Ap1c] cells meant that the p1c] disruptant 
strain created by Slaaby (1995) died in a freezer break down so a new p1c] 
disruptant Sz. pombe cell needed to be produced. 
This chapter will summarise the construct produced to disrupt the p1c] gene and 
will describe the Southern blot analysis of pIcI. -. -ura4+ disruptants. Following 
the conformation of the p1c] disruptants through Southern blot it will discuss the 
studies performed helping to identify the role of Plc I within the cell. 
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4.1.1 Creation of the plcl:: ura4+ disruption construct 
The C-terminal section of the X catalytic domain and some of the Y catalytic 
domain were replaced with the selectable marker gene ura4+ (see Chapter 3). 
Briefly, pKSpIcl containing both the untranslated regions upstream (5') and 
downstream (Y) was digested with HindIll. The Hindlll digested 2.5 kb 
fragment containing three quarters of the ORF of p1c] and some of the 
untranslated 3' region was sub-cloned into the HindlII site in pKS. An Nrul and 
BstBI digest was performed on this new clone removing 670 bp which 
encompasses three-quarters of the X and some of the Y catalytic domain. The 
Nrul and the BstBI sites were end-filled and phosphatase treated. The ura4+ 
cassette contains BamHl sites at the end for cloning purposes but it needed to be 
cloned into the end-filled Nrul and BstBI sites inp1c]. The BamHI sites on the 
ura4_ cassette were end-filled and cloned into Nrul and BstBI sites of the p1c] 
construct. The insertion of the ura4+ cassette into the ORF of p1c] created the 
disruption construct. This 3.67 kb fragment can be purified after digestion with 
HindIII (Figure 25) and used for transformation into JY 383 and JY 402 (see 
Materials for genotypes). The construct was transformed into the yeast strains 
using the lithium acetate method and the stable ura4+ transformants were 
initially screened by PCR. Potentially correct strains were confirmed by 
Southern blot analysis. 
4.1.2 Southern blot analysis of plcl:: ura4+ disruptants 
The introduction of a linear HindIll fragment containing the disruption construct 
replaces three quarters of the X domain and a small region of the Y domain (Nrul 
to BstBI) of Plc I. Removal of the X and Y catalytic region was found to 
inactivate mammalian PLCs (Ellis et al., 1993; Yagisawa et al., 1994; Emori et 
al., 1989). By replacing a section of the X and Y catalytic region with the ura4 
cassette it will remove a functional Plc I enzyme from the genome. Genomic 
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DNAs from selected transformants were digested with EcoRl. The DNA was 
separated on a standard 1% agarose gel and transferred onto a nitrocellulose 
filter. The filter was then probed with a radiolabelled 638 bp p1c] fragment 
isolated from pKSpIcI by digestion with Clal and Nrul. 
The Southern blot (Figure 25) identified the strains that had a single ura4+ 
integration at the p1c] locus. The integration of the ura4 cassette was identified 
by a 3.95 kb band, compared to the 2.77 kb band observed from a wild-type 
strain. Once ap1c] disruptant strain was identified the characterisation studies 
could be performed. 
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Figure 25 Southern blot analysis of ApIcI strains 
p1c] was disrupted in aP strain (JY383). Potential p1c] disruptants were 
isolated by PCR and then confirmed through Southern blot. An EcoRI 
digest enabled the identification of the ura4 intergrants as the probe 
binds to a 3.95 kb band. The strains where p1c] has not been disrupted 
the probe binds to 2.77 kb band. The HindIll sites indicate the construct 
which was transformed into wild-type Sz. pombe cells (JY383) to disrupt 
p1c]. 
0'7 
W, 
4.2 Characterisation of ApIcI cells 
4.2.1 The disruption of p1c] affects the growth rate of cells in rich and 
minimal media 
To see if the disruption of p1c] had any effect on cell growth the following 
growth assays were conducted to characteriseplcl. Briefly, cells were cultured 
in rich medium (YEALU) until they reached a concentration of 5x 1 06 cells/ml. 
The cells were then sub-cultured into either YEALU or DMM at a concentration 
Of IX105 cells/ml and left overnight at 230C in a shaking incubator. The reason 
for initially growing the cells in YEALU is because ApIcl cells are known to 
grow in this medium and then they are transferred to the required medium to 
assay their growth rates. The cells were then counted after 12 hrs period. If the 
growth assay was concerned with cellular growth at 370C then after 12 hrs the 
flask was moved to a 37'C shaking water bath. The cell concentration was 
determined every hour over aI 0-hour period to determine the doubling time. 
Figure 25 demonstrates that the disruption of the p1c] ORF in P-cells had some 
effect on the growth rate of cells in rich (YEALU) medium at 230C (Figure 26 
top panel). The doubling time of p1c] + strain was 3 hours compared to the 
doubling time of the ApIcI strain, which was 6 hours. The growth rate of these 
cells was different when measured at 370C. Theplcl+ cells had a doubling time 
of 2.5 hours whereas the ApIcl cells were unable to grow at 370C (Figure 26 
lower panel). 
When the doubling time of p1c] + is compared to ApIcI in minimal (DMM) media 
it can be concluded that Ap1c] cells are unable to grow irrespective of the 
temperature (Figure 27 top and bottom panels). Even at a normally viable 
temperature of 230C Ap1c] cells were unable to grow in DMM- Conversely, 
pIcI+ cells are able to grow at both 230C and 37'C with doubling times of 5 
98 
hours and 3.5 hours respectively. This suggests that Ap1c] cells are unable to 
grow in minimal media. 
It appears that under stressful conditions such as high temperature or minimal 
media ApIcl cells are unable to grow. Under less stressful conditions such as 
rich media and low temperatures there might be an alternative pathway that is 
able to compensate for the loss of Plcl activity. When these cells are placed 
under more stressful conditions such as high temperature and minimal media 
these pathways may not now be able to compensate resulting in cell death. It has 
been shown in S. cere vislae that mutant forms of PLC I (PLC 1 -2 and PLC 1 -4) 
which had no detectable activity in vitro but was detectable through 
immunoblotting were able to complement for the loss of PLC I activity at 25'C in 
A. PLCI cells. This suggests that very small amounts of PLC I activity is required 
for cell growth at 25'C (Yoko-o, et al 1995). At 370C however, PLCI-2 and 
PLC 1 -4 were unable to complement and it was calculated that at least one 
seventh of the wild-type activity is required for cell growth (Yoko-o, et al 1995). 
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Figure 26 Growth rate of ApIcl in rich medium (YEALU) 
Measurement of the growth rate of pIc I+ (circles) and the Ap1c] (squares) 
strains. The top panel demonstrates the ability of these cells to grow in 
rich media at 23'C. The bottom panel demonstrates when exponentially 
growing cells at 23'C were transferred to a 370C shaking water bath at 0 
hrs. The doubling time (td) of each strain is indicated to the right of the 
graph 
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Figure 27 Growth rate of ApIcI in minimal medium (DMM) 
Measurement of the growth rate of pIcJ+ (circles) and the ApIc I (squares) 
strains. Before the growth rate of ApIcI cells were measured in DMM 
they were grown in YEALU, these cells were then collected through 
centrifugation and resuspended in DMM at a concentration Of IX, 05 
cells/ml. The top panel demonstrates the ability of these cells to grow in 
DMM at 23T. The bottom panel demonstrates when exponentially 
growing cells at 230C were transferred to a 37'C shaking water bath at 0 
hrs. The doubling time (td) of each strain is indicated to the right of the 
graph. 
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4.2.2 Expression of Plcl in vivo 
Wild-typep/cl was cloned into the expression vectors pREP3x and pREP8 Ix 
(for constructs see Chapter 3). The constructs pREP3xpIc] pREP81xplcl, 
pREP3x and pREP8 Ix were transformed into ApIc] cells. Approximately five 
thousand of these transformed cells were plated onto DMM plates (see Methods 
2.2.4) with or without thiamine. These plates were incubated at either 23'C or at 
370C and colony formation was recorded by photographing plates on the gel 
documentation system (see Methods, section 2.1.5). 
AnIcI cells are unable to grow on DMM plates irrespective of the thiamine I- 
content or the temperature at which they are incubated (Figure 28). ApIcI cells 
that have been transformed with pREP3x or pREP8 Ix alone are unable to grow 
on DMM plates. As expected, these cells display a phenotype similar to ApIcI 
cells (Figure 28). 
When pREP3xplcl and pREP8 I xp1c] are expressed in vivo the cells display a 
phenotype similar to p1c] + cells. The ApIcl cells expressing pREP3xplcl or 
pREP 81 xp1c] are unaffected by temperature or minimal medium which normally 
results in Ap1c] cell death. Expression levels are controlled by the nmt] 
promoters contained on pREP3x (highest level of expression) and pREP8 Ix 
(lowest level of expression). As discussed in Chapter 3, thiamine controls the 
expression levels of these promoters. In the absence of thiamine the promoter is 
switched on but in the presence of thiamine the expression level of the promoter 
is substantially reduced but not fully switched off. The strong growth of cells 
transformed with pREP8 I xp1c] (Figure 28) indicates that only a small amount of 
PlcI activity is required for ApIcl cells to be rescued on DMM plates at 37'C. 
102 
thiamine - thiamine 
23'C 37'C 23'C 37'C 
pREP8lxPIcl 
'xPlc I pREP 
pR-EP 81x 
pREP3x 
Figure 28 Expression of Plcl in vivo 
pREP3x, o1c], pREP81xp1c], pREP3x and pREP81x alone were 
transformed into ApICI cells. Approximately five thousand of these 
transformants were spread onto DMM plates either with or without 
thiamine (see Methods 2.2.4). The plates were placed at either 
23'C or at 37'C and colony formation was recorded. 
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4.2.3 Determining the cellular phenotype of ApIcI cells 
To determine the cellular phenotype of individual wild-type cells and ApIcl cells, 
the cells were cultured on microscope slides (see Methods section 2.2.3). 
Briefly, the cells are placed on a microscope slide containing a small amount of 
medium containing I% LMP agarose. A cover slip is placed over the top and the 
cells are incubated at the required temperature for 24 hours. The cells are then 
viewed using the Nomarski digital camera (see Methods section 2.2.3). 
From the growth assays it was shown that plcl+ cells are able to grow at both 
23'C and 37'C (see Figure 29). When theplcl+ cells were viewed after 24 hours 
they formed colonies at both 23'C and at 370C (Figure 29). The colonies that are 
formed at 230C consist of about 10 to 15 cells and these cells can be described as 
'barrel shaped'. The colonies formed at 370C consist of about 25 to 30 cells but 
these cells are smaller and fatter (Figure 29). This shape is probably due to the 
increased rate at which these cells are dividing due to the increased temperature. 
The ApIcI cells cultured at 23'C for 24 hrs divided in an irregular fashion (Figure 
29) and colony formation was different to the wild-type cells. When ApIcI cells 
were observed at 37'C after a 24 hrs period, no colonies were observed; instead 
there were elongated cells, which were unable to divide (Figure 29). Sometimes 
there were cells that were up to 4-fold longer than wild-type cells and 
occasionally bulbous-shaped cells were observed (Figure 29). 
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Figure 29 Phenotype of Aplcl cells 
Pictures showing the growth of Sz. pombe cells after 24 hrs incubation 
at 230C or at 370C in slide culture on rich media. The top panel 
displays wild-type P-cells, the bottom panel displays ApIcI cells. 
These photographs were taken on a Nomarski digital camera. 
105 
4.3 Summary 
A construct was designed to produce a p1c I disruptant cell, this linear piece of 
DNA containing the ura4 cassette was transformed into aP cell strain and the 
cells were cultured on medium lacking uracil. The possible p1c] disruptant cells 
were initially screened by PCR and the correct ApIcI confirmed using Southern 
blot analysis. 
The ApIcI were characterised using growth assays. When ApIcI cells were 
cultured in rich medium they were able to grow in at 230C with a doubling time 
(td) of 5 hr but not at 37'C. When the growth rate of ApIcI cells was determined 
in minimal medium the cells were unable to grow irrespective of the temperature. 
This confirmed that ApIcI cells are unable to grow on minimal medium or at 
temperatures of 370C. Conversely, wild-type Sz. pombe cells were able to grow 
on minimal medium at 37'C. This suggests that Plc I may regulate pathways 
that are associated with stress responses such as nutrient starvation and increased 
temperature. 
When pREP3xp1c] or pREP81xplcl was transformed into ApIcI cells they were 
able to rescue the phenotype. The ApIcI cells were now able to grow on minimal 
medium at 37T. 
These studies confirmed that the characteristic phenotypes of ApIcl Sz. pombe 
cells, observed by other groups (Andoh el al., 1995; Fankhauser et al., 1995; 
Slaaby and Davey, 1995) were also detected in this p1c] disruption strain. 
106 
Chapter 5 
The characterisation of Picl 
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5.1 Introduction 
Plc I activity is not detectable in wild-type Sz. pombe cells, so before the 
characterisation of Plc I could be carried out, an assay needed to be developed 
where Plcl activity could be measured in vitro. This chapter describes howpIcI 
was expressed and once activity was detected how its activity was determined. A 
lot of different substrate mixtures are used to assay PLC activity so it also 
discusses which substrate mixture was selected and why. It finally describes the 
characterisation studies including temperature and pH profiles that allowed the 
optimum assay conditions for Plc I to be identified. This assay is used to 
determine how active the Plc I mutants are in vitro (discussed in Chapters 6-8). 
5.1.1 An assay to determine the activity of Plcl 
Sz. pombe cells expressing p1c] are cultured in liquid culture, the cells are 
homogenised and a crude extract of Ple I is produced (see Methods 2.2.2.1). The 
assay is outlined in detail in the Methods 2.2.2.2; briefly, the crude extract 
containing expressed Plc I is added to a substrate containing 3 H-PIP2 and 
incubated at 30'C for the required length of time. After the required length of 
time a mixture of chloroform / methanol is added to the reaction mix to separate 
the substrate 3 H-PIP2 (which is hydrophobic) from the product 3 H-InSP3 (which 
is hydrophilic). The 3 H-InsP3 contained within the aqueous phase can be 
withdrawn and measured using a liquid scintillation counter (see Methods 
2.2.2.2). The rate Of PIP2 hydrolysis under different assay conditions can be 
calculated by plotting IP3 production against time. These linear sections of 
graphs can be used to determine the rate at which PIP2 is hydrolysed to InSP3 and 
DAG over a period of 20 min / mg of total protein (see appendix for an example 
of the calculations). Total protein concentration is used because the activity of 
Plc I is determined in a crude extract prepared from cells and Plc 1 is not purified 
(see Methods 2.1.4 for protein concentration determination) 
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5.1.2 The pR-EP expression vectors 
The pREP vectors are based upon the thiamine-repressible nmt] promoter. The 
nmil gene product is involved in thiamine biosynthesis and consequently the 
level of cellular thiamine tightly regulates the promoter. Therefore, in the 
absence of external thiamine it is highly expressed but is repressed by the 
addition of thiamine to media (Maundrell, 1990; Tommasino, and Maundrell, 
1991). Different expression levels can be obtained by using different versions of 
the pREP vectors that contain mutations within their TATA boxes resulting in 
different expression from the nmt] promoter (Basi, et al., 1993). There are three 
levels of expression that can be attained, the highest level of expression can be 
achieved by using pREP3 x, the intermediate level through pREP41 x and the 
lowest level is through pREP8 I x. The expression levels of these pREP vectors 
can be reduced by 10 fold with the addition of 167ýtg/ml of thiamine to the 
growth medium. 
5.1.3 Expressing Plcl in Sz. pombe 
Since Plc I activity in wild-type Sz. pombe cells is undetectable when measured 
in vitro, expression of p1c] was required so that its activity could be measured in 
vitro. The p1c] gene was therefore, cloned into pREP3x (JD627), pREP4 Ix 
(JD628) and pREP81x (JD629) by Rita Slaaby. These plasmids were 
transformed into the Sz. pombe strains JY330 and JY402, mating type-stable P 
cell and M cell, respectively. These cells were inoculated into two cultures the 
first was DMM containing 167ýtg/ml of thiamine and the second was DMM in 
the absence of thiamine. A crude extract was made from these cells (see 
Methods 2.2.2.1) and activity was measured using the Plc I assay 2.2.2.2). The 
rate at which PIP2 was hydrolysed into InSP3 and DAG was calculated from 
linear sections of a time course graph (see appendix for examples). 
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Figure 30 demonstrates the different levels of Plc I activity detected in vitro using 
the three pREP vectors. It also displays the difference in levels of activity both 
in the presence and absence of thiamine. Figure 30 demonstrates that wild-type 
cells alone have undetectable levels of Plc I activity, as do wild-type cells 
transformed with pREP3x alone. The bars on the graph represent the level of 
background activity probably caused by the natural breakdown Of PIP2- It can 
also be observed that Plc I under the control of the nmt] promoter on pREP3x 
cultured in the absence of thiamine has the highest level of activity, with 
pREP8 Ix being the lowest and pREP41 x being the intermediate. Extract 
produced from cells cultured in the presence of thiamine demonstrates that there 
is very little difference in activity detected between the different pREP vectors 
(pREP3x-p1c1 and pREP8 I x-p1c] have the same amount of activity, data not 
shown). Extracts prepared from cells cultured in the presence of thiamine (see 
Methods 2.2.2.1) have very low Plc I activity levels irrespective of the nmt] 
promoter selected. This Plc I activity however, is still higher than extracts 
prepared from wild-type cells. This suggests that even in the presence of 
thiamine the nmt] promoter is not fully switched off. 
Figure 30 also demonstrates that M cell and P cells have comparable levels of 
Plc I expression, so all other in vitro studies were carried out in P cells. 
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Wild-type cells and cells containing pREP3x alone have undetectable levels of 
Plc I activity. Wild-type cells expressing Plc I from the nmt] promoters in the 
absence of thiamine have different levels of expression, with pREP3xpIcI being 
the highest and pREP8 I xp1c] being the lowest. When pREP3xplcl is expressed 
in the presence of thiamine, the levels of Plc I activity reduced to almost wild- 
type cell levels. Activity of Ple I was used to measure the expression levels of the 
nmt] promoters. The rate of InsP3 production by Plc I was calculated using the 
linear sections of graphs (see Appendix for for an example of the calculations). 
The assay determining Ple I activity under the control of different nmt] promoters 
was performed at pH 7.5,300C and using a sodium cholate concentration of 6.4% 
w/v. The bars represent the standard error of the mean for triplicate 
determinations. 
5.1.4 Expression of Plcl containing the Hexahistidine-tag 
A hexahistidine tag (HiS6) has been shown to assist protein purification (Hidaka 
et al., 1997; Rumbley et al., 1997). The HiS6protein can be purified by metal 
affinity chromatography, this involves the his-tag sequence binding to divalent 
metal ions such as Ni2+, which are immobilised onto a metal chelation resin. The 
HiS6protein binds to the Ni2+_charged resin while other unbound proteins wash 
away. The HiS6protein is then eluted using an elution buffer containing 4M 
imidazole, which is known to be involved in the catabolism of histidine. It 
therefore breaks the bond between the histidine and Ni 2+ , so after the excess 
protein has been washed away the imidazole is used to elute the protein 
containing the HiS6away from the Ni 2+ resulting in a purified protein. 
A Hl*S6-tag was introduced at either the N or C-terminus of p1c] through PCR 
amplification, and cloned into pKS (JD725 and JD726 respectively) (see Chapter 
3, Figures 12 and 13). Double stranded DNA sequencing was performed to 
confirm that the HiS6 had been introduced at either the N- or C-terminus and no 
other errors had been included. The p1c] gene containing the HiS6 was sub- 
cloned into the expression vector pREP3x (JD727 N-terminal HIS6 and JD728 C- 
terminal HiS6, see Chapter 3 sections 3.1.3.1-3.1.1.2). Introducing the H1S6 onto 
the N (HiS6PIC I) and C-terminus (Plc I HiSO was performed with the rationale 
that one of the HiS6 would be exposed from the folded protein allowing Plc I to 
bind to the Ni2+ resin. The constructs pREP3xHis6p1c] and pREP3xplc]HiS6 
were transformed into aP cell (JY330) (see Methods 2.2.1.4), since assays 
carried out on pREP vectors demonstrated there was no difference between 
activity levels of Plc I expressed in P and M cells (Figure 3 0). 
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To confirm that the HIS6 was not having an adverse effect upon Plc I activity, the 
expressed proteins HiS6PIC I and Plc I HiS6 were assayed in vitro using the Plc I 
assay (see Methods 2.2.2.2). Figure 31 demonstrates that the activity of HiS6PIC I 
and Plc I HiS6 was determined in vitro and the HiS6 had no significant effect upon 
activity when compared to wild-type Plc I expressed in aP cell. All further 
constructs produced contain the HiS6 on the C-terminus of Plc I (unless otherwise 
stated, see Chapter 3 Constructs) due to its activity in vitro appeared to be more 
similar to wild-type Plc I- 
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Figure 31 Determining the activity Of HiS6PIC1 and PICIHiS6 
Expression of Plc I HiS6 resulted in activity similar to wild-type Plc I. There was 
a small decrease in activity when the HiS6 was on the N-terminus of Plc I but the 
expression levels were still considerably higher than extract prepared from wild- 
type (JY330) cells. Activity of Plc I was measured using the scintillation 
counter method (see Methods 2.2.2.2) using a substrate containing 3 H-PIP2, PIP2 
and a sodium cholate concentration of 6.4% w/v. The rate was determined at pH 
7.5, and at 300C. The bars represent the standard error of the mean for triplicate 
determinations. 
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5.2 Possible substrate mixtures for PIcI 
The substrate for phospholipase C has already been discussed in Chapterl 
(section 1.3), and it is also known from previous work performed by Rita Slaaby 
that Plc I has the ability to hydrolyse PIP2 into InSP3 and DAG (discussed in 
Chapter I section 1.4.2). A common assay has been developed by many 
different research groups to determine the activity of certain phospholipases in 
Otro. The difference between these research groups, however, is the different 
compounds they mix with PIP2, to create a substrate that allows the 
phospholipase to bind to and hydrolyse PIP2. For example, phospholipids often 
found in mammalian membranes include phosphatidy1choline (PC) and 
pho sphatidyl ethanol amine (PE) are mixed with PIP2 to create a substrate (Martin 
et al., 1996). Lipid substitutes are also used such as sodium cholate (Katan and 
Parker, 1987) and dodecylmaltoside (Wang et al 1996). When sonicated all 
these substrate mixtures create a micellar structure that will permit phospholipase 
C to bind to their structure and facilitate PIP2 hydrolysis. 
5.2.1 Phosphatidyleholine and Phosphatidylethanolamine 
PC and PE are phospholipids commonly found in eukaryotic cell membranes. 
They consist of a polar head group; for example PC has a polar head group 
comprising an inorganic phosphate attached to choline (Figure 32). They have a 
glycerol backbone which generally have two side chains composed of esterified 
fatty acids and alcohols (RI and R2Figure 32). These phospholipids (including 
PIP2) are amphipathic so they contain both polar (hydrophilic) and non-polar 
regions (hydrophobic). When placed in an aqueous environment it causes these 
phospholipids, to spontaneously arrange into ordered structures including, 
micelles, vesicles and membrane bilayers. It is possible that after sonication the 
PC, PE and PIP2 form structures similar to the ones suggested above, permitting 
Plc I to bind and hydrolyse PIP2 
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Figure 32 The chemical structures of PC and PE 
PC and PE have very similar structures and they are common 
phospholipids that are found in eukaryotic membranes. They contain a 
polar head group which is hydrophilic and also contain hydrophobic 
side chains (RI and R2). This results in them creating bilayers within 
cellular membranes, the polar head groups are exposed to the cytosol 
and external surface. 
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5.2.2 Dodecy1maltoside and sodium cholate 
It has been demonstrated that the presence of increasing concentrations of non- 
substrate phospholipids reduces PLC activity indicating that these lipids may 
inhibit enzyme action (James et al., 1995). PIP2 can be mixed with alternative 
substrate mixtures such as dodecylmalto side and sodium cholate (Wang et al., 
1996; Katan and Parker, 1987). Dodecylmaltoside and sodium cholate behave as 
an inert diluent Of PIP2 (Hepler et al., 1993; James et al., 1995; Wu et al., 1997), 
which is able to create a mixed micellar system. Since PLCs operate with 
several lipid binding and then catalytic steps, enzyme activity is dependent upon 
the amount Of PIP2 that is exposed on the surface. 
There are four possible substrate mixtures that can be used to determine the 
activity of Plc 1; these include, PIP2 alone or alternatively PIP2 mixed with PC 
and PE or with dodecylmaltoside or with sodium cholate. Figure 33 
demonstrates that when sodium cholate is mixed with PIP2 it creates a micelle 
that could effectively exposes PIP2 on the surface allowing Plc I to bind and 
hydrolyse PIP2. Dodecylmaltoside however, does not appear to create a micelle 
that exposes sufficient quantities PIP2 on the surface. When Plc I was assayed in 
vitro with this substrate mixture, undetectable levels of Plc I activity were 
observed (Figure 33). When PC and PE were incorporated into the substrate 
mixture (Figure 33) the activity of Plc I was ten-fold lower than when PIP2 was 
mixed with sodium cholate, perhaps this is due to the inhibiting nature of these 
non-substrate phospholipids (James et al., 1995). When PIP2 was used alone as 
the substrate Plcl activity was indistinguishable from background levels (Figure 
33), this suggests that PIP2 on its own is unable to form a substrate which allows 
Plc I to bind and hydrolyse the PIP2. 
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Figure 33 Possible substrate mixtures for Plel 
CIA 
The ability of Plc I to hydrolyse PIP2 in the presence of other lipids 
(PC and PE) or lipid substitutes such as dodecylmalto side and sodium 
cholate. The rate was calculated from linear plots as described in the 
text (see appendix for an example of the calculations). The assay 
conditions include pH 7.5 and at 30'C. The bars represent the 
standard error of the mean for triplicate determinations. 
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5.3 Optimising the conditions for Plcl activity 
5.3.1 A precise ratio of sodium cholate to PIP2 is necessary for Plel activity 
Since the concentration of sodium cholate added to the substrate may affect PIP2 
hydrolysis. It has been shown that if the concentration Of PIP2 is either too high 
or too low then Plc I has a reduced binding and processing affinity for the 
substrate (James et al., 1995), therefore, an optimum ratio of sodium cholate to 
PIP2 was identified. Sz. pombe cells were transformed with pREP3xplc]HiS6 
and the resulting transformants were cultured in DMM minus thiamine. The 
nmt] promoter contained on the pREP vectors is switched on in the absence of 
thiamine but repressed in the presence of thiamine. Extracts were prepared from 
cells expressing Plc I HiS6 and assays were completed in which the concentration 
Of PIP2 remained constant while the concentration of sodium cholate added to the 
PIP2 substrate was increased from 0.16% to 9.6% w/v. The assays were 
performed at 30'C and in 50mM Tris buffer pH 7.5 (see Methods section 
2.2.2.2). This demonstrated that there were significant differences in the ability 
of Plc I to hydrolyse PIP2 depending upon the concentration of sodium cholate 
within the substrate mixture. Figure 34 demonstrates that the optimum 
concentration of sodium cholate that is required for PIP2 hydrolysis is 6.4%. 
Any deviation from this concentration of sodium cholate results in a rapid 
decrease in Plc I activity. Values for the rate of reaction were calculated using a 
time course, measuring the production Of IP3 over a 20 min period. Linear 
sections of the graph were used to calculate the amount of InSP3 produced /min 
/mg protein (see appendix for an example of the calculation). 
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Figure 34 Identifying the optimum sodium cholate concentration when 
assaying Plcl activity in vitro 
The ability of Plc I to hydrolyse PIP2 under different concentrations of 
sodium cholate was investigated using the assay described in the Methods 
section 2.2.2.2. The rate was calculated using linear sections of time course 
graphs as described in the text (see appendix for examples). Activity is 
expressed in pmoles/min/mg protein at a temperature of 300C and a pH of 
7.5. The bars represent the standard range of the mean for triplicate 
determinations. 
120 
10 
5.3.2 Plcl activity is dependent upon temperature 
Crude extracts of Plc I were incubated and assayed at a range of temperatures to 
determine if Plc I activity was dependent upon temperature. A crude extract was 
prepared from ýz. pombe cells transformed with pREP3xp/c]HlS6 (see Methods 
section 2.2.2.1) which were cultured in DMM minus thiamine (the nmt] 
promoter is switched on in the absence of thiamine, see Section 3.1.2). The 
crude extract containing the expressed Plc I was incubated at temperatures 
ranging from 40C to 500C for a 20 min period and the level of Plc I activity was 
detected using the scintillation counter (see Methods section 2.2.2.2). The rate 
was calculated from linear sections of time course graphs to give a temperature 
profile (calculations are described in the appendix). The temperature profile 
(Figure 35) displays a rapid increase in Plc I activity from 40C to 30'C and then a 
rapid decrease in activity as the temperature is increased to 420C. Plc I has a 
specific working temperature of 300C in a 50mM Tris buffer pH 7.5 and a 
substrate containing 6.4% w/v of sodium cholate. Inactivation of Plc I at high 
temperatures is irreversible (Table 1); extracts preincubated at temperatures 
above 42'C are unable to hydrolyse PIP2 once the extracts are returned to 30'C. 
This indicates that Plc I has been heat inactivated. 
The substrate, a sodium cholate / PIP2 mixture was not so sensitive to heat. 
When the substrate was preincubated at a range of temperatures it appeared to be 
intact up to 420C (Table 1). After a 20 min preincubation the substrate was 
returned to 300C and incubated with the extract. At this temperature Plcl could 
still hydrolyse PIP2 suggesting that the substrate had not been denatured by heat. 
Preincubation of the substrate at 500C or above resulted in a small decrease in 
PIP2 hydrolysis. This could be due to some of the micellular structures breaking 
down but as Plc I was inactivated at this temperature this slight reduction would 
not have any effects on the assay. 
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Figure 35 The temperature profile of Plel 
The ability of Ple I to hydrolyse PIP2 under different temperatures was 
investigated using the assay described in the Methods section 2.2.2.2. 
The rate was calculated using linear sections of time course graphs as 
described in the text (see appendix for examples). Activity is expressed 
in pmoles/min/mg protein at a pH of 7.5 and a sodium cholate 
concentration of 6.4% w/v. The bars represent the standard range of 
the mean for triplicate determinations. 
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Assay conditions Activity 
pmoles/min/mg 
protein pH 7.5 
Activity of extract 
pmoles/min/mg 
protein pH7.5 
returned to 300C 
Activity of substrate 
pmoles/min/mg 
protein pH7.5 
returned to 30'C 
30'C 14.6 13.7 15.8 
3 VC 6.0 10.8 15.2 
42'C 0.7 6.5 17.2 
500C 0.3 0.1 8.3 
Table I Determining the nature of temperature inhibition 
When Plc I was preincubated in temperatures above 3 70C for 20 min it was 
irreversibly inhibited. Extracts that were preincubated at 37'C, 42'C and 500C 
were returned to 300C but the enzyme did not retain its full activity, suggesting 
that the activity had not returned due to Plc I being denatured. Substrate 
preincubated at 50'C showed a decrease in activity when returned to 300C. All 
preincubations were for 20min before readjustment to 300C. 
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5.3.3 Plel activity is affected by pH 
Extracts containing expressed Plc I HIS6were prepared in the same way as 
described in Method section 2.2.2.1. The extract was then incubated at different 
pHs over a period of 20 min and Plc I activity was determined using the 
scintillation counter (see Methods section 2.2.2.2). Linear sections of the graphs 
were used to determine the rate Of PIP2 hydrolysis over a pH range of 5.5 to 8.5. 
Using different buffers (50mM concentration for all) with overlapping ranges, 
the effect of pH on Plc I activity was investigated. The different buffers were 
shown to have no effect on the activity of the enzyme (Table 2). The pH profile 
(Figure 3 6) for Plc I is proportionately symmetrical with a relatively tight range 
of enzyme activity, with the enzyme being inactive at pHs 5.5 and 8.5. Plc I has 
an optimum working pH of 7.5, at a temperature of 300C and a sodium cholate 
concentration of 6.4% w/v. 
The pH value at which the enzyme has 50% of the maximal rate corresponds to 
the pKa values of amino acids within the active site of the enzyme. These amino 
acids that correspond to the pKa values are concerned with the binding and 
selecting of substrates. The pKa values of Plc I correlate to pH 6.5 and pH 8.1. 
The amino acid that has a pKa value in the region of pH 6.5 is histidine (pKa 
6.04). Cysteine has a pKa value of 8.33, which is comparable to the value of 8.1 
seen in Figure 36. Figure 45 (Chapter 7) demonstrates that there are both 
histidines and cysteine amino acid residues present within the active site of Rat 
PLC-6. As there is a high percentage of amino acid similarity conserved 
between the X and Y catalytic regions (Figures 37 and 44) it may be possible that 
these amino acid residues are involved in the activity of Plc I. 
Even though Plc I is inactive at the extreme pH of the curve (pH 5.5 and pH 8.5), 
this inactivity is reversible (Table 3). Preincubation of the extracts in either pH 
5.5 or pH 8.5 for 20 min before replacing them back to pH 7.5 results in the 
enzyme regaining most of its activity, suggesting it is reversibly 
inhibited. 
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Figure 36 pH profile of Plcl 
The ability of Plc I to hydrolyse PIP2 under different pH conditions was 
investigated using the assay described in the Methods section 2.2.2.2. 
Two buffers (MES and Tris) at a concentration of 50mM were used to 
assay Plc I activity over this pH range. Activity is expressed in 
pmoles/min/mg protein at 300C and a sodium cholate concentration of 
6.4% w/v. The bars represent the standard range of the mean for 
triplicate determinations. 
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Buffer type (50mM) 
MES 
pH of the assay 
5.5 
Plc I activity 
p ioles/min/mg protein 
0.9 
MES 6.8 13.1 
Tris 6.8 11.6 
Tris 8.5 1.6 
Table 2 Control assays to determine Plel. activity using different buffers 
Two overlapping pH buffers were used to determine the pH profile of Plc 1. The 
overlaps of the buffers (pH 6.8) were assayed to justify that the buffer 
composition was not having any effect upon Plc I activity. The assays were 
performed at 30'C and the substrate contained a sodium cholate concentration of 
6.4% w/v. 
Assay conditions Activity of extract 
pmoles/min/mg protein 
Activity of extract 
pmoles/min/mg protein 
returned to pH7.5 
pH 5.5 0.9 17.2 
pH 7.5 19.2 18.4 
pH 8.5 1.6 16.3 
Table 3 Determining the nature of pH inhibition 
After a 20 min preincubation at pH 5.5 and pH 8.5, the extract is returned to pH 
7.5 where Plc I activity is restored. This suggests that Plc I is reversibly inhibited 
by pH. The assay was carried out at 300C and with a substrate containing 6.4% 
w/v sodium cholate, using the Plcl assay (see Methods 2.2.2.2). 
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5.4 Summary of the characterisation of Plcl 
Using a crude extract prepared fromSz. pombe cells expressing Plcl, 
characterisation has been accomplished. Different levels of PlcI activity were 
obtained by using the three different pREP expression vectors. The expression 
vector pREP3xplcl had the highest level of activity, pREP8 I xp1c] had the 
lowest level of Plc I activity with pREP41xplcl being somewhere in the middle. 
This result was expected as the nmt] promoter found on pREP3x is supposed to 
give the highest level of protein expression whereas the nmt] promoter on 
pREP8 Ix should give the lowest. This indicates that there is a positive 
correlation between Plc I expression levels and Plc I activity. The addition of a 
HiS6 to either the N or C-terminus of Plc I resulted in no change in activity when 
assayed in vitro. 
From Figure 33 it was determined that PIP2 mixed with sodium cholate appeared 
to create a structure that allowed Ple I to bind and hydrolyse PIP2. It was then 
determined that the optimum concentration of sodium cholate, which was mixed 
with PIP2, was 6.4% w/v. Deviation from this concentration appears to result in 
a decrease in Plc I activity. 
Activity of Plc I increases with increasing temperature up to 30'C but above this 
temperature Ple I is irreversibly inactivated. The substrate mixture Of PIP2 and 
sodium cholate is unaffected by the temperature range used in this study. 
The optimum pH for Plc I was established to be pH 7.5, and the pKa values 
obtained from the pH profile suggest that histidine and cysteine may be involved 
in catalytic activity. After preincubation at pH 5.5 and pH 8.5 the extract is still 
active when returned to pH 7.5. This suggests that Plc I is reversibly inhibited by 
the extreme pHs investigated in this study. 
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Chapter 6 
Investigating the role for Plel signalling in Sz. pombe 
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6.1 Introduction 
It is known that Plc I is involved in the hydrolysis of phosphoinositide lipids to 
create second messengers but the role of these second messengers and thus the 
role of Plc I within Sz. pombe cells is unknown. The disruption of p1c] in Sz. 
pombe cells resulted in slow-growing cells and a distinctive phenotype (see 
Chapter 4). One way in which the role of Plc I could be investigated is by 
creating strains where the activity of Plc I could be controlled. This chapter will 
describe how temperature sensitive mutations in S. cerevisiae PLC I were used to 
introduce mutations in Sz. pombe Plc I that may result in a temperature sensitive 
enzyme. Once the mutations have been introduced this chapter will discuss how 
these mutants were characterised. This included determining their level of 
activity at different temperatures using an in vitro assay (described in Chapter 2, 
section 2.2.2.2) and assessing their activity when expressed in vivo. When the 
mutants were expressed in vivo, cell growth on DMM plates (described in 
Chapter 2, section 2.2.4) and cell culture doubling times at different temperatures 
were used to confirm their level of temperature sensitivity. Analysis of these 
mutants using the above methodology may indicate possible roles for Plc I and 
the second messengers it produces within Sz. pombe cells. 
6.1.1 The role of Plcl might be discovered through controlled expression 
If Plc I activity could be switched on and off the initial effects of a cell lacking 
Plc I could be observed and this might suggest a possible role for Plc I- One way 
of achieving this is to create a temperature sensitive mutation within the open 
reading frame of p1c]. Cells growing at low temperatures would contain an 
active Plc I but when incubated at a higher temperature Plc I activity would 
cease. 
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6.1.2 Using S. cerevisiae PLO as a model 
In the yeast S. cerc0siae, five temperature sensitive PLC] mutants were 
identified following in vitro mutagenesis (Yoko-o et al., 1995). These 
temperature sensitive mutants were created by amino acid substitution within the 
X or the Y catalytic domains (Yoko-o et al., 1995). There were two mutants that 
demonstrated true temperature sensitive phenotypes when assayed in vitro 
whereas, the others had no detectable activity in vitro but were detectable 
through immunoblotting. This indicates that the mutations resulted in a major 
change in the enzymes active site without affecting its tertiary structure domains 
(Yoko-o et al., 1995). 
One of the mutations within PLC] was identified in the X catalytic domain; a 
glycine residue was substituted for a serine, a second mutation was in the Y 
catalytic domain where an arginine was substituted for a cysteine (Yoko-o et al., 
1995). The catalytic domain is conserved among PLC isozymes so the X and Y 
regions of Sz. pombe, S. cerevisiae and mammalian PLCs can be compared to 
show regions of sequence similarity within these domains (Figure 37). These 
same mutations created in S. cerevisiae PLC] can be introduced into Sz. pombe 
Plc 1, [serine was substituted for glycine in the X catalytic domain (Plc I [G481 S]) 
and arginine was substituted for cysteine in the Y catalytic domain 
(Plc I [R8 73 Q] through PCR amplification and then sub-cloned into the pREP 
vectors (see Chapter 3, Figures 19 and 20). Double stranded DNA sequencing 
(see Chapter 2 section 2.2.1.5) was used to confirm that the mutation had been 
introduced and that the rest of the sequence was correct. These mutants could be 
used to help identify the role of Plc I within the cell. 
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X region 
s 
Sz. p plcl 463 QFGGESSIEGYIRSLQRGCKCIEIDCWDG 
S. c PLC] 385 QIAETPSVEGYIQVLQQGCRCVEIDIWDG 
Rat PLC-p 1 321 QLAGNSSVEMYRQVLLSGCRCVELDCWKG 
Human PLC-P2 317 QFSGLSSAEblYRQVLLSGCRCVELDCWKG 
Rat PLC-P3 303 QLAGTSSVEMYRQALLWGCRCVELDVWKG 
Rat PLC-P4 318 QFGGKSSVEMYRQVLLAGCRCVELDCWDG 
Rat PLC-, yl 325 QFSSESSLEAYARCLRMGCRCIELDCWDG 
Rat PLC-y2 317 QLRSESSTEAYIRCLRAGCRCIELDCWDG 
Rat PLC-81 301 QLTGPSSTEAYIRALCKGCRCLELDCWDG 
Bovine PLC-82 295 QLCGQSSVEGYIRALKRGCRCVEVDIWDG 
Y region 
c 
Sz. p plcl 859 FANFTCPIDRLQQGYRHIRLLNMQGENL 
S. c PLC] 830 IASVCLKLNYLRMGYRHIPLFNMRGEQY 
Rat PLC-p 1 757 IGHRILPVQAIRPGYHYICLRNERNQPL 
Human PLC-P2 759 LGHRIIPINALNSGYHHLCLHSESNMPL 
Rat PLC-P3 788 VGHRILPVSAIRSGYHYVCLRNEANQPL 
Rat PLC-P4 782 IGQRILPLDGLQAGYRHISLRNEGNKPL 
Rat PLC-, yl 1173 LAQATFPVKGLKTGYRAVPLKNNYSEDL 
Rat PLC-72 1148 LAHATYPIKGIKSGFRSVPLKNGYSEDI 
Rat PLC-81 716 IGQSTIPWNSLKQGYRHVHLLSKNGDQH 
Bovine PLC-82 717 IGQYTLPWSCMQQGYRHIHLLSKDGLSL 
Figure 37 Comparisons of the amino acid sequence in eukaryotic PLCs 
Comparisons of the amino acid sequence of the X and Y regions of Sz. pombe, 
S. cerevisiae and mammalian PLCs. The positions at which the amino acids are 
identical to Sz. pombe are coloured red. The position of the substitution creating 
a temperature sensitive S. cerevisiae PLC] is coloured blue and the substituted 
amino acid is shown above the blue amino acids. These substitutions were made 
in Sz. pombe p1c] by PCR (see constructs Chapter 3, Figures 19 and 20). The 
position of the amino acid residues is indicated to the left of each sequence. 
I'll 
6.2 Expression of the temperature sensitive mutants in vitro 
The open reading frames of Ple I [G481S] and Plc I [R873C] were subcloned into 
the expression vector pREP3x (see Chapter 3 for constructs). Sz. pombe cells 
transformed with these constructs were cultured at 230C in DMM minus 
thiamine. The nmt] promoter found on the pREP vectors is switched on when 
cells are cultured in the absence of thiamine resulting in increased expression 
levelsofp1c]. Crude extracts were prepared from cells expressing the Plcl 
mutants (see Methods section 2.2.2.1) so that the activity of these Plc I mutants 
could be measured in Otro using the Plc I assay (see Methods section 2.2.2.2). 
6.2.1 Plcl mutants are more sensitive to temperature when assayed in vitro 
Crude extracts of cells expressing wild-type Plc I, Plc I [G481S] and Plc I [R873C] 
were incubated and assayed at a range of temperatures to determine if the activity 
of the mutants was sensitive to temperature. The temperature profile of wild- 
type Plcl (Figures 38 and 39) demonstrates that there is a rapid increase in Plcl 
activity from 40C to 300C. When wild-type Plcl was assayed at 370C the activity 
was reduced by almost 50% and when assayed at 420C there was a further 
reduction in Plc I activity. The temperature profile of Plc I [R873 C] (Figure 3 8) 
shows an increase in activity from 40C to 300C. This increase in activity 
corresponds to the increase in activity seen by wild-type Plc I. When the 
temperature is increased above 300C a decrease in activity is seen; this reduction 
in activity is comparable to the wild-type Plc I. When assayed in vitro at a range 
of temperatures, Plc I [R873 C] and wild-type Plc I appear to have similar 
activities. 
The temperature profile of Plc I [G481 S] (Figure 39) was investigated over a 
range of temperatures, from 40C to 300C. Over this temperature range, the 
activity of Plcl[G481S] shows a similar profile to that of wild-type Plcl. 
When 
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the temperatures were increased to 3 VC the Plc I [G481 S] extract was inactive, 
while the wild-type Plc I retained approximately 50% of the maximum activity. 
When assayed in vitro it would appear that Plc I [G481 S] is more temperature 
sensitive than wild-type Plcl, it is inactivated at 370C which is normally a 
permissive temperature for wild-type Plc I- 
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Figure 38 The temperature profile of Plcl [R873C] 
F, Pic I 
El Plcl[R873C] 
The activity of Plc I [R8 73 C] was compared to wild-type Plc I over a range of 
temperatures. This was investigated using the assay described in the Methods 
section 2.2.2.2. Plc I activity is expressed in pmoles/min/mg protein at a pH of 7.5 
and a sodium cholate concentration of 6.4% w/v. 
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Figure 39 The temperature profile of Plel [G481S] 
El Pici 
ED Plc][G481S] 
The activity of Plc I [G48 I S] was compared to wild-type Plc I over a range of 
temperatures. This was investigated using the assay described in the Methods 
(section 2.2.2.2). Plc I activity is expressed in pmoles/min/mg protein at a pH of 
7.5 and a sodium cholate concentration of 6.4% w/v. 
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6.2.2 Preparation of the extract is vital in producing functional Plcl 
mutants 
In this chapter it has already been demonstrated that the mutant Plc I [G481 S] is 
more sensitive to temperatures above 300C than wild-type Plcland the mutant 
Plcl[R873G]. The extracts used in these assays were produced from cells 
cultured at 23'C. The next step was to discover if cells cultured at high 
temperatures (for example 370C) affected the activities of both wild-type Plcl 
and the mutants when assayed in vitro. The following constructs were 
transformed into P cells; pREP3xp1c], pREP3xp1c1[R873C] and 
pREP3xplcl [G481 S] (see Chapter 3 for constructs). The transformed cells were 
cultured at either 230C or at 37'C. Crude extracts containing the expressed 
enzyme were prepared from these cells and were assayed at 300C in vitro using 
the Plc I assay (see Methods section 2.2.2.2). 
When extracts prepared from cells expressing wild-type Plc I were assayed in 
vitro there was no difference in activity between the extracts prepared from cells 
cultured at 23'C or 37'C (Table 4). Extracts of wild-type Plc I prepared from 
cells cultured at 23'C and assayed at 300C had 14.9 units of activity and wild- 
type extracts prepared from cells cultured at 37'C but assayed at 300C had 14.6 
units of activity. Extract prepared from cells cultured at 23'C expressing 
pREP3xplcl [R873 C] and assayed at 3 OT resulted in a Plc I which had a level of 
activity similar to the wild-type Plc I. Extract prepared from cells cultured at 
37'C and assayed at 30'C resulted in a decrease in activity of about 70% when 
compared to Plc I [R873] extract prepared from cells cultured at 230C (Table 4). 
Extract prepared from cells cultured at 230C expressing pREP3xpIc] [G481 S] and 
assayed at 3 OT produced a Plc I that had similar activity to the wild-type Plc 
I 
Extracts of Plc I [G481 S] prepared from cells cultured at 3 70C and assayed at 
300C resulted in an inactive Plcl (Table 4). 
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This data suggests that the mutant Plc I [G481 S] is probably temperature sensitive 
but the mutant Plc I [R873C] is not as sensitive to temperature as its temperature 
profile closely resembles wild-type Plc I 
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Plc I construct Activity IP3 release Activity IP3 release 
pmoles/mInJmg protein pmoles/min/mg protein 
Cells cultured at 230C, Cells cultured at 37'C, 
extracts assayed at 300C extracts assayed at 300C 
pREP3xplcl 14.9 14.6 
pREP3xpIcI[R873C] 17.2 5.0 
pREP-3)xpIc1[G481S] 15.4 0.1 
Table 4 Demonstrating cellular growth temperature is vital in producing 
functional Plcl mutants. 
Wild-type Plc I expressed in cells cultured at either 23'C or 370C has the same 
activity when measured in vitro. Cells cultured at 37'C expressing the mutated 
forms of Plc I resulted in an inactive mutant (pREP3xpIcI [G481 Sj) and a mutant 
which had less activity (pREP3xp1cI[R873C]) than wild-type Plc I when assayed 
at 300C in vitro. Activity is expressed as pmoles/ min/ mg protein at 300C, pH 
7.5 and a sodium cholate concentration of 6.4% w/v. 
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6.3 Expression of the Plcl mutants in vivo 
Chapter 4 demonstrated Sz. pombe cells lacking Plc I are only able to grow on 
rich media such as YE and at low temperatures such as 230C. Figure 28 (Chapter 
4) indicates that ApIcl expressing the pREP vectors alone are unable to grow on 
DMM plates irrespective of the temperature or the thiamine content. ApIc] 
expressing wild-type Plc I are able to grow at 23'C and 370C. This growth is not 
dependent upon the expression levels of Plc I (pREP3 x and pREP8 I x) as growth 
was seen irrespective of the promoter or the thiamine concentration in the plates. 
6.3.1 Cell growth is not dependent upon the expression levels tested 
Wild-type Plc I, Plc I [R873C] (under the control of the nmt] promoters on 
pREP3x and pREP8 I x), pREP3x and pREP8 Ix vector alone were transformed 
into P cells ApIc] (see Chapter 3 Figures 19 and 20). Cells transformed with 
these constructs were then cultured in culture overnight and 5x 103 cells were 
spread on each of a series of DMM plates: 
DMM plus thiamine 
DMM minus thiamine 
DMM plus thiamine 
DMM minus thiamine 
incubated at 23'C 
incubated at 23'C 
incubated at 37'C 
incubated at 37'C 
Replicate plates were then placed at 23 0C or 37 OC and colony formation was 
recorded (see Methods 2.2.4) (Figure 40). 
Plcl [R873C] expressed in vivo displays a phenotype similar to the wild-type. 
Within the specific parameters that this study was investigating the Aplcl cells 
expressing Ple I [R873 C] were unaffected by temperature or level of expression 
(Figure4l). This suggests that the mutant Plcl[R873C] does not demonstrate 
the temperature sensitive phenotype that was discovered from a similar sequence 
mutation identified in S cerevisiae PLC I (Yoko-o et al., 1995). 
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Figure 40 demonstrates that ApIcI cells expressing pREP vector alone are unable 
to grow on DMM plates, ApIcI cells expressing wild-type Plc I are able to grow 
at either temperature both in the presence and in the absence of thiamine. The 
mutant Plc I [G481 S] which is under the control of the nmt] promoters on 
pREP3x and pREP8 Ix was transformed into ApIcl cells. When this mutant is 
expressed in vivo (Figure 41) it can be seen that cells are able to grow at 230C but 
are unable to grow at 37'C irrespective of the thiamine concentration. This 
strongly suggests that Plc I [G48 I S] is a temperature sensitive mutation. 
6.3.2 In vivo growth assays 
The growth characteristics of the temperature sensitive Plc I strains were 
investigated (pREP8 I xp1c] [R873C] and pREP8 I xp1c] [G481 S]). The mutant 
strains had doubling times (td) of 5 hrs and 5.5 hours respectively (Figure 42, 
panel A), which is similar to the wild-type strain (JY 383) incubated at 23'C in 
DMM (Chapter 4, Figure 27). The ApIcI strain is unable to grow in selective 
medium such as DMM but is able to grow very slowly in a. a. medium. Although 
a. a. medium has been shown to isolate auxotrophic mutants, it contains more 
nutrients than DMM thus, ApIcI cells are able to grow very slowly in a. a. 
medium at 23'C (td: 6 hr). When cells growing exponentially were shifted to 
37'C (Figure 42, panel B), the ApIcI strain stopped growing; this is because 
under stressful conditions such as high temperature and minimal medium ApIcI 
cells are unable to grow (see Chapter 4). The mutant strains behaved differently 
when compared to the ApIcI cells, pREP8lxpIcI[R873C] continued to grow over 
the 10 hrs assay period with a doubling time of 4 hrs but this was at a slower rate 
than wild-type strain which had a doubling time of 3.5 hrs in DMM (see Figure 
27, Chapter 4). The other mutant, pREP8lxpIc][G48lS] when incubated at 370C 
grew for the first 4hrs but no further growth was observed over the next six 
hours. This confirmed that the mutation G481 S was temperature sensitive and 
that the mutation R873C was not. 
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+ thiamine - thiamine 
23'C 37'C 23'C 37'C 
pREP8lxPIcl 
p REP3xPIc I 
pREP81x 
pREP3x 
Figure 40 Expression of the Plel and the pREP vectors in ApIcl cells 
Plc I under the control of pREP3x and pREP8 Ix nmt] promoters, pREP3x and 
pREP8lx alone were transformed into ApIc] cells. Five thousand of these 
transformants were plated out on DMM plates either containing thiamine or 
without thiamine, these plates were incubated at either 
230C or at 37'C and 
colony formation was noted after 4 days (see Methods 
2.2.4). 
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+ thiamine - thiamine 
23'C 37'C 23'C 37'C 
pREP81x 
Plcl[G481S] 
pREP3x 
Plc I [G48 I S] 
Figure 41 Expression of the Plcl mutants in vivo 
Plc I [R873C], Plc I [G481S] (under the control of pREP3x and pREP8 Ix nmt] 
promoters), were transformed into ApIcl cells. Five thousand of these 
transformants were plated out on DMM plates either containing thiamine or 
without thiamine, these plates were incubated at either 230C or at 
370C and 
colony formation was noted after 4 days (see Methods 2.2.4). 
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Figure 42 Growth assays 
APIC 1 
Plcl[R873C] 
Plc 1 [G48 1 S] 
td: 5 hrs 
td: 5.5 hrs 
td: 6 hrs 
A Plc I 
Plcl[RS73C] 
Plc I [G48 I S] 
td: 4 hr 
td: unable to divide 
td: unable to divide 
Growth curve of temperature sensitive mutants Plc I [R8 73 C] (squares), 
Plc I [G481 S] (triangles) and ApIcI cells (circles). Panel A demonstrates 
these cells grown in at 230C in AA media. Exponentially growing cells 
were transferred to a 370C shaking water bath (Panel B) at 0 hrs. Cell 
numbers were determined using a Coulter Channelyser (see Methods 
2.1.7). 
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6.4 Cells lacking Plel display a very distinct phenotype 
It is known that ApIcl cells display a very distinct phenotype that was described 
in Chapter 4. Assays performed on Plc I [G481 S] in vitro and in vivo confirmed 
this to be a temperature sensitive mutation which was inactivated at 370C. Now 
that a temperature sensitive Plc I had been produced, the next step was to observe 
cells expressing a functional Plc I at 230C, then shift them to 37'C switching off 
Plc I activity. This will demonstrate the initial effects of a cell without Ple I 
activity and may give an insight into the role of Plc I within Sz, pombe cells. 
Cells cultured on microscope slides were used (see Methods section 2.2.3) to 
observe single ApIcI cells expressing Plc 1, Plc I [R873 C] and Plc I [G481 S] in 
either a 23'C or 370C environment. Briefly the cells were cultured in culture at 
23'C and were then transferred to a slide containing I% LMP agarose plus the 
appropriate media. After a 24 hrs period photographs of the cells were taken 
using the Nomarski digital camera. Wild-type Sz. pombe cells are able to grow 
equally well at both 23'C and 37'C, forming small colonies after 24 hrs (Figure 
43). This same phenotype is observed by ApIcl cells expressing Plcl [R873C] 
(Figure 43). The ApIcI cells however, form irregular colonies at 230C after a 24 
hrs period, no colonies are seen when cells taken from the same culture and 
incubated at 37'C. Instead there are elongated cells, which are unable to divide 
across the septum, and sometimes-small bulbous-shaped cells can be seen 
suggesting perhaps cell wall or membrane defects within the cell (Figure 43). 
The same phenotype is seen in cells expressing Plc I [G481 S] (Figure 43) except 
that at 230C the formation of colonies is more regular (similar to wild type cells). 
At 370C these cells are unable to divide forming elongated structures and small 
bulbous cells. These pictures do not confirm the role of Plc 
I but they do indicate 
that Plc I is involved in functions such as cell growth and that it may play a role 
in osmoregulation. 
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P cell A p1c] 
P cell A p1c] 
Plc I [G481 S] 
P cell A p1c] 
Plc I [R873 C] 
Figure 43 Phenotype of Aplcl cells 
Pictures showing the growth of Sz. pombe cells after 24 hrs incubation at 23'C or at 37'C 
in slide culture on rich media. The top panel displays wild-type P-cells, the next panel 
displays Ap1c] cells. The bottom two panels display the mutants Plc I [G481 S] and 
Plc I [R873 C1. It demonstrates that at 230C ApIcl cells expressing Plc I [G481 S] grows in a 
similar fashion to wild-type cells, but when incubated at 37'C these cells are unable to 
divide displaying a phenotype similar to Ap1c] cells. The mutant Plcl[R873C] when 
expressed in Ap1c] cells displays a phenotype similar to wild-type Sz. pombe cells. These 
photographs were taken using a Nomarski digital camera. 
3 70C 
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6.5 Summary 
Using S. cerevisiae PLC I as a model, a temperature sensitive Sz. pombe Plc I has 
been isolated and characterised. The mutation that results in the temperature 
sensitive Plc I phenotype is G481 S. Another mutant, R873C was created based 
on S. cerevisiae PLC I but this was found to exhibit a phenotype similar to wild- 
type Plc I when expressed from the pREP vectors. 
When Plc I [G481 S] was assayed in vitro over a temperature range from 4'C to 
30'C it had an activity similar to wild-type Plcl. At370CPlcl[G481S] became 
inactivated whereas wild-type Plc I retained about 60% of the maximum activity. 
When Plc I [G481 S] was expressed in vivo in ApIc I Sz. pombe cells it was able to 
rescue these cells on minimal media at 230C but when placed at 370C it was 
unable to complement irrespective of expression levels. The growth assays 
demonstrate that cellular growth stops after about 4 hrs incubation (one doubling 
time) at 370C. 
When individual ApIcl cells expressing Plc I [G4 8 IS] were analysed, at 23'C 
they formed normal organised colonies similar to cells expressing wild-type 
Plcl. When ApIcl cells expressing Plcl[G481S] were shifted to 37'C however, 
they were unable to divide and created bulbous structures suggesting that Plc I 
may play important roles in cell division, cell organisation and perhaps even 
osmoregulation. 
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Chapter 7 
Identifying the possible substrates for Plcl 
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7.1 Introduction 
The substrates for pombe Plc I are unknown. Assays have shown that it has 
the ability to hydrolyse PIP2 efficiently but this may not be its only substrate or 
even its major substrate. If PIP2 is the primary substrate of Plc I then the 
products of its hydrolysis (InSP3 and DAG) may play an important role within the 
Sz. pombe cells. Searches carried out on the S. cerevisiae and Sz. pombe genomes 
were unable to identify an InSP3 receptor within yeast cells. InSP3 in yeast is 
probably not involved in Ca 2+ release from intracellular stores. Instead its 
principal function could be as a precursor for the production of alternative 
inositol polyphosphates. Conversely, DAG has been shown to be an important 
activator of PKC which regulates other signal transduction pathways (Nishizuka, 
1988). 
Mutations identified in mammalian PLCs resulted in a change in specificity for 
its substrate. Instead of the PLCs preferentially hydrolysing PIP2>PIP>P1 they 
were now only able to hydrolyse Pl. If similar mutations could be introduced 
into Plc I, this may help identify the role of Plc 1. These mutations might also 
indicate the importance Of PIP2 concentration or the production of InSP3 and 
DAG, it may even highlight the importance of all of these factors. 
This chapter will initially describe the mutations that resulted in altered substrate 
specificity within mammalian PLCs. It will demonstrate which mutations were 
introduced into Sz. pombe Plc I and why those changes were made. Finally this 
chapter will describe the experiments performed on the Plc I mutants attempting 
to elucidate a possible role for Plc 1. 
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7.1.1 Mammalian PLCs are able to hydrolyse PIP2, PIP and PI 
Although mammalian PLC isozymes differ in the way that they are regulated, 
they have similar enzymatic properties. The three members of the PLC family; 
P, 7 and 6 contain both and X and Y catalytic domains, enabling them to 
recognise PI, PIP and PIP2 (Cheng et al., 1995). Once bound to the substrate, 
PLCs can carry out Ca 2+ -dependent hydrolysis of these phosphoinositide lipids, 
Prokaryotic PLCs do not contain the conserved Y catalytic domain that is seen in 
mammalian PLCs (Kuppe ef al., 1989). The active site of bacterial PLCs 
therefore are unable to recognise PIP or PIP2 but are able to bind and hydrolyse 
Pl. PI hydrolysis by bacteria is independent of Ca 2+ , another factor that 
distinguishes prokaryotic PLCs from eukaryotic PLCs (Cheng et al., 1995). 
7.1.2 The substrate of Plcl 
From comparisons of amino acid sequences (Figure 44) it can be seen that Plc I 
from Sz. pombe contains an X and Y catalytic domains with significant sequence 
similarity to mammalian PLCs. This suggests that Plc I displays more similarity 
to eukaryotic PLCs than prokaryotic PLCs. The products Of PIP2 hydrolyses by 
mammalian PLCs result in the production of InSP3, which is hydrophilic, and a 
hydrophobic product, DAG. It is known that when Plc I activity is measured in 
vitro the scintillation counter is used to detect a hydrophilic radioactive product 
(see Methods 2.2.2.2). This product was likely to be an inositol phosphate, so 
the hydrophilic products were passed through a dowex column and then loaded 
onto a HPLC column. Fractions were collected and were compared to the elution 
time of the standards inositol polyphosphates (Work done by Rita Slaaby). This 
confirmed that Plcl hydrolysed PIP2 into Ins 1,4,5-P3 (InsP3) and DAG. As Plcl 
contains the X and Y catalytic domain and it is able to hydrolyse PIP2 it is likely 
that it also has the ability to hydrolyse PIP and PI similar to other higher 
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eukaryotic, PLCs. Alternatively, it may have a single specificity as demonstrated 
by bacterial PLCs. 
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X region 
R/A 
Sz. p plcl 567 VLPSPEDLLNKILLKVXCSATP 
S. c PLC] 499 TRTDKLPSPRELKHKILLKSKK 
Rat PLC-p 1 444 ESGVPLPSPMDLMYKILVKNKK 
Human PLC-p2 440 KPGVPLPSPEDLRGKILIKNKK 
Rat PLC-p3 426 SAGTPLPSPQDLMGRILVKNKK 
Rat PLC-yl 441 IAADGLPSPNQLKRKIIIKHKK 
Rat PLC -y2 433 ASADQLPSPSQLREKIIIKHKK 
Human PLC-61 417 GVTNSLPSPEQLKGKILLKGKK 
Y region 
K/L 
Sz. p plcl 679 MVPRLSKHNLRYLCRVYPGPLRVG 
S. c PLC] 630 LKLSLDKHNRRYLMRVYPHVLRYK 
Rat PLC-0 1 583 SPVEFVEYNKMQLSRIYPKGTRVD 
Human PLC-P2 585 SNVQFVDYNKRQMSRIYPKGTRMD 
Rat PLC-03 615 SPMEFVEYNKQQLSRIYPKGTRVD 
Rat PLC-yl 996 KGKKFLQYNRLQLSRIYPKGQRLD 
Rat PLC-y2 973 KPVDLLRYNQKGLTRVYPKGQRVD 
Human PLC-61 535 SGNGFVRENVGHLSRIYPAGWRTD 
Figure 44 Comparison of the amino acid sequences within the X and Y regions of 
eukaryotic PLCs 
Comparison of the amino acid sequences within the X and Y regions of Sz. pombe, S. 
cerevisiae and mammalian PLCs- The positions at which the amino acid sequence is 
identical to Sz. pombe is marked in red. The position of the substitution creating a 
substrate specificity mutant in Human PLC- 6 (Y catalytic domain), Human PLC- P (X 
catalytic domain) are marked in blue. The amino acids substituted in Sz. pombe p1c] are 
shown above the blue amino acids in black. The amino acids marked in green in the X 
catalytic region are a basic amino acid motif [(K/R)xxxKxK(K/R)]; x denotes any amino 
acid, this motif has been shown to be present in most PLCs and PIP2actin binding 
proteins but is not found in Sz. pombe Plc I. The number of the amino acid is indicated to 
the left of each an-uno acid sequence. 
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7.2 The active site of phospholipase C 
The X and Y catalytic domains are highly conserved among eukaryotic PLCs 
(Figures 37 and 44). Presence of the conserved X and Y domains is essential for 
PLC activity, deletion of either the X (Ellis et al., 1993 and Yagisawa et al., 
1994) or the Y domain (Emori et al., 1989) inactivates the enzyme. 
7.2.1 Precise amino acid configuration within the active site is essential for 
PLC activity 
The X catalytic domain of most PLCs and actin binding proteins such as gelsolin 
contain a basic amino acid motif (Figure 44 green letters) [(K/R)xxxKxK(K/R); 
x denotes any amino acid], which represents a possible PIP2 binding site. 
Replacing one or several residues within this motif results in reduced enzyme 
activity (Simoes et al., 1995). Replacement of lysine 461 (Lys461) within this 
motif results in complete loss of PLC-P activity (Simoes et al., 1995). Lys 461 is 
conserved among most eukaryotic PLCs including Sz. pombe p1c] but p1c] is the 
only eukaryotic PLC that does not contain this basic amino acid motif seen in all 
other PLCs (Figure 44 green letters). This suggests that Lys461 may be a 
catalytically important residue within the X catalytic domain. The homologue of 
lys461 in Sz. pombe Plc I is lysine 582 (Lys 582) and can be identified in the X 
catalytic domain (Figure 45). Other residues that may be catalytically important 
in the X domain include arginine 338 and histidine 356. Replacement of these 
residues with leucine results in no detectable PIP2 or PI hydrolysis in human 
PLC-61 (Cheng, et at., 1995). Replacement of histidine 311 and tyrosine 314 
with alanine resulted in a thousand-fold and I 0-fold reduction in rat PLC-6 I 
activity respectively (Ellis, et al., 1995). 
Within the Y catalytic domain of human PLC-6 there are four arginine residues 
(Arg527, Arg549, Arg556, and Arg701) which are highly conserved amongst 
eukaryotic PLCs. The mutant PLC-6s containing a substituted arginine resulted 
in them being either moderately defective or fully active in their abilities to 
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hydrolyse PIP2 and PI (Wang, et al., 1996). When Arg549 was replaced with 
glycine or histidine in PLC-6 it could no longer hydrolyse PIP2 but still retained 
the ability to hydrolyse Pl. Replacing Arg549 with lysine had only a small effect 
on PIP2 and PI hydrolysis this suggests that the positive charge at residue 549 is 
important for the specific binding Of PIP2 or PI (Wang, et al., 1996). Arginine 
549 is conserved throughout all eukaryotic PLCs and therefore an equivalent 
arginine 693 can be identified in the Y catalytic domain of Sz. pombe Plc I 
(Figure 45). This evidence gained from human PLC-6 suggests that Arg693 may 
play an important role in the catalytic activity of Plc I. 
The amino acids Lys461 and Arg549 were identified in mammalian PLC-6, to 
have an important role in binding and hydrolysing the substrates, PIP2 and Pl. It 
has been hypothesised from a 2.4-A resolution crystal structure of rat PLC-6 
(Essen et al., 1996) that Lys461 forms a salt bridge with the 4-phosphoryl group 
of the substrate (Simoes et al., 1995). The residue Arg549 on the other hand 
with its positively-charged guanidinium group may form a salt bridge with the 
negatively-charged phosphate at position 4 and 3'-hydroxyl group of the inositol 
ring (Wang, et al., 1996) (Figure 45). 
Equivalent amino acids have been identified in Sz. pombe Plc I, Lysine 582 and 
Arginine 693. If these similar amino acid replacements that were performed in 
mammalian PLCs were now introduced into Sz. pombe Plc I it may help 
determine its true substrate. These mutant forms of Plc I may identify if the 
generation of the second messenger Ins 1,4,5-P3 is important, as similar 
mutations in mammalian PLCs were unable to bind or hydrolyse PIP2 thus there 
was no generation of Ins 1,4,5-P3. This reduction of Ins 1,4,5-P3 production in 
Sz. pombe cells may implicate a role for Plc L 
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Figure 45 The active site of PLC-8 
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A schematic diagram of the network of substrate and amino acid interactions 
within the active site. Coloured in blue in the centre of the diagram is the 
substrate PIP2. The amino acid residues coloured in red (Lys 461 and Arg 549) 
are the ones important in binding and hydrolysing the substrate. The 
corresponding amino acids in Sz. pombe Plcl were identified as Lys 582 and 
Arg 693. Other an-tino acids that are important in binding the substrate are also 
indicated on the diagram in black. 
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7.2.2 Amino acid charge and shape is important for Plcl activity 
Previous experiments carried out by numerous groups (Wang et al., 1996; Cheng 
et al.,, 1995; Simoes et al., 1995; Ellis and Katan, 1995) on mammalian PLCs 
have demonstrated it is not just the charge of amino acids that is important for 
catalytic activity but the shape of the amino acid is also important. Mutations of 
the basic residues seen in the X catalytic domain (Figure 44 highlighted in green) 
indicated that it was not just charge that was important for enzyme activity but 
other properties were also important. These properties include the 
hydrophobicity and / or correct spacing of the basic amino acids (Simoes et al., 
1995). 
The amino acids selected for mutation in Sz. pombe p1c] were lysine 582 and 
arginine 693. Lysine 582 was replaced by arginine (Figure 46) because it had a 
similar charge to lysine. When this same mutation was carried out on human 
PLC-P, it led to a complete loss Of PIP2 hydrolysis activity (Simoes et al., 1995). 
Lysine 582 was also replaced alanine (Figure 46) because it had no charge but 
reduces the chances of structural modification within the active site. When this 
was carried out in PLC-6 it resulted in loss of both PIP2 and PI hydrolysis 
activity but did not affect the binding of the substrate (Cheng et al., 1995). 
Arginine 693 was replaced by lysine (Figure 46), when this was carried out on 
Human PLC-6 there was no effect on its ability to hydrolyse PIP2 or PI (Wang et 
al., 1996). The other substitution was arginine for leucine (Figure 46); when this 
was performed on Human PLC-6 it was unable to hydrolyse PIP2 but was still 
able to hydrolyse PI (Wang et al., 1996). These amino acid replacements may 
indicate whether charge or shape is important for catalytic activity at this active 
site residue. 
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Figure 46 The amino acid replacements carried out in the active site of Plcl 
This illustrates the amino acid replacements carried out within the active site of 
Plcl. Lysine 582 was replaced by alanine because it had no charge but this 
change results in less structural disruption. Lysine was also exchanged for 
arginine because it because it had a charge similar to lysine. Arginine 693 was 
replaced by leucine because it was structurally similar but had no charge. 
Arginine was also exchanged for lysine because of the similar charge they carry 
on their side chain. 
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7.3 Determining the hydrolysis activity of the active site mutants in vitro 
The amino acid replacement was introduced into the ORF of p1c] by using 
inverse PCR (see Chapter 3, Figure 14). Double stranded DNA sequencing (see 
Methods section 2.2.1.5) was then performed on the inverse PCR products 
confirming no errors other than the required amino acid replacement had been 
introduced into the ORE The ORFofPlcl[R693K], Plcl[R693L], Plcl[K582R] 
and Plc 1 [K5 82A] were sub-cloned into the expression vector pREP3x (see 
Chapter 3, Figures 15,16,17 and 18). The pREP vectors are yeast expression 
vectors that contain the nmtl promoter. The nmt] promoter is expressed in the 
absence of thiamine and is repressed in the presence of thiamine. Wild-type Sz. 
pombe cells transformed with pREP3x containing wild-type p1c] or one of the 
mutant forms of Plcl. The transformed cells were cultured in cultures at 30'C in 
DMM minus thiamine. Crude extracts were prepared from cells (see Methods 
section 2.2.2.1) expressing mutant forms of Plc I so that the activity of these 
mutants could be determined in vitro using the Plcl assay (see Methods section 
2.2.2.2). 
The activity of the Plc I mutants in vitro was determined against the substrates 
PIP2 and PI. This was to determine whether the substrate specificity of the Plc I 
mutants had been modified in a similar manner to the mammalian PLC mutants 
(see Sections 7.2.1-7.2.2). The method that uses PIP2 or PI as a substrate in vitro 
is stated in the methods (see Methods 2.2.2.2) but briefly the PI substrate mixture 
consists of unlabelled PIP2,3 H-PI and 6.4% sodium cholate. Without PIP2 in the 
substrate mixture the PH domain of Plc I would not be able to bind to the 
substrate and hydrolyse PI (Wang, et al., 1996). A high concentration Of PIP2 
was added to the substrate, because saturating concentrations Of PIP2 appear not 
to affect PI hydrolysis (Wang et al., 1996). 
Wild-type Plc I hydrolysed PIP2 and PI, but appeared to have a ten-fold lower 
rate of PI hydrolysis compared to PIP2 hydrolysis (Figure 
47). All of the mutant 
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forms of Plc I (Plc I [R693 K], Plc I [R693 L], Plc I [K5 82R] and Plc I [K5 82A]) had 
lost the ability to hydrolyse PIP, in vitro but still retained some ability to 
hydrolyse PI (Figure 47). The mutations that retained the charge at position 582 
or 693 had greater PI hydrolysing activity than mutants maintaining an 
uncharged amino acid that was structurally similar to the original residue. This 
result confirmed that when these mutants are assayed in vitro no PIP2 activity can 
be detected above the normal background levels but they retain varying abilities 
to hydrolyse P1. This suggests that the two amino acid residues investigated 
here, Lys582 and Arg693 may play an important role when selecting and 
hydrolysing PIP2 but not Pl. 
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Figure 47 Activity of the active site mutants in vitro 
Wild-type Plc I and the mutants Plc I [R693K], Plc I [R693L], Plc I [K582R] and 
Plc I [K5 82A] were sub-cloned into pREP3 x and transformed into P cells. 
Crude extracts were prepared from these cells and assayed in vitro. I mg/ml of 
crude protein extract was mixed with a substrate comprising Of PIP2,3 H-PIP2 
or 3 H-PI (depending on which substrate the enzyme is being assayed against) 
and 6.4% w/v sodium cholate. The buffer consisted of 50mM Tris pH 7.5 and 
reaction was incubated at 30'C. The bars represent the standard range of the 
mean for triplicate determinations. 
159 
7.4 Expression of the active site mutants in vivo 
Once it had been confirmed that these mutant forms of Plc I were no longer able 
to hydrolyse PIP2 but retain varying levels of PI hydrolysis in vitro. The next 
step was to express these mutants in ApIcl Sz. pombe cells to see if the mutants 
were able to suppress their temperature and nutritional sensitive phenotype. This 
may give some insights into the catalytic role of Plc I in Sz. pombe and might 
indicate whether Ins 1,4,5-P3 production is important. In order to express these 
mutants in vivo they were firstly cloned into PREP81x. Wild-typePIcl, 
Plcl[R693K], Plcl[R693L], Plcl[K582R] and Plcl[K582A] were sub-cloned 
into pREP 81x (see Chapter 3 for constructs) and transformed into ApIc IP cells. 
The expression vector pREP 81x has the lowest level of expression due to the 
lower efficiency with which RNA polymerase can bind to the promoter region 
(Maundrell, 1990) (see Methods for information on the pUP expression 
vectors). Approximately five thousand of these transformed cells were plated 
onto DMM plates containing 167ýtg/ml of thiamine or DMM plates without 
thiamine (see Methods section 2.2.4). Plates were incubated at either 230C or 
370C and colony formation was recorded (Figure 48). 
The active site mutants when expressed in vivo are under the control of the nmt] 
promoter incorporated in pREP8 I x. Figure 48 demonstrates that the mutant 
forms of PlcI (PlcI [R693K], Plc I [R693L], Plcl [K582R] and Plcl [K582A]) 
when expressed in vivo display growth that is identical to wild-type cells. The 
transformed cells are able to grow on DMM plates incubated at 23'C and 370C 
both in the presence or absence of thiamine. ApIcI cells when transformed with 
pREP vector alone are unable to grow on DMM medium regardless of the 
temperature or the thiamine content (Figure 40). 
From the results of the in vitro analysis of the Plc I active site mutants 
it would 
seem reasonable to assume that all of the PIP2 hydrolysis activity 
had been 
abolished. When these mutants were expressed in vivo under the control of 
pREP8 Ix in both the presence and absence of thiamine they were able 
to 
160 
suppress the temperature and nutritional sensitive phenotype. This would 
suggest that very low levels of PI hydrolysis might be required for ApIcI cells to 
function normally. This suppression may be due to the production of DAG or IP 
may be an important precursor for another inositol polyphosphate signalling 
molecule. Alternatively if all the PIP2 hydrolysis has not been abolished then 
undetectable levels Of PIP2 hydrolysis may be responsible for ApIcl suppression 
on minimal media and high temperatures. 
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Figure 48 Expression of the active site mutants in vivo 
Plc I, Plc I [R693 K], Plc I [R693 L], Plc I [K5 82R] and Plc I [K5 82A] were sub- 
cloned into pREP8 Ix (see Chapter 3) and transformed into APIc I cells. Five 
thousand of these transformants were plated out on DMM plates either 
containing thiamine of without thiamine (see Methods section 2.2.4). These 
plates were incubated at either 230C or at 37'C and colony formation was 
noted after 4days. 
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7.5 Summary 
Using the information gained from mammalian PLCs, two residues within the 
catalytic domain (one in the X domain and one in the Y domain) have 
demonstrated their importance in binding and selecting substrates within the 
acti've site (Wang et al., 1996; Cheng et al., 1995; Simoes et al., 1995; Ellis and 
Katan, 1995). Equivalent residues were identified in Sz. pombe p1c], lysine 582 
and arginine 693. Plc I mutants were constructed in which arginine and alanine 
replaced lysine 582 and lysine and leucine replaced arginine 693. When assayed 
in vitro these mutants were unable to hydrolyse PIP2 but still retained some level 
of PI hydrolysis. Expression of the mutants in Aplcl cells resulted in cell growth 
on DMM media irrespective of the temperature and the thiamine content (Aplcl 
cells are normally unable to grow on DMM media even at low temperatures). 
From these experiments the following conclusions can be drawn. Similar to 
mammalian PLCs which preferentially hydrolyse PIP2 to PI, wild-type Plcl 
appears to recognise, bind and hydrolyse both PIP2 and PI. This confirms that Sz. 
pombe Plc I is more similar to mammalian PLCs than prokaryotic PLCs but has 
different amino acid requirements at the active site. 
An1c] cells are unable to grow on DMM or at temperatures above 29'C but this is T- 
suppressed by the expression of the Plc I active site mutants, which are unable to 
hydrolyse PIP2 but able to hydrolyse Pl. This suggests that PI hydrolysis is 
sufficient for cell growth. In Sz. pombe cells PI hydrolysis probably results 
in the 
production of DAG, which may activate either PKC or another protein 
kinase. 
PI hydrolysis also results in the production of InsP, which may be an 
important 
precursor for the production of other inositol polyphosphates. 
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Chapter 8 
Investigating the N-terminal domain of Plcl 
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8.1 Introduction 
8.1.1 The regulation of mammalian PLCs 
The regulators of mammalian PLC-P and PLC-7 have been identified. PLC-P and 
PLC-7 contain extra domains that are known to interact with GTP binding 
proteins, tyrosine kinase receptors or nonreceptor tyrosine kinases. 
8.1.1.1 The regulation of PLC-P 
The extended C-terminal domain of PLC-P (Figure 49) is known to interact with 
heterotrimeric G-proteins. Activation of a receptor that is coupled to a 
heterotrimeric G-protein results in GTP binding to the (x subunits. The G-protein 
then dissociates into three subunits; the oc and Py subunits. Once dissociated 
either the (x subunit of the G-protein (Gq family) (Taylor, et al., 1991; Hepler, et 
al., 1993) or the Py subunits (Go family) (Katz, et al., 1992; Hepler, et al., 1993) 
interact with the C-terminal domain of PLC-P facilitating its activation. 
8.1.1.2 The regulation of PLC-y 
PLC-y has an extra five domains encoding 400 amino acids (two PH domains, 
two SH2 domains and an SH3 domain) that are not found in other PLC isoforms 
(Figure 49). The activation of PLC-7 is by the phosphorylation of identical 
tyrosine residues identified within the SH 2 domains (Kim, et al., 199 1). This is 
thought to create a structural change in PLC-y allowing the SH3 domain to bind 
to proteins such as profilin (Goldschmidt-Clermont, et al., 1991) which is 
associated with the membrane, bringing PLC-y in close proximity to the 
substrate. This phosphorylation step is regulated by receptor or nonreceptor 
tyrosine kinase activities. Ligands such as epidermal growth factor (EGF) 
bind 
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to the receptor which results in auto-phosphorylation of the receptor. The 
tyrosine kinase activity found on the intracellular portion of the receptor 
phosphorylates specific tyrosine residues on PLC-y facilitating its interaction 
with proteins on the membrane. The non-receptor tyrosine kinase activation of 
PLC-7 is essentially the same but a cytosolic tyrosine kinase phosphorylates 
specific residues on PLC-7 aiding its interactions with proteins on the membrane. 
8.1.1.3 The regulation of PLC-6 
Unlike PLC-P and PLC-7, PLC-6 does not contain any extra domains (Figure 
49). The regulator of PLC-6 therefore, is unknown but it has been suggested that 
it may be regulated through a GTP-binding protein known as G(Xh (Feng, J-F et 
al., 1996). Reconstitution studies with PLC-6, the cc I -adrenergic receptor and Gh 
resulted in PIP2 hydrolysis (Das et al., 1993). Co-imunoprecipitation of PLC-6 
in the cc I -adrenergic system demonstrates that PLC-6 only associates with the 
GTP-bound form of Gh (Das et al., 1993). It is also known that all eukaryotic 
PLCs require calcium for activation so regulation of PLC-6 may be facilitated by 
fluctuations in cytosolic Ca 2+ concentrations. It appears however that PLC-6 is 
more sensitive to cytosolic Ca 2+ concentrations than PLC-P and PLC-7. 
Increases in Ca 2+ concentration within the range of 0.1 -I OýM was sufficient to 
stimulate PLC-6 activity but insufficient to stimulate PLC-P or PLC-y (Allen et 
al., 1997). 
8.1.2 The N-terminus of yeast PLCs 
The PLC isozymes from S cerevisiae and Sz. pombe appear to have an extended 
N terminal domain (Figure 49). This extended N-terminal domain is not a 
lengthened part of the PH domain and bears no resemblance to the extended 
C- 
terminal domains seen in PLC-P or any of the extra domains observed 
in PLC-7- 
The extended N-terminus of Sz. pombe p1c] is longer than 
S. cerevisiae PLC] 
166 
and there is no sequence similarity between them. Payne and Fitzgerald-Hayes 
(199' )) reported that the N-terminal end of S. cerevisiae PLC I contains a possible 
nuclear localisation signal (KKLRK) as well as five potential sites for 
phosphorylation by protein kinase C. Expression of the PLC I open reading 
frame starting from the second methionine (79th codon) complemented the loss of 
the PLC] gene suggesting that the 78 N-terminal residues are not essential for 
activity (unpublished data mentioned in Yoko-o et al., 1993). Flick and Thorner 
(1993) inferred that this extended N-terminal section of PLC I might reflect some 
distinctions in regulatory properties or subcellular localisation between yeast and 
mammalian PLCs. 
8.1.3 The N-terminus of Sz. pombe Plcl 
It has been shown that the N-terminus of Sz. Pombe Plc I is approximately 147 
amino acids in length that constitutes one sixth of the total protein size. This N- 
terminal section of Plc I might have a role associated with regulation, cellular 
localisation, protein folding or binding of Plc I to the membrane. Since PLC-P 
and PLC-y contain extra domains involved in their regulation and the N-terminal 
domain of PLC I from S. cerevisiae may be involved in regulation (Flick and 
Thorner, 1993) , it would seem reasonable to suggest that 
this N-terminal section 
of PIc I might also be involved in regulation. Although the N-terminal domain in 
Plc I displays no sequence similarity to the extra regulatory domains seen in 
PLC-P and PLC-y, there may be alternative regulators that bind specifically to 
the N-terminal domain. As the N-terminus of Sz. pombe Plc I and S. cerevisiae 
PLC I display no sequence similarity it is unlikely that they regulated by similar 
methods. 
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Figure 49 The structure of eukaryotic PLCs 
PLCs contain four conserved domains these include the Pleckstrin Homology 
domain (PH), the EF hand domain (EF), the X and Y catalytic domain and 
the C2 domain. PLC-p has an extended C-terminal domain and PLC-7 has 
an extra four domains, these extra domains are involved in their regulation. 
The yeast PLCs have an extended N-terminus, which is not seen in any other 
eukaryotic PLCs. The function of this N-terminal domain is unknown. 
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8.2 Plel truncations 
The simplest way to identify the importance of this N-terminal domain is to 
create a truncation of Plc I that removes the first 144 amino acids. When assayed 
in vitro or expressed in vivo this truncated form of Plc I may reveal whether or 
not this domain plays an important role in regulation, interaction with other 
proteins, or perhaps membrane binding. 
8.2.1 Removal of the N-terminus results in a PLC structurally more 
similar to PLC-8 
If the first 144 amino acids are removed from the N-terminus of Plc I by PCR 
(Plc I AN-term144) (see Chapter 3 Figure 22) it results in a PLC that looks 
structurally similar to Rat PLC-6 I (Figure 50). Plc I AN-term]44now simply 
contains the four domains that are common to all PLCs. Double stranded DNA 
sequencing (see Methods, section 2.2.1.5) was performed on the PCR product of 
Plc 1 AN-term144without the N-terminus at this stage to confirm that no unwanted 
errors had been incorporated. This construct was sub-cloned into the yeast 
expression vectors pREP3x and pREP8 Ix (see Chapter 3, Figure 22). 
8.2.2 Expressing the N-terminus of Sz. pombe Plcl 
The N-terminus of Sz. pombe Plc I might be a site that interacts with other 
proteins regulating its activity. If the N-terminal domain does interact with 
regulatory proteins, then expression in wild-type cells may display possible 
growth defect due to competitive inhibition. The wild-type cells expressing the 
N-terminus might display a phenotype that is more similar to Ap1c] cells because 
proteins that normally interact with the N-terminus of the full length protein 
could now also recognise and bind to this short N-terminal peptide. To test this 
hypothesis, the first 147 amino acids of Plcl (N-term) (Figure 50) were amplified 
using PCR (see Chapter 3, Figure 24) and was sequenced using 
double stranded 
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DNA sequencing (see Methods section 2.2-1-5). The N-term was then sub- 
cloned into pREP3x and pREP81x. 
8.2.3 Expressing Rat PLC-6 in Sz. pombe cells 
Since ýz. pombe PIc 1 AN-term144 looked structurally similar to a PLC-6 (Figure 
50) it would be interesting to discover if rat PLC-8 was able to complement for 
the loss of Plcl activity in ApIcI cells. Rat PLC-6 was shown to complement in 
S. cerevisiae APLCI cells but it is not known whether rat PLC-6 is able to 
complement in ApIcI cells. The Rat PLC-8 gene was amplified by using PCR 
and was sequenced to confirm that no errors had been introduced during the PCR 
process (see Chapter 3, figure 21). Rat PLC-6 was then cloned into the yeast 
expression vectors pREP3x and pREP8 I x. 
8.2.4 Fusion of the Plcl N-terminus to PLC-8 results in a mammalian PLC 
structurally similar to Sz. pombe 
Fusion of the N-terminal 144 amino acids of Plc I to the amino terminus of rat 
PLC-6 results in a PLC that looks structurally similar to Sz. pombe PIC I (Figure 
50). The N-terminus of Sz., pombe was introduced to see if this Plcl/ Rat PLC-6 
fusion (PIC I 144-PLC-6) was active and see if it was able to suppress the loss of 
PIC I activity in ApIcl cells. PIC I 144-PLC-6 was produced through PCR 
amplification. Double stranded DNA sequencing was performed on the PIC 1144- 
PLC-6 to confirm no errors had been introduced into the sequence. The PIC 1144- 
PLC-6 was subsequently cloned into the yeast expression vectors PREP3x and 
pREP8 Ix (see Chapter 3, Figure 23). 
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Figure 50 Constructs which may help identify the role of the Plcl N- 
terminus 
A diagram displaying the mutants constructed to investigate the N-terminal 
domain or PIC I. Highlighted in red is Sz. pombe PIC I and highlighted in blue is 
Rat PLC-6. This figure demonstrates the clones produced, the removal of the N- 
terminus from p1c] to make PIC I look structurally similar to PLC -8. The N- 
terminus of Plcl was fused to Rat PLC-6 to make it look structurally similar to 
PIC 1. 
8.3 Activity of the N-terminal domain mutants in vitro 
The open reading frames of PIC I AN-term 144, Rat PLC-8, N-term and PIC 1144- 
PLC-6 were sub-cloned into the yeast expression vector pREP3x. Wild-type Sz. 
pombe cells expressing these mutants were cultured at 300C in DMM minus 
thiamine. Crude extracts were prepared from cells expressing the mutant forms 
of PIC I (see Methods section 2.2.2.1), so the activity of these mutants could be 
determined in vitro using the PIC I assay (see Methods section 2.2.2.2). Mutants 
were assayed at 300C, pH 7.5 and using a substrate containing PIP2 with 6.4% 
sodium cholate. 
When wild-type PIC I was assayed in vitro it had about 15 pmoles of InsP3 
released /min /mg protein. When PIC I AN-term]44was assayed in vitro its activity 
was determined to be almost zero. Assuming that PIC I AN-term144is being 
expressed in the wild-type Sz. pombe cells it would suggests that the extended N- 
terminus of PIC I may have an important role in forming a fully functional PIC I 
(Figure 5 1). When pREP3xPIc 1 is compared to pREP3xPLC-6, pREP3xPLC-6 
is ten times more active (Figure 5 1), over 150 pmoles of InsP3 is released /min 
/mg protein. Fusing the N-terminus of Sz. pombe PIC I to rat PLC-6 had a 
dramatic effect on activity. The activity of the rat PLC-6 decrease about ten fold 
to 17 pmoles of InsP3 is released /min /mg protein (Figure 5 1), suggesting the 
activity of this fusion more closely resembles that of wild-type PIC I than rat 
PLC-6. The extracts prepared for assaying PLC activity are very crude and the 
rate Of PIP2 hydrolysis per minute is based on the total amount of protein within 
the extract. This assay assumes that the level of expression by the nmt] promoter 
contained on pREP3x is the same for PIC I AN-term]44, rat PLC-6 and PIC 1144- 
PLC-6 and that large differences in expression levels are not causing these 
contrasting levels of activity. 
When the Plc 1 N-term147was expressed in wild-type Sz. pombe cells, growth 
defects were seen. The wild-type cells expressing N-term were able to grow at 
37'C in DMM media; if they were displaying a phenotype similar to ApIcl cells 
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then reduced or no growth should have been observed. This could be for one of 
three reasons the first that the N-term may not be involved in regulating the 
activity of Plc I. The second is that the N-term is not being expressed resulting in 
no competitive inhibition. Finally the N-term is being expressed but the 
expression level is not high enough to affect the Plc I activity of wild-type cells. 
When the activity of the N-term was investigated in vitro no activity was seen 
which is unsurprising considering this is only a short section of the Plcl protein 
which does not contain any catalytic domains. 
From these results it suggests that the N-terminal domain may have an important 
function in perhaps regulating PIC I activity. This is because PIC I AN-term144was 
unable to hydrolyse PIP2 as efficiently as PIC I and rat PLC-8 which does not 
contain this N-terminal domain had extremely high levels of activity ten-times 
higher than wild-type PIC I. When the activity of the mutant PIC I 144-PLC-5 was 
assayed in vitro it demonstrated levels of activity closer to wild-type PIC I. This 
N-terminal domain of PIC I and the mutant PIC I 144-PLC-6 may have a regulatory 
protein that interacts with it controlling the level of PLC activity, without it rat 
PLC-6 had uncontrollable levels of PLC activity and PIC I AN-term144was 
inactive. 
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Figure 51 Determining the activity of the PLCs and their mutants in vitro 
Wild-type PIC 1, Rat PLC-6 and the mutants PIC I N-term, PIC I AN-term144and 
PIC I 144-PLC- 6 were sub-cloned into pREP3x and transformed into aP cell. Crude 
extracts were prepared from these cells and assayed in vitro. The substrate comprised 
PIP2) 3 H-PIP2 and 6.4% w/v sodium cholate. The assay conditions included a 50mM 
Tris buffer pH 7.5 and incubation temperature was 30'C. The bars represent the 
standard range of the mean for triplicate determinations. 
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8.4 Expression of the N-terminal mutants in vivo 
Wild-type PIC 1, rat PLC-6, PIC I AN-term and PIC I 144-PLC-6 were sub-cloned 
into the expression vectors pREP3x and pREP8Ix- These constructs were 
transformed into P cells Ap1c]; approximately five thousand of these transformed 
cells were plated onto DMM Plates either with or without thiamine. Plates were 
then incubated at either 230C or 370C and colony formation was recorded (see 
Methods, section 2.2.4). 
When pREP3xpIcI or pREP8 I xp1c] is expressed in ApIcl cells, growth is 
observed on all plates irrespective of the temperature or thiamine content. When 
pREP3xpIcIAN-term or pREP81xpIcIAN-term is expressed in vivo no growth is 
detected on any of the plates (Figure 52). When ApIcI cells are expressing wild- 
type Plc I, they are able to grow under normally non-permissive conditions such 
as temperatures above 29'C or on DMM. When this N-terminal domain is 
removed and Plc I AN-term is subsequently expressed in ApIcI cells, no growth is 
observed. This suggests that this N-terminal domain may have an important role 
in producing a functional Plc I. 
When pREP3xPLC-6 or pREP8 I xPLC-6 is expressed in ApIcI cells no cell 
growth is detected under any of the conditions studied (Figure 52). This is 
unexpected because when rat PLC-6 was assayed in vitro it displayed ten times 
more activity than wild-type Plc I, but when expressed in ApIcI cells rat PLC-6 
was unable to complement for the loss of Plc I activity. 
When pREP3xPIc I 144-PLC-6 and pREP8 I xPIc I 144-PLC-6 were expressed 
in vivo 
growth was seen on all plates irrespective of temperature or the presence of 
thiamine (Figure 52). This suggests that this N-terminus of Plc I might have an 
important role, because without it both Plc I AN-term and rat PLC-6 are unable to 
suppress the loss of Plc I activity under non-permissive conditions. 
When the N- 
terminus of Plc I is fused to the amino terminus of rat PLC-6 
it is able to 
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complement for the loss of Plc I activity under non-permissive conditions such as 
temperatures above 29'C or on DMM. In the in vitro experiments rat PLC-6 
activity was extremely high, more than ten-fold greater than wild-type Plc L One 
possible reason why the clone pREP3xrat PLC-6 may not complement for the 
loss of PIc I activity may be due to this high level of activity observed in vitro. In 
contrast extract prepared from cells expressing the clone pREP8 I xPLC-6 in the 
presence of thiamine had very low levels of PLC activity. When measured in 
vitro activity was indistinguishable from background levels but was still unable 
to complement for the loss of PIc I activity (data not shown). As demonstrated in 
Chapter 7, the minimum level of Plc I activity is required to rescue ApIcl cells so 
the level of expression may not be the only factor preventing cell growth. 
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thiamine - thiamine 
23T 3 7'C 
pRFP3xl)/c, l 
pREP8 I xp1c I 
pR-EP-')xPLC6 
pREP8lxPLC6 
pREP3x 
plc]AN-term]44 
pREP81x 
plc]AN-term]44 
pREP3x 
PIC ] 144PL C-6 
PREP81x 
P'C I 144PLC-6 
230C 3 7'C 
Figure 52 Expression of the N-terminal mutants in vivo 
Plc I, Plc I AN-term]44, rat PLC-6 andPIC I 144-PLC-6 were sub-cloned into 
pREP3x, pREP8 Ix and transformed into ApIcI cells. Five thousand of these 
transformed cells were plated out on DMM plates either containing thiamine or 
without thiamine (see Methods section 2.2.4). These plates were incubated at 
either 23'C or at 37'C and colony formation was observed. 
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8.5 Summary 
When PIc I AN-term is expressed in vitro activity was reduced to undetectable 
levels when compared to wild-type Plc I- The activity of Plc I AN-terminus is 
lower than detectable levels using this assay but when this is expressed in ApIcI 
cells it is unable to complement at any temperature or expression level. 
When rat PLC-6 was expressed in vitro it displayed ten times more activity when 
compared to wild-type Plc I. When expressed in Ap1c] cells however, it was 
unable to complement irrespective of the expression levels. When the N- 
terminus of Plc I was fused to rat PLC-6 and its activity was investigated in vitro, 
this construct had an activity similar to the wild-type Plc I. When expressed in 
ApIcI cells it was able to complement irrespective of the temperature or level of 
expression. 
These results suggest that that the N-terminus of Plc I may have an important role 
as Plc I lost its ability to hydrolyse PIP2 without it and rat PLC-6 activity is 
unable to complement for the loss of Plc I activity without it. This N-terminal 
domain may interact with other proteins regulating its activity in some way. 
Andoh et al., (1998) identified that a 14-3 -3 protein interacted with the N- 
terminus of Plc I in response to UV light but unfortunately they did not elaborate 
further on the precise interaction points within the N-terminus. This could be 
one of many proteins that interact with Plc I regulating its activity resulting in the 
desired responses within the cell. 
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Chapter 9 
Discussion 
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9.1 Overview 
The loss of Plc I activity in Sz. pombe resulted in a very distinct cellular 
phenotype. ApIcl cells demonstrated a temperature sensitive phenotype on rich 
medium, these cells grew at 23'C but not at 370C. On DMM ApIcl cells were 
unable to grow, possibly due to the increased stresses enforced on the cells as a 
result of the limiting nutrients available. Previous studies have demonstrated that 
Plc I is a phospholipase C enzyme that is able to hydrolyse PIP2 into the second 
messengers InSP3 and DAG (Slaaby, 1996). In this thesis I have utilised three 
different approaches (Chapters 6,7 and 8) to help identify possible regulators of 
Plc I and also signalling pathways that might require the activity of Plc I within 
Sz. pombe cells. 
Interpretation of these results was difficult due to the difficulty in trying to 
quantify the amount of Plc I present in the in vitro and in vivo assays. Numerous 
attempts were made to quantify Plc I concentrations using Western blots but no 
bands were detected. A second approach was used to quantify Plel 
concentration in Sz. pombe cells by purifying Plc I using the hexahistidine-tag 
introduced on to the N- or C-terminus or the protein. Plc I activty was observed 
after elution away from the nickle column but no bands were seen on the protein 
gels that corresponded to the predicted size of Plcl. 
9.2 Regulation of Plel 
9.2.1 The N-terminus may be a site for Plcl regulation 
Yeast PLCs have an extended N-terminal domain, which is not seen in 
mammalian PLCs. The N-terminal domains of S. cerevisiae PLC I and Sz. 
pombe Plc I bear no sequence similarity. It would seem reasonable to assume 
that if the N-terminus does have a role in regulating yeast PLCs, then S. 
cerevisiae and Sz. pombe will have different regulatory mechanisms which 
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control PLC activity through this N-terminal domain. Wild-type PIC I when 
expressed in Ap1c] cells was able to overcome the loss of PIC I activity. 
Conversely, when the mutant PIC I AN-term was expressed in Ap1c] cells it was 
unable to suppress the loss of PIC I activity. This could possibly be a result of 
protein not correctly folding creating an inactive PIC I. Alternatively without the 
presence of the N-terminus the activity of PIC I might be switched off because a 
regulatory influence was unable to bind. When the activity of rat PLC-8 was 
assayed in Otro it had ten-times the amount of activity compared to wild-type 
Plcl but when rat PLC-6 was expressed in ApIcl cells it was unable to suppress 
the loss of Plcl activity on DMM plates incubated at either 230C or 370C. In 
contrast the mutant PIC I 144-PLC-6 had lower PLC activity (similar to wild-type 
PIC I) but was able to complement for the loss of PIC I activity in Ap1c] cells. The 
mutant PIC I 144-PLC-6 demonstrated a ten-fold decrease in activity compared to 
PLC-6. This reduction in activity could be due to the Plcl N-terminus not 
allowing the protein to fold correctly or alternatively the N-terminal domain may 
have a regulatory protein that binds to this domain controlling rat PLC-6 activity. 
It has been demonstrated that the UV checkpoint proteins may interact with the 
N-terminus of PIC I in Sz. pombe and this is discussed in more detail in section 
9.2.2. 
9.2.2 14-3-3 proteins interact with the N-terminus of Plel 
Two-hybrid interaction assay was performed and discovered that Plc I interacted 
with the proteins Rad24 and Rad25 which are members of the 14-3-3 protein 
family (Andoh et al., 1998). Mammalian 14-3-3 proteins have been suggested to 
regulate signal transduction pathways through MAP kinase cascades (reviewed 
by Aitken, 1995) and it is possible that yeast use a similar mechanism (Delgols 
and Russell, 1997)(see Section 9.3.2). The genes rad24 and rad25 that encode 
for 14-3-3 proteins are reported to be DNA damage checkpoint genes. These 
genes are required for Sz. pombe cells to recover from DNA damage brought 
about by UV radiation (Ford et al., 1994). The two-hybrid analysis carried out 
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by Andoh, et al., (1998) suggested that the N-terminal region of Plc I but not the 
catalytic (C-terminal) region was required for the interaction of the 14-3-3 
proteins. Unfortunately Andoh, et al., (1998) do not elaborate further on the 
precise interaction points within the N-terminus. The interaction of the 14-3-3 
proteins with the N-terminus of Sz. pombe Plc I might be a regulatory role 
controlling the enzymes activity. Wild-type rat PLC-6 and PlclAN-term were 
unable to complement the loss of PIC I activity but the PIC I 144-PLC-8 mutant was 
able to complement. This suggests that the N-terminal domain might interact 
with the 14-3-3 proteins, which subsequently may not control its activity. Andoh 
et al., (1998) demonstrated that Sz. pombe cells over-expressing PIC 1, Arad24 
mutant cells and cells over-expressing Rad24 showed almost the same Plcl 
activity. This confirmed that although 14-3-3 proteins may interact with the N- 
terminus of PIC I they do not appear to directly regulate its activity. 
9.2.3 [Ca 2+1 might play a role in regulating Plcl activity 
It was demonstrated that the PIP2 hydrolysing activity of Plc I is Ca 2+ -dependent 
(Slaaby, 1996), similar to mammalian PLCs. It has been shown that Ca 2+ ion 
concentration within a physiological range of 0.1 -I OýM was sufficient to 
stimulate PLC-6 activity, but not PLC-P and PLC-7 (Allen et al., 1997). As Plcl 
bears closest resemblance to PLC-6 changes in Ca 2+ concentration might be 
enough to activate Plc I. The role of Ca 2+ -mediated hydrolysis Of PIP2 needs to 
be investigated in order to identify whether or not Ca 2+ concentrations may 
regulate PlcI activity. 
9.2.4 Growth conditions that might regulate Plcl activity 
It has been confirmed that Ap1c] cells are unable to grow under conditions that 
may cause the cell stress, this includes temperatures above 300C and growth on 
minimal medium. It has been demonstrated in many experiments that Plc I 
activity in wild-type cells appears to increase when placed under stressful 
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conditions. This includes UV light (Andoh el al., 1998), hyper-osmotically 
stressed cells (Ongusaha et al., 1998) and incubation at 370C on DMM (York et 
al., 1999). These studies demonstrated that PIP2 hydrolysis increased over the 
stress-induced period, resulting in increased IP6 production (Ongusaha et al., 
1998; York et al., 1999) or possibly acting on a MAP kinase cascade (Andoh et 
al., 1998). It appears that these external factors are able to regulate the activity 
of Plcl. This may either take place directly through a receptor or perhaps by a 
novel mechanism whereby proteins interact with Plcl, controlling its activity. 
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9.3 Pathways which may require Plcl activity 
9.3.1 Plcl activity may be required for IP6 production 
The S. cere0siae genome lacks a recognisable InS-P3 sensitive receptor or Ca 2+ 
channel (Ongusaha et al., 1998). It therefore seems reasonable to assume Ins-P3 
in yeast does not regulate the concentration of Ca 2+ in a manner that has been 
identified in mammalian cells. It is more likely that the released Ins-P3 is either 
dephosphorylated and recycled into phosphatidylinositols or it could be 
phosphorylated into Ins-P6. The functions of Ins-P6 in eukaryotic cells were 
reviewed in section 1.2.3.3. The roles of Ins-P6 briefly include stimulating Ca 2+ 
entry into neurones, serine-threonine phosphatases are inhibited by increased 
concentrations of Ins-P6 stimulating the activity of L-type Ca 2+ channels. Ins-P6 
also regulates endocytosis and exocytosis of clatharin coated vesicles through the 
inhibition of assembly proteins. 
Concentrations of Ins-P6 within yeast cells are thought to range from ýM to mM 
and when cells are osmotically stressed there is a rapid increase in Ins-P6 
concentration probably synthesised from Ins 1,4,5-P3 (Ongusaha et al., 1998). 
A-PLC] S. cerevisiae cells were unable to produce Ins-P6, thus demonstrating 
further evidence that InS-P6 is synthesised directly from Ins 1,4,5-P3 and not from 
some other InsPP source (York et al., 1999). In Sz. pombe Ins-P6 production is 
probably carried out by a multifunctional kinase that is capable of 
phosphorylating the spare OH residues on the inositol ring of Ins 1,4,5-P3 
(Ongusaha et al., 1998). In S cerevisiae cells it appears that a multifunctional 
kinase phosphorylates Ins 1,4,5-P3 to Ins 1,3,4,5,6-P5, which is followed by Ins- 
P5 2-kinase, phosphorylating it into Ins-P6 (York et al., 1999). 
It has been demonstrated that S cerevisiae cells cultured under stressful 
conditions such as synthetic medium or high growth temperatures synthesise Ins- 
P6, which subsequently results in enhanced mRNA export (York et al., 1999). It 
is not fully understood how Ins-P6 promotes the export of mRNA but it has been 
suggested that Ins-P6 may be a positive regulator of GLE I -mediated mRNA 
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export (York et al., 1999). GLE I is an essential protein in the nuclear pore 
complex (NPQ that is required for mRNA export in both yeast and mammalian 
cells (Murphy and Wente, 1996). The NPC is an essential protein complex that 
spans the nuclear envelope allowing the selective cxchange of proteins, RNAs 
and ions (York et al., 1999). Conformational changes in the NPC induced by 
Ins-P6 regulating GLEI may facilitate the translocation of heterogeneous nuclear 
ribonucleoprotein complexes (Daneholt, 1998). Alternatively Ins-P6 may 
facilitate the removal of an export inhibitor resulting in mRNA export (Ohno et 
al., 1997). 
It has been demonstrated in S. cerevisae that InSP6 is produced directly from Ins 
1,4,5-P3 resulting from PIP2 hydrolysis by PLC I (York et al., 1999). If Sz. pombe 
cells use the same method of InSP6 production then the Plc I active site mutants 
described in chapter 7 could be used. The active site mutants were able to 
hydrolyse PI but not PIP2. These mutants may identify if InSP6 is only produced 
directly from Ins 1,4,5-P3 using the multifunctional kinase described by 
Ongusaha et al., (1998) or if there is an alternative pathway which can 
phosphorylate InSP6 from IP. Inositol polyphosphate production in Sz. Pombe 
cells could be identified using HPLC analysis that distinguishes between the 
different inositol polyphosphates produced within the cell. 
9.3.2 Plcl is part of a complex that is involved in UV resistance 
It has been illustrated that Plc I is responsible for resistance to UV irradiation but 
is not involved in the DNA damage checkpoint pathway in co-operation with 
Rad24 and Rad25 (Andoh et al., 1998). Rad24 and Rad25 are 14-3-3 proteins, 
which are necessary for cells to recover from DNA damage induced by UV 
irradiation (Ford et al., 1994). Immunoprecipitation techniques were used to 
confirm that the N-terminus but not the catalytic region of Plc I appeared to form 
a complex with the 14-3-3 proteins (Andoh et al., 1998). 
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in mammalian cells, UV irradiation causes oxidative stress rather than DNA 
damage. Oxidative stress initiates the signalling mechanism that results in the 
induction of genes encoding metal lothioniens. These work as scavengers of free 
radicals that appear to be the activator of the MAP kinase cascade (Devary et al., 
1992; 1993). Reports indicate that Sty I (also known as Phh I), an Sz. pombe 
MAP kinase, is activated by UV irradiation in a MAPKK-dependent manner. 
This is similar to the MAP kinase cascades that are activated in mammalian UV 
response (Degols and Russell, 1997). Since Pic I and Sty I appear to belong to 
the same epistasis group with reference to UV resistance, Pic I may therefore be a 
regulator of the MAP kinase cascade in the UV response pathway (Andoh et al., 
1998). 
9.3.3 DAG may stimulate PKC in Sz. pombe 
Mutations were introduced into the active site of Plc I so that these mutants were 
unable to hydrolyse PIP2 but still retained some ability to hydrolyse Pl. When 
expressed in ApIcl cells the active site mutants could suppress the loss of Plc I 
activity even on DMM plates incubated at 370C; normally a non-permissive 
growth condition. This suggested that DAG might be performing an important 
signalling function in Sz. pombe cells as the other second messenger Ins-P is 
probably recycled into phosphatidylinositols. In mammalian cells DAG is 
known to activate PKC and Sz. pombe has two PKC related genes named pck] 
and pck2. When a Apck2 Sz. pombe cell was created it displayed a distinct 
phenotype displaying irregular cell shapes such as small round cells or pear-like 
shapes and Apkc2 cells were unable to grow on minimal media (Toda et al., 
1993). A double disruptant of pck] and pck2 in a haploid cell is lethal suggesting 
that these genes together perform an essential function in maintaining cell 
viability (Toda et al., 1993). The pck2 disruptant cell displays a similar 
phenotype to Aplcl cells which suggests that they may be a part of the same 
signalling pathway which regulates cytokinesis, cell morphology and cell wall 
structure. 
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In mammalian cells PKCs are known to be connected to MAP kinase pathways 
(Marshall, 1995-, Li el al., 1996). In S. cerevisiae MPK I was identified as a 
kinase involved in cell wall integrity that worked downstream of the PKC 
homologue (Errede and Levin, 1993). The homologue of MPK I in Sz. pombe is 
PmkI and may interact with Pck1 and Pck2. Two models have been considered 
for the interaction of Pck I /Pck2 with Pmk I (Toda et al. , 1996). The first of these 
models is that if Pck I /Pck2 acts upstream of Pmk I then they must have a 
bifurcated role where one branch acts through Pmk I whereas the other is through 
an alternative pathway (Toda et al., 1996). This is because the double pckllpck2 
disruptant is lethal whereas cells lacking pmkl are viable. The second model is 
that Pmk I, Pck I and Pck2 pathways are related but they regulate different 
aspects of the pathway (Toda et al., 1996). If DAG does activate either Pck I or 
Pck2 which subsequently acts through the Pmkl MAP kinase cascade then a 
change in the phosphorylation states of the MAP kinase would be observed. This 
could be measured using assays described in Toda et al., (1996) and it could be 
determined from this how much involvement DAG has in this signalling 
pathway. 
This suggests that DAG produced as a result Of PIP2 or PI hydrolysis by Plc I 
may be sufficient to regulate this MAP kinase pathway which is involved in 
maintaining cell wall integrity, cytokinesis and cell morphology. Expression of 
Pck1 or Pck2 in Ap1c] cells may give an indication if they are part of the same 
pathway. Increased expression of Pck1 or Pck2 may suppress the loss of Plcl 
activity in ApIcl cells resulting in growth on DMM incubated at 370C. 
Elimination of one or more of these regulators in the pathway and the cells either 
display aberrant morphology or ultimately it could result in cell death. 
9.4 Summary 
Although the regulator of Plc I has not been identified, from the investigation of 
the N-terminal domain it seems reasonable to assume that this may play an 
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important role in regulating the enzyme's activity. Plc I without this domain had 
no detectable activity whereas wild-type rat PLC-6 which does not contain this 
domain had ten fold higher activity. When the N-terminal domain of Plci was 
added onto the N-terminus of PLC-6 the activity dropped by ten-fold, closely 
resembling wild-type Plc I activity levels. Assuming that the expression levels of 
the proteins are roughly the same this evidence suggests that a regulator might 
interact with this N-terminal domain controlling the activity of Plc I. 
A summary of the possible regulatory roles of Plc I in Sz. pombe can be seen in 
Figure 53. It demonstrates that external signals such as UV light, temperature 
and osmotic stress may lead to the activation of Plc I which hydrolyses PIP2 into 
the second messengers InSP3 and DAG. DAG in mammalian cells is known to 
activate PKC and in Sz. pombe two PKC homologues have been identified Pck I 
and Pck2 (Toda et al., 1993). Pmk1 is a MAP kinase that is involved in 
controlling cell structure and might be regulated by the activity of Pck2. 
Alternatively Pck1 or Pck2 may act independently of Pmk1 resulting in 
responses in cell morphology, cell wall integrity and cytokinesis (Toda et al., 
1996). Pck I or Pck2 may also regulate another MAP kinase cascade; it has been 
suggested that UV light activates a MAP kinase cascade through the activity of 
Plc I (Andoh et al., 1998). The MAP kinase cascade which includes the MAP 
kinase Styl (Phhl) which is known to respond to UV light and could be 
regulated through Plc I activity (Toda et al., 1996). 
The other second messenger produced from PIP2 hydrolysis is InSP3- It is 
believed that InsP6 is produced directly from InsP3, as ApIcl cells are unable to 
produce InSP6. Analysis of Sz. pombe or S. cerevisiae cells that are either placed 
under osmotic stress or are incubated at 370C have increased levels of InsP6 
(Ongusaha et al., 1998; York et al., 1999). Increased levels of InSP6 may 
activate GLE I an essential protein in the NPC that is required for mRNA export 
or InSP6 may remove an inhibitor of mRNA export in S. cerevisiae cells (York et 
al., 1999). Alternatively if InSP6 production is due to an osmotic response it 
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might activate the MAP kinase cascade containing Sty I as this is known to be 
associated with maintaining an osmotic balance. 
Obviously this speculation is based upon research performed on mammalian 
PLCs and on S. cerevisiae PLC 1, but there may be many alternative roles for the 
phosphatidylinositols (PI) and the inositol polyphosphates (InsPP) in Sz. pombe. 
The roles of Pls and lnsPPs were discussed in the general introduction but, 
briefly, they are known to regulate vesicle traffic such as endocytosis and 
exocytosis, bind cytoskeletal proteins such as gelsolin and profilin and lnsPPs are 
known to regulate cytosolic Ca 2+ concentration in cells. 
This demonstrates the complexities of PLC signalling not only in mammalian 
cells but also in simple eukaryotes such as yeast cells. In Sz. pombe cells it 
suggests that Plc I might regulate many pathways, which have not yet been 
identified, and suggests that small changes in Plc I activity may have exaggerated 
outcomes due to many pathways being influenced. Perhaps this explains why 
cells lacking Plc I activity need precise conditions for growth such as rich growth 
medium and growth temperatures below 290C. Any deviation from these 
conditions results in Sz. pombe cells being put under stress and eventually results 
in cellular death. 
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Figure 53 A summary of the possible Plcl responses in Sz. pombe 
I 
I 
MAPKKK 
? MAPKK 
(: Pý: MAPK 
cell morphology 
cytokinesis 
cell wall integrity 
A schematic diagram of an Sz. pombe cell which displays the external signals (red writing) 
which result in Plc I activation. Plc I hydrolyses PIP2 into the second messengers InSP3 and 
DAG. InSP6 is known to be produced from InSP3 in response to stress signals such as osmotic 
stress and increased temperature. InSP6 then either acts directly on GLE1 facilitating mRNA 
export or it removes export inhibitors this pathway was identified in S. cerevisiae. InSP6 is 
also produced in response to osmotic stress it may also have some regulatory influence on the 
MAP kinase cascade(dotted line) which regulates osmoregulation. In mammalian systems 
DAG is known to activate PKC, two PKC homologues have been identified in Sz. pombe 
(Pckl and Pck2) which may regulate the MAP kinase cascade that regulates cell morphology 
and cytokinesis. It is possible that Pckl, 2 may regulate cell wall integrity independently of the 
MAP kinase cascade(dotted line) As Plc I is required for UV resistance it may be possible that 
by activating Pckl, 2 through DAG it may activate the MAP kinase cascade (dotted line) 
known to be required for UV response, osmoregulation and stress responses. The 
? indicate 
kinases that have not been identified in the MAP kinase cascade. 
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Appendix 
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ATAGATGACCAAAGGTTTAATCTTACAAAGGAGTT 
MTESAIDDQRFNLTKEL 
51 ACAACGACACTCATGCAGAGATCAAGGGAAAATAACACAAAAGGATGATG 
18 QRHSCRDQGKITQKDD 
101 CTTTAGATTTTATAAGTTACAGTTCTTTTCAATCCTCTTTTAATACTGAC 
34 ALDFI SYS SFQS SFNTD 
151 CAAAAAAGCGCGAACAATGGAAGTACTGTGAGAAGAAGCATAAGGTCGAT 
51 QKSANNGSTVRRSIRSI 
201 TTTTAGAAGAGCAGCCGAATTGCCTAGAGTCCATATGGGGCCTCTTACTT 
68 FRRAAELPRVHMGPLT 
251 ATTCACATGGGATAAATGAGCTTGTTAACAAGAAATTAAGAAAAGACTGT 
84 YSHGINELVNKKLRKDC 
301 GATCTCAGCACGCTATGTCGCGTATTGCAAAGAGGAATCAGGATGATTAG 
101 DLSTLCRVLQRGIRMIR 
351 GATGACAAGAAGAAGAAGGAAGTTCTATGAATTTAAATTAATCAATAACA 
118 MT RRRRKFYE FKL INN 
401 ACGGGCAAATAATATGGAAAGATGGTTCGAAGTATCTGGAATTAGACTCC 
134 NGQIIWKDGSKYLELDS 
451 GTTAAAGACATCAGAATCGGTGATACGGCGAGTACTTATCAAGAGGAAGT 
151 VKDIRIGDTASTYQEEV 
501 AGATCCGAAAAGATTGAGATCGGACAGTAAACTTTGGATTGCTATTATTT 
168 DPKRLRSDSKLWIAII 
551 ATAAGGTTTCCAACAAATTGAAAGCGTTACACGTAGTTGCTTTGAATGAA 
184 YKVSNKLKALHVVALNE 
601 TTGGACTTTAACACATTCTTAAGCTGCATTTGCGGTTTAGTGAAGTTAAG 
201 LDFNTFLSCICGLVKLR 
651 GAGGGAATTAATGGAAAGCATACTTTTGCCTGATAATTCGCAATTCGCTA 
218 RELMESILLPDNSQFA 
701 GGATACATTGGCAAATTACTGTTTCTGAAAAAGAGGAAGATGAGAAAAAG 
234 RIHWQITVSEKEEDEKK 
751 GACACATTGAGCTTTGCAGATGTGAAGAAACTATGTGATAAATTTCATAT 
251 DTLSFADVKKLCDKFHI 
801 TTATGTGTCAACTGGTCAATTGTTAGAGTTTTTCCAATTAGCAGACATCA 
268 YVSTGQLLEFFQLADI 
851 ATCATAACGGACTATTAAATTATTTTGAATTTGAAAAGTTCATTAAAATC 
284 NHNGLLNYFEFEKFIKI 
901 TTAAAGAATAGGAAAGAGGTAAATATGATTTGGTCTAAATTTACAAAACC 
301 LKNRKEVNMIWSKFTKP 
951 TCCACACTCCCACTTATCATTTGAAAATTTTTTTCAATTTTTAATTACAG 
318 PHSHLSFENFFQFLIT 
1001 AGCAGCATGAGCAAGTGGATCGTCAAACTGCATGGTCATATTTTATTAAG 
334 EQHEQVDRQTAWSYFIK 
1051 TACAGAGAACCGACTCAGCTGACGATGGGGCAAGATGGTTTTACCAAGTT 
351 YREPTQLTMGQDGFTKF 
1101 CTTGAAGGAGCAACCATATTTGGTGGAGGTTAAAGAGGAGTTATATTCAA 
368 LKE Q PYLVEVKEE LYS 
1151 AGCCATTAAACCATTATTTTATTGCATCTTCACATAATACTTATTTATTG 
384 KPLNHYFIASSHNTYLL 
1201 GGGAAACAAATTGCAGAAACTCCATCTGTGGAGGGATATATTCAAGTCCT 
401 GKQIAETPSVEGYIQVL 
1251 ACAACAAGGTTGTAGGTGCGTAGAAATTGATATATGGGATGGTGAAAATG 
418 QQGCRCVEIDIWDGEN 
1301 GGCCAGTGGTATGCCATGGATTTTTAACGTCAGCTATTCCCTTAAAAACA 
434 GPVVCHGFLTSAIPLKT 
1351 GTTATACGCGTGATAAAGAAGTACGCTTTTATAACGTCTCCGTATCCTTT 
451 VIRVIKKYAFITSPYPL 
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1401 GATTATTTCACTGGAAATAAACTGTAACAAGGATAATCAAAAATTGGCAA 
468 11SLEINCNKDNQKLA 
1451 GCCTGATAATGAGAGAGGTTTTAGCAGAACAGCTGTACTTTGTTGGCACA 
484 SLIMREVLAEQLYFVGT 
1501 AGAACTGATAAACTGCCATCACCAAGGGAATTAAAACATAAAATACTGTT 
501 RTDKLPSPRELKHKILL 
1551 GAAATCCAAGAAGACGAGTGAAGCAACTAGAGGTCTTAGCGTTAATGAGC 
518 KSKKTSEATRGLSVNE 
1601 CATTTCCATCTTCTTTTAGTTCTTCTTACGAATCAGCTAATGAACAGGAA 
534 PFPSSFSSSYESANEQE 
1651 TTAAGAATGAAAGATGACTCCACGAACAGTAGTAGCGCAACAAATTCTTC 
551 LRMKDDSTNSSSATNSS 
1701 TAGTATGCAACGCATCAAAAGAATTGGATTAAAAAAGCACGCTGATATAA 
568 SMQRIKRIGLKKHADI 
1751 TTAATGATGTTTCTAACATTTCTGGAATACATGGCATCAAGTTCAGGAAT 
584 1NDVSNISGIHGIKFRN 
1801 TTCTCTTTACCAGAGTCCAAAACGATAGCGCATTGTTTTTCACTGAATGA 
601 FSLPESKTIAHCFSLNE 
1851 GCGCAAAGTAGAATACATGATAAAAGACAAACACTTAAAATTATCGTTGG 
618 RKVEYMIKDKHLKLSL 
1901 ATAAACATAATAGAAGATATTTGATGAGAGTCTATCCTCACGTTTTACGA 
634 DKHNRRYLMRVYPHVLR 
1951 TACAAATCATCAAATTTTAACCCAATACCTTTTTGGAAGGCCGGTGTACA 
651 YKSSNFNPIPFWKAGVQ 
2001 AATGGTGGCTACGAATTGGCAAACTAATGATATTGGACAGCAACTTAATC 
618 MVATNWQTNDIGQQLN 
2051 TGGCAATGTTTCAAATATTAGATCACCAACCTGATGGAAGTTTTAAATCA 
684 LAMFQILDHQPDGSFKS 
2101 GGATACGTGCTAAAACCAAAAAAGTTGCTACCTGTAGTAACAAAGGCGAA 
701 GYVLKPKKLLPVVTKAK 
2151 AATGATTCCATTAATTTACGAACATTTTGAAAATGGTAGTGATCCTGTTA 
718 MIPLIYEHFENGSDPV 
2201 CTGTTAAAATTCGAATTTTATCTACACAGTTATTGCCCAGATTGAATGAT 
734 TVKIRILSTQLLPRLND 
2251 ACATCGCCAAGCAGAAATAACACCAATTCCTTTGTTAAAGTGGAGTTTCA 
751 TSPSRNNTNSFVKVEFH 
2301 TACCGATGACGAGCCGACAATGCCCATCTCAATCGATAAGGGTACAAGGA 
768 TDDEPTMPISIDKGTR 
2351 TTTCTGCCACTGAAGCATCCACTAAGAGTTCTCAAGGGAATGGATTCAAC 
784 1SATEASTKSSQGMGFN 
2401 CCAATATGGGATGCTGAAGTTTCTATCACATTGAAAGATACAGACCTCAC 
801 PIWDAEVSITLKDTDLT 
2451 ATTTATAAAATTCATGGTTATCTCTGAAGAGACCCAGATTGCATCTGTTT 
818 FIKFMVISEETQIASV 
2501 GCCTTAAGCTGAACTATTTGAGGATGGGATATCGTCACATTCCGTTGTTT 
834 CLKLNYLRMGYRHIPLF 
2551 AACATGGAGGGGGAACAATACATATTTTGCACTTTATTTATTCATACACA 
851 NMEGEYIFCTLFIHT 
2601 AATTTTATAG 
868 1Lo 
Sequence of p1c] 
The amino acid sequence of the p1c] gene. The gene was predicted 
to encode a 
sequence of 869 amino acids. Numbering of the nucleotide sequence 
and 
amino acids are from the start of the plcl 
ORF. 
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Oligonucleotides for the sequencing of plcl 
Primer (5' to Y) Direction Position 
Relative to p1c] relative to 
open reading frame p1c] ATG 
J0208 CCGCTAACGAATCAGTTC Sense 1698-1705 
J0213 GCCACATATTCTCATTT Sense 1985-2001 
J0218 CATATCTGGGCAACAAC Sense 2322-2339 
J0224 CTTATTTACTAGGTAAG Sense 1373-1384 
J0300 GGTGCGCCAACGTAAAGTC Sense 534-552 
J0318 CGTCGCCTGAATCGGTC Sense 20-36 
J0319 CGTAAACGATCAAATTC Sense 232-249 
J0321 GATTATGGCTTTAGAAG Sense 792-808 
J0322 TCAGCATTTTGTAAGCC Sense 1065-1081 
J0324 GGCTATAGACATATTCG Sense 2611-2627 
J0204 CCATTCGGTCCATCCCAGC Antisense 1484-1466 
J0219 AGTGCTGTAATGGACAC Antisense 2723-2707 
J0220 GAGAAGTTGATAGAAAGTGACG Antisense 1183-1162 
J0221 CGGTAACGGGTTTCATC Antisense 1690-1674 
J0222 GAATATGTGGCTATACG Antisense 1995-1979 
J0223 GGAAGTCCTTCTTCGCC Antisense 2294-2278 
J0299 CTATCGCATGAGTAAGGG Antisense 410-393 
J0301 CCAACTGTGCACTTTGCTCC Antisense 943-924 
J0306 CCTATTGCCAACATATGG Antisense 165-147 
J0320 CGAGCATCGCGGCCCTG Antisense 662-646 
J0323 GTCATCACTAATTATAC Antisense 
2511-2495 
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Oligonucleotides for the PCR amplification of p1d 
Primer 
J0508 TCGCTACAGCGTtctTGCAAGTGTATTGAAATC 
J0509 TTCAATACACTTGCAagaACGCTGTAGCGAACG 
J0512 CTGCAACAAGGCTATtgtCATATTCGTTTATTGG 
J0513 ATCCAATAAACGAATATGtgtATAGCCTTGTTGCAG 
J0514ggatcccaccatgcatcatcatcatcatcatGGCGGCAATTGTGAAATGGTAAC 
GTCG 
J0515 gggat ccaat gga ca cagcgt t ct agat gatgat gat gattagGGCCGCC 
AATGTCTT 
J0594 a at a gat at cat aATGAGCTCGGTGAATCAAAACTTTA 
J0622 gggggatccCTACACCGAGCTCAGAGTAGATAAG 
J0750 ACACAAATAGC GTAAAT TAT G 
J0751 aaaGTATACCCTGGCCCATTG 
J0752 ttaGTATACCCTGGCCCATTG 
J0754 GACTTGTTTTAAAACGAC 
J0755 cgtGTCAAATGTTCAGCAACACC 
J0756 gctGTCAAATGTTCAGCAACACC 
Oligonucleotides for the PCR amplification of Rat PLC-6 
Primer 
J0548 gggggatatcataATGGACTCGGGTAGGGACTTCCTGACCC 
J0549 gggggatatcagcgttTTAGTCCTGGATGGAGATCTTCAC 
J01068 GAATAGATGAGACTCGAGC 
J01069 GGTAGGGACTTCCTGACC 
A list of oligonucleotide PCR primers used within this study. Nucleotides shown 
in capital text indicate sequence shared with the p1c] gene. Nucleotides shown 
in 
lower case indicate sequence not found within the p1c] gene. 
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3000 
0 
C) 
C 
CD 
2000 
1000 
0 
Time (min) 
Determining the rate of production of InSP3 
4 OC 
15 OC 
23 OC 
30 OC 
37 oC 
42 oC 
-----4- 50 oC 
An example of a graph from which the rate of InsP3 was calculated. Extracts 
were prepared from Sz. pombe cells expressing Plc I (see Section 2.2.2.1) 
and samples were assayed at various temperatures using the scintillation 
counter method (see Section 2.2.2.2). The production of InSP3 is linear over 
a period of 20 min, so the rate could be calculated (see overleaf for 
calculations associated with this graph). 
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10 20 
An example of the calculations taken form the linear plots of the graph shown on 
the previous page. They demonstrate how the rates of InSP3 production were 
calculated. All rates shown in this thesis were calculated in the same way. 
Calculations: 
For 40C 
After 0 min incubation: 
After 20 min incubation: 
302-96= 206 cpm 20min-1 
206 / 20=10.3 cpm min-' 
96 cpm. produced 
302 cpm produced 
I mg protein extract incubated per assay 
10.3 / 1= 10.3 cpm min-' mg protein- I 
I cpm ==I 10 fmoles of InSP3 produced 
10.3xllO= 1133 fmoles of InsP3 produced min-' 
I 
mg protein 
or 1.133 pmoles of InSP3 produced min- mgprotein-1 
For 150C 
After 0 min incubation: 
After 20 min incubation: 
1299-96= 1203 cpm 20min-1 
1203 / 20= 60.2 cpm min-' 
96 cpm produced 
1299 cpm produced 
I mg protein extract incubated per assay 
60.2 / 1= 60.2 cpm min-' mg protein-' 
I cpm =I 10 Emoles of InSP3 produced 1 -1 60.2 xI 10 6622 fmoles of InSP3 produced min- mg protein 
or 6.622 pmoles of InSP3 produced min- 
I mg protein - 
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For 23'C 
After 0 min incubation: 
After 20 min incubation: 
2014-104= 1910 cpm 20min-1 
1910 / 20= 95.5 cpm min-' 
104 cpm produced 
"0 14 cpm Produced 
I mg protein extract incubated per assay 
95.5 / 1= 95.5 cpm min-' mg protein- I 
I cpm. =I 10 fmoles of InsP3 produced 
95.5 x 110 10,505 fmoles of InSP3 produced min-' 
I 
mg protein-' 
or 10.505 pmoles of InSP3 produced min- mg protein-' 
For 30'C 
After 0 min incubation: 
After 20 min incubation: 
2698-102= 2596 cpm 20min- 
2596 / 20= 129.8 cpm min- I 
102 cpm produced 
2698 cpm produced 
I mg protein extract incubated per assay 
1 129.8 / 1= 129.8 cpm min-' mg protein- 
I cpm. =I 10 fmoles of InSP3 produced 
129.8 xI 10 = 14,278 fmoles of InsP3 produced min-' mg protein-' 
or 14.278 pmoles of InsP3 produced min-' mg protein-' 
For 370C 
After 0 min incubation: 
After 20 min incubation: 
11 95-83= 1112 cpm 20min-1 
1112 / 20= 55.6 cpm min -1 
83 cpm produced 
1195 cpm produced 
I mg protein extract incubated per assay 
5 5.6 /I=55.6 cpm min- 1 mg protein- 
1 
I cpm =I 10 fmoles of InsP3 produced -1 1 55.6 xI 10 6,116 fmoles of InsP3 produced min mg 
protein- 
or 6.116 pmoles of 
InsP3 producect min mg proLun, 
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For 42'C 
After 0 min incubation: 
After 20 min incubation: 
83 cpm produced 
720 cpm produced 
720-83= 637 cpm 20min-1 
637 / 20= 32 cpm min- I 
I mg protein extract incubated per assay 
32 / 1= 32 cpm min- I mg protein-' 
i cpm =I 10 fmoles of InsP3 produced 
32 x 110 3,520 fmoles of InSP3 produced min- mg protein- 
or 3.520 pmoles of InSP3 produced mid' mg protein- 
For 50'C 
After 0 min incubation: 
After 20 min incubation: 
127 cpm produced 
487 cpm produced 
487-127= 360 cpm 20min- 
360 / 20= 18 cpm min-' 
I mg protein extract incubated per assay 
18 /I= 18 cpm min- 1 mg protein- I 
I cpm =I 10 fmoles of InSP3 produced 
.1 -1 18X 110= 1 980 fmoles of InSP3 produced min- mg protein 
or 1.980 pmoles of InSP3 produced min-' mg protein-' 
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